TNF-.alpha. ribozymes

Abstract

Enzymatic RNA molecules which cleave TNF-.alpha. mRNA.

Description

FIELD OF THE INVENTION

The present invention relates to therapeutic compositions and methods for the treatment or diagnosis of diseases or conditions related to TNF-.alpha. levels, such as septic shock, rheumatoid arthritis, HIV and AIDS, psoriasis, inflammatory or autoimmune disorders.

BACKGROUND OF THE INVENTION

The following is a brief description of the physiological role of TNF-.alpha.. The discussion is not meant to be complete and is provided only for understanding of the invention that follows. This summary is not an admission that any of the work described below is prior art to the claimed invention.

The identification and cloning of the cytokines have provided a wealth of data on endogenous immunological and inflammatory mediators and their role in host defense against infection (van Deuren et al., 1992 J. Pathol. 168, 349-356). Cytokines also have been associated with pathology due to over-expression or inappropriate production. Cytokine cascades are implicated in the tissue damage that occurs during gram negative septic shock (Parrillo, 1993 N. Engl. J. Med. 328, 1471-1477), in the joint inflammation and tissue destruction that occurs during rheumatoid arthritis (Harris, 1990 N. Engl. J. Med. 322, 1277), and in a positive feedback loop between cytokine production and the replication of human immunodeficiency virus (HIV) (Fauci, 1990 Lymphokine Res. 9, 527-531). A common thread interweaving these pathological conditions is their association with abnormally high levels of the proinflammatory cytokine tumor necrosis factor-.alpha. (TNF-.alpha.).

Tumor necrosis factor-.alpha. (TNF-.alpha.) is a protein, secreted by activated leukocytes, that is a potent mediator of inflammatory reactions. Injection of TNF-.alpha. into experimental animals can simulate the symptoms of systemic and local inflammatory diseases such as septic shock or rheumatoid arthritis.

TNF-.alpha. was initially described as a factor secreted by activated macrophages which mediates the destruction of solid tumors in mice (Old, 1985 Science 230, 4225-4231). TNF-.alpha. subsequently was found to be identical to cachectin, an agent responsible for the weight loss and wasting syndrome associated with tumors and chronic infections (Beutler, et al., 1985 Nature 316, 552-554). The cDNA and the genomic locus for TNF-.alpha. have been cloned and found to be related to TNF-.beta. (Shakhov et al., 1990 J. Exp. Med. 171, 35-47). Both TNF-.alpha. and TNF-.beta. bind to the same receptors and have nearly identical biological activities. The two TNF receptors have been found on most cell types examined (Smith, et al., 1990 Science 248, 1019-1023). TNF-.alpha. secretion has been detected from monocytes/macrophages, CD4+ and CD8+ T-cells, B-cells, lymphokine activated killer cells, neutrophils, astrocytes, endothelial cells, smooth muscle cells, as well as various non-hematopoietic tumor cell lines ( for a review see Turestskaya et al., 1991 in Tumor Necrosis Factor: Structure, Function, and Mechanism of Action B. B. Aggarwal, J. Vilcek, Eds. Marcel Dekker, Inc., pp. 35-60). TNF-.alpha. is regulated transcriptionally and translationally, and requires proteolytic processing at the plasma membrane in order to be secreted (Kriegler et al., 1988 Cell 53, 45-53). Once secreted, the serum half life of TNF-.alpha. is approximately 30 minutes. The tight regulation of TNF-.alpha. is important due to the extreme toxicity of this cytokine. Increasing evidence indicates that overproduction of TNF-.alpha. during infections can lead to severe systemic toxicity and death (Tracey & Cerami, 1992 Am. J. Trop. Med. Hyg. 47, 2-7).

Antisense RNA and Hammerhead ribozymes have been used in an attempt to lower the expression level of TNF-.alpha. by targeting specified cleavage sites �Sioud et al., 1992 J. Mol. Biol. 223; 831; Sioud WO 94/10301; Kisich and co-workers, 1990 abstract (FASEB J. 4, A1860; 1991 slide presentation (J. Leukocyte Biol. sup. 2, 70); December, 1992 poster presentation at Anti-HIV Therapeutics Conference in SanDiego, Calif.; and "Development of anti-TNF-.alpha. ribozymes for the control of TNF-.alpha. gene expression"--Kisich, Doctoral Dissertation, 1993 University of California, Davis! listing various TNF.alpha. targeted ribozymes.

SUMMARY OF THE INVENTION

This invention relates to ribozymes, or enzymatic RNA molecules, directed to cleave mRNA species encoding specific sites in TNF-.alpha.. In particular, applicant describes the selection and function of ribozymes capable of cleaving this RNA and their use to reduce activity of TNF-.alpha. in various tissues to treat the diseases discussed herein. Such ribozymes are also useful for diagnostic applications.

Ribozymes that cleave the specified cites in TNF-.alpha. mRNA represent a novel therapeutic approach to inflammatory or autoimmune disorders. Applicant indicates that ribozymes are able to inhibit the activity of TNF-.alpha. and that the catalytic activity of the ribozymes is required for their inhibitory effect. Those of ordinary skill in the art, will find that it is clear from the examples described that other ribozymes that cleave these sites in TNF-.alpha. encoding mRNAs may be readily designed and are within the invention.

Six basic varieties of naturally-occurring enzymatic RNAs are known presently. Each can catalyze the hydrolysis of RNA phosphodiester bonds in trans (and thus can cleave other RNA molecules) under physiological conditions. Table I summarizes some of the characteristics of these ribozymes. In general, enzymatic nucleic acids act by first binding to a target RNA. Such binding occurs through the target binding portion of a enzymatic nucleic acid which is held in close proximity to an enzymatic portion of the molecule that acts to cleave the target RNA. Thus, the enzymatic nucleic acid first recognizes and then binds a target RNA through complementary base-pairing, and once bound to the correct site, acts enzymatically to cut the target RNA. Strategic cleavage of such a target RNA will destroy its ability to direct synthesis of an encoded protein. After an enzymatic nucleic acid has bound and cleaved its RNA target, it is released from that RNA to search for another target and can repeatedly bind and cleave new targets.

The enzymatic nature of a ribozyme is advantageous over other technologies, such as antisense technology (where a nucleic acid molecule simply binds to a nucleic acid target to block its translation) since the concentration of ribozyme necessary to affect a therapeutic treatment is lower than that of an antisense oligonucleotide. This advantage reflects the ability of the ribozyme to act enzymatically. Thus, a single ribozyme molecule is able to cleave many molecules of target RNA. In addition, the ribozyme is a highly specific inhibitor, with the specificity of inhibition depending not only on the base pairing mechanism of binding to the target RNA, but also on the mechanism of target RNA cleavage. Single mismatches, or base-substitutions, near the site of cleavage can completely eliminate catalytic activity of a ribozyme. Similar mismatches in antisense molecules do not prevent their action (Woolf, T. M., et al., 1992, Proc. Natl. Acad. Sci. USA, 89, 7305-7309). Thus, the specificity of action of a ribozyme is greater than that of an antisense oligonucleotide binding the same RNA site.

In preferred embodiments of this invention, the enzymatic nucleic acid molecule is formed in a hammerhead or hairpin motif, but may also be formed in the motif of a hepatitis delta virus, group I intron or RNaseP RNA (in association with an RNA guide sequence) or Neurospora VS RNA. Examples of such hammerhead motifs are described by Rossi et al., 1992, Aids Research and Human Retroviruses 8, 183, of hairpin motifs by Hampel et al., "RNA Catalyst for Cleaving Specific RNA Sequences," filed Sep. 20, 1989, which is a continuation-in-part of U.S. Ser. No. 07/247,100 filed Sep. 20, 1988, Hampel and Tritz, 1989 Biochemistry 28, 4929, and Hampel et al., 1990 Nucleic Acids Res. 18, 299, and an example of the hepatitis delta virus motif is described by Perrotta and Been, 1992 Biochemistry 31, 16; of the RNaseP motif by Guerrier-Takada et al., 1983 Cell 35, 849, Neurospora VS RNA ribozyme motif is described by Collins (Saville and Collins, 1990 Cell 61, 685-696; Saville and Collins, 1991 Proc. Natl. Acad. Sci. USA 88, 8826-8830; Collins and Olive, 1993 Biochemistry 32, 2795-2799) and of the Group I intron by Cech et al., U.S. Pat. No. 4,987,071. These specific motifs are not limiting in the invention and those skilled in the art will recognize that all that is important in an enzymatic nucleic acid molecule of this invention is that it has a specific substrate binding site which is complementary to one or more of the target gene RNA regions, and that it have nucleotide sequences within or surrounding that substrate binding site which impart an RNA cleaving activity to the molecule.

The invention provides a method for producing a class of enzymatic cleaving agents which exhibit a high degree of specificity for the RNA of a desired target. The enzymatic nucleic acid molecule is preferably targeted to a highly conserved sequence region of a target TNF-.alpha. encoding mRNA such that specific treatment of a disease or condition can be provided with either one or several enzymatic nucleic acids. Such enzymatic nucleic acid molecules can be delivered exogenously to specific cells as required. Alternatively, the ribozymes can be expressed from DNA vectors that are delivered to specific cells.

Synthesis of nucleic acids greater than 100 nucleotides in length is difficult using automated methods, and the therapeutic cost of such molecules is prohibitive. In this invention, small enzymatic nucleic acid motifs (e.g., of the hammerhead or the hairpin structure) are used for exogenous delivery. The simple structure of these molecules increases the ability of the enzymatic nucleic acid to invade targeted regions of the mRNA structure. However, these catalytic RNA molecules can also be expressed within cells from eucaryotic promoters (e.g., Scanlon et al., 1991, Proc. Natl. Acad. Sci. USA, 88, 10591-5; Kashani-Sabet et al., 1992 Antisense Res. Dev., 2, 3-15; Dropulic et al., 1992 J. Virol, 66, 1432-41; Weerasinghe et al., 1991 J. Virol, 65, 5531-4; Ojwang et al., 1992 Proc. Natl. Acad. Sci. USA 89, 10802-6; Chen et al., 1992 Nucleic Acids Res., 20, 4581-9; Sarver et al., 1990 Science 247, 1222-1225). Those skilled in the art realize that any ribozyme can be expressed in eucaryotic cells from the appropriate DNA vector. The activity of such ribozymes can be augmented by their release from the primary transcript by a second ribozyme (Draper et al., PCT WO 93/23569, and Sullivan et al., PCT WO94/02595, both hereby incorporated in their totality by reference herein; Ohkawa et al., 1992 Nucleic Acids Symp. Ser., 27, 15-6; Taira et al., 1991, Nucleic Acids Res., 19, 5125-30; Ventura et al., 1993 Nucleic Acids Res., 21, 3249-55).

Inflammatory mediators such as lipopolysaccharide (LPS), interleukin-1 (IL-1) or tumor necrosis factor-a (TNF-.alpha.) act on cells by inducing transcription of a number of secondary mediators, including other cytokines and adhesion molecules. Ribozyme therapy, due to its exquisite specificity, is particularly well-suited to target intracellular factors that contribute to disease pathology. Thus, ribozymes that cleave the mRNA sites encoded by TNF-.alpha. may represent novel therapeutics for the treatment of inflammatory and autoimmune disorders.

Thus, in a first aspect, the invention features ribozymes that inhibit TNF-.alpha. production by cleavage at designated sites in TNF-.alpha. encoding mRNA. These chemically or enzymatically synthesized RNA molecules contain substrate binding domains that bind to accessible regions of their target mRNAs. The RNA molecules also contain domains that catalyze the cleavage of RNA. The RNA molecules are preferably ribozymes of the hammerhead or hairpin motif. Upon binding, the ribozymes cleave the target TNF-.alpha. encoding mRNAs, preventing translation and TNF-.alpha. protein accumulation. In the absence of the expression of the target gene, a therapeutic effect may be observed.

By "inhibit" is meant that the activity or level of TNF-.alpha. encoding mRNA is reduced below that observed in the absence of the ribozyme, and preferably is below that level observed in the presence of an inactive RNA molecule able to bind to the same site on the mRNA, but unable to cleave that RNA.

Such ribozymes are useful for the prevention of the diseases and conditions discussed above, and any other diseases or conditions that are related to the level of TNF-.alpha. activity in a cell or tissue. By "related" is meant that the inhibition of TNF-.alpha. mRNA and thus reduction in the level of TNF-.alpha. activity will relieve to some extent the symptoms of the disease or condition.

Ribozymes are added directly, or can be complexed with cationic lipids, packaged within liposomes, or otherwise delivered to target cells. The RNA or RNA complexes can be locally administered to relevant tissues ex vivo, or in vivo through injection, infusion pump or stent, with or without their incorporation in biopolymers. In preferred embodiments, the ribozymes have binding arms which are complementary to the sequences in Tables II, IV, VI-VII. Examples of such ribozymes are shown in Tables III, V-VII. Examples of such ribozymes consist essentially of sequences defined in these Tables. By "consists essentially of" is meant that the active ribozyme contains an enzymatic center equivalent to those in the examples, and binding arms able to bind mRNA such that cleavage at the target site occurs. Other sequences may be present which do not interfere with such cleavage.

In another aspect of the invention, ribozymes that cleave target molecules and inhibit TNF-.alpha. activity are expressed from transcription units inserted into DNA, RNA, or viral vectors. Preferably, the recombinant vectors capable of expressing the ribozymes are locally delivered as described above, and transiently persist in target cells. Once expressed, the ribozymes cleave the target mRNA. The recombinant vectors are preferably DNA plasmids or adenovirus vectors. However, other mammalian cell vectors that direct the expression of RNA may be used for this purpose.

Other features and advantages of the invention will be apparent from the following description of the preferred embodiments thereof, and from the claims.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

The drawings will first briefly be described.

Drawings:

FIG. 1 is a diagrammatic representation of the hammerhead ribozyme domain known in the art. Stem II can be .gtoreq.2 base-pair long, or can even lack base pairs and consist of a loop region.

FIG. 2a is a diagrammatic representation of the hammerhead ribozyme domain known in the art; FIG. 2b is a diagrammatic representation of the hammerhead ribozyme as divided by Uhlenbeck (1987, Nature, 327, 596-600) into a substrate and enzyme portion; FIG. 2c is a similar diagram showing the hammerhead divided by Haseloff and Gerlach (1988, Nature, 334, 585-591) into two portions; and FIG. 2d is a similar diagram showing the hammerhead divided by Jeffries and Symons (1989, Nucl. Acids. Res., 17, 1371-1371) into two portions.

FIG. 3 is a representation of the general structure of the hairpin ribozyme domain known in the art. H, is A, U or C. Y is U or C. N is A, U, G, or C. N' is the complementary sequence of N. Helix 4 can be .gtoreq.2 base-pair long.

FIG. 4 is a representation of the general structure of the hepatitis delta virus ribozyme domain known in the art.

FIG. 5 is a representation of the general structure of the VS RNA ribozyme domain.

FIG. 6 is a schematic representation of an RNAseH accessibility assay. Specifically, the left side of FIG. 6 is a diagram of complementary DNA oligonucleotides bound to accessible sites on the target RNA. Complementary DNA oligonucleotides are represented by broad lines labeled A, B, and C. Target RNA is represented by the thin, twisted line. The right side of FIG. 6 is a schematic of a gel separation of uncut target RNA from a cleaved target RNA. Detection of target RNA is by autoradiography of body-labeled, T7 transcript. The bands common to each lane represent uncleaved target RNA; the bands unique to each lane represent the cleaved products.

FIG. 7 schematic representation of hairpin ribozymes targeted against sites in TNF-.alpha. mRNA. Helix1 and Helix2 represents intermolecular helices formed between ribozyme and the target RNA. Helix3 and Helix4 represents intramolecular helices within the ribozyme. The arrow indicates the site of cleavage. Circled nucleotides are mutations that render the ribozyme catalytically inactive. A) Structure of the hairpin ribozyme.substrate complex for site 1393 in mouse TNF-.alpha. mRNA. B) Structure of the hairpin ribozyme.multidot.substrate complex for site 1435 in mouse TNF-.alpha. mRNA.

FIG. 8 shows the 1393 hairpin ribozyme-mediated inhibition of TNF-.alpha. expression in mouse macrophages.

FIG. 9 shows the 1435 hairpin ribozyme-mediated inhibition of TNF-.alpha. expression in mouse macrophages.

Ribozymes

Ribozymes of this invention block to some extent TNF-.alpha. expression and can be used to treat disease or diagnose such disease. Ribozymes will be delivered to cells in culture and to cells or tissues in animal models of septic shock and rheumatoid arthritis. Ribozyme cleavage of TNF-.alpha. mRNA in these systems may prevent inflammatory cell function and alleviate disease symptoms.

Target sites

Targets for useful ribozymes can be determined as disclosed in Draper et al supra. Sullivan et al., supra, as well as by Draper et al., "Method and reagent for treatment of arthritic conditions" U.S. Ser. No. 08/152,487, filed Nov. 12, 1993, and hereby incorporated by reference herein in totality. Rather than repeat the guidance provided in those documents here, below are provided specific examples of such methods, not limiting to those in the art. Ribozymes to such targets are designed as described in those applications and synthesized to be tested in vitro and in vivo, as also described. Such ribozymes can also be optimized and delivered as described therein. While specific examples to mouse and human RNA are provided, those in the art will recognize that the equivalent human RNA targets described can be used as described below. Thus, the same target may be used, but binding arms suitable for targeting human RNA sequences are present in the ribozyme. Such targets may also be selected as described below.

The sequence of human and mouse TNF-.alpha. mRNA can be screened for accessible sites using a computer folding algorithm. Hammerhead or hairpin ribozyme cleavage sites were identified. These sites are shown in Tables II, IV, and VI-VII. (All sequences are 5' to 3' in the tables.) While mouse and human sequences can be screened and ribozymes thereafter designed, the human targeted sequences are of most utility. However, as discussed in Stinchcomb et al., "Method and Composition for Treatment of Restenosis and Cancer Using Ribozymes," filed May 18, 1994, U.S. Ser. No. 08/245,466,(and hereby incorporated herein by reference), mouse targeted ribozymes are useful to test efficacy of action of the ribozyme prior to testing in humans. The nucleotide base position is noted in the Tables as that site to be cleaved by the designated type of ribozyme. (In Table III, lower case letters indicate positions that are not conserved between the human and the mouse TNF-.alpha. sequences.)

Hammerhead ribozymes are designed that could bind and are individually analyzed by computer folding (Jaeger et al., 1989 Proc. Natl. Acad. Sci. USA, 86, 7706-7710) to assess whether the ribozyme sequences fold into the appropriate secondary structure. Those ribozymes with unfavorable intramolecular interactions between the binding arms and the catalytic core are eliminated from consideration. Varying binding arm lengths can be chosen to optimize activity. Generally, at least 5 bases on each arm are able to bind to, or otherwise interact with, the target RNA.

Referring to FIG. 6, mRNA is screened for accessible cleavage sites by the method described generally in McSwiggen, U.S. patent application Ser. No. 07/883,849 filed on May 1, 1992, entitled "Assay for ribozyme target site", hereby incorporated by reference herein. Briefly, DNA oligonucleotides representing potential hammerhead or hairpin ribozyme cleavage sites are synthesized. A polymerase chain reaction is used to generate a substrate for T7 RNA polymerase transcription from human or murine TNF-.alpha. cDNA clones. Labeled RNA transcripts are synthesized in vitro from the two templates. The oligonucleotides and the labeled transcripts are annealed, RNAseH is added and the mixtures are incubated for the designated times at 37.degree. C. Reactions are stopped and RNA separated on sequencing polyacrylamide gels. The percentage of the substrate cleaved is determined by autoradiographic quantitation using a Phosphor Imaging system. From these data, hammerhead or hairpin ribozyme sites are chosen as the most accessible.

Ribozymes of the hammerhead or hairpin motif are designed to anneal to various sites in the mRNA message. The binding arms are complementary to the target site sequences described above. The ribozymes are chemically synthesized. The method of synthesis used follows the procedure for normal RNA synthesis as described in Usman et al., 1987 J. Am. Chem. Soc.. 109, 7845-7854 and in Scaringe et al., 1990 Nucleic Acids Res.. 18, 5433-5441 and makes use of common nucleic acid protecting and coupling groups, such as dimethoxytrityl at the 5'-end, and phosphoramidites at the 3'-end. The average stepwise coupling yields were >98%. Inactive ribozymes were synthesized by substituting a U for G.sub.5 and a U for A.sub.14 (numbering from Hertel et al., 1992 Nucleic Acids Res., 20, 3252). Hairpin ribozymes are synthesized in two parts and annealed to reconstruct the active ribozyme (Chowrira and Burke, 1992 Nucleic Acids Res., 20, 2835-2840). Hairpin ribozymes are also synthesized from DNA templates using bacteriophage T7 RNA polymerase (Milligan and Uhlenbeck, 1989, Methods Enzymol. 180, 51). All ribozymes are modified to enhance stability by modification of five ribonucleotides at both the 5' and 3' ends with 2'-O-methyl groups. Ribozymes are purified by gel electrophoresis using general methods or are purified by high pressure liquid chromatography (HPLC; See Usman et al., Synthesis, deprotection, analysis and purification of RNA and ribozymes, filed May, 18, 1994, U.S. Ser. No. 08/245,736 the totality of which is hereby incorporated herein by reference) and are resuspended in water.

The sequences of the chemically synthesized ribozymes useful in this study are shown in Tables III, V-VII. Those in the art will recognize that these sequences are representative only of many more such sequences where the enzymatic portion of the ribozyme (all but the binding arms) is altered to affect activity. For example, stem-loop 11 sequence of hammerhead ribozymes listed in Tables III and V (5'-GGCCGAAAGGCC-3') can be altered (substitution, deletion, and/or insertion) to contain any sequences provided a minimum of two base-paired stem structure can form. Similarly, stem-loop IV sequence of hairpin ribozymes listed in Tables VI and VII (5'-CACGUUGUG-3') can be altered (substitution, deletion, and/or insertion) to contain any sequence, provided a minimum of two base-paired stem structure can form. The sequences listed in Tables III, V-VII may be formed of ribonucleotides or other nucleotides or non-nucleotides. Such ribozymes are equivalent to the ribozymes described specifically in the Tables.

Optimizing Ribozyme Activity

Ribozyme activity can be optimized as described by Stinchcomb et al., supra. The details will not be repeated here, but include altering the length of the ribozyme binding arms (stems I and III, see FIG. 2c), or chemically synthesizing ribozymes with modifications that prevent their degradation by serum ribonucleases (see e.g., Eckstein et al., International Publication No. WO 92/07065; Perrault et al., 1990 Nature 344, 565; Pieken et al., 1991 Science 253, 314; Usman and Cedergren, 1992 Trends in Biochem. Sci. 17, 334; Usman et al., International Publication No. WO 93/15187; and Rossi et al., International Publication No. WO 91/03162, as well as Usman, N. et al. U.S. patent application Ser. No. 07/829,729, and Sproat, European Patent Application 92110298.4 and U.S. Pat. No. 5,334,711 and Jennings et al., WO 94/13688 which describe various chemical modifications that can be made to the sugar moieties of enzymatic RNA molecules. Modifications which enhance their efficacy in cells, and removal of stem 11 bases to shorten RNA synthesis times and reduce chemical requirements. (All these publications are hereby incorporated by reference herein.),

Sullivan, et al., supra, describes the general methods for delivery of enzymatic RNA molecules . Ribozymes may be administered to cells by a variety of methods known to those familiar to the art, including, but not restricted to, encapsulation in liposomes, by iontophoresis, or by incorporation into other vehicles, such as hydrogels, cyclodextrins, biodegradable nanocapsules, and bioadhesive microspheres. For some indications, ribozymes may be directly delivered ex vivo to cells or tissues with or without the aforementioned vehicles. Alternatively, the RNA/vehicle combination is locally delivered by direct injection or by use of a catheter, infusion pump or stent. Other routes of delivery include, but are not limited to, intravascular, intramuscular, subcutaneous or joint injection, aerosol inhalation, oral (tablet or pill form), topical, systemic, ocular, intraperitoneal and/or intrathecal delivery. More detailed descriptions of ribozyme delivery and administration are provided in Sullivan et al., supra and Draper et al., supra which have been incorporated by reference herein.

Another means of accumulating high concentrations of a ribozyme(s) within cells is to incorporate the ribozyme-encoding sequences into a DNA expression vector. Transcription of the ribozyme sequences are driven from a promoter for eucaryotic RNA polymerase I (pol I), RNA polymerase II (pol II), or RNA polymerase III (pol III). Transcripts from pol II or pol III promoters will be expressed at high levels in all cells; the levels of a given pol II promoter in a given cell type will depend on the nature of the gene regulatory sequences (enhancers, silencers, etc.) present nearby. Prokaryotic RNA polymerase promoters are also used, providing that the prokaryotic RNA polymerase enzyme is expressed in the appropriate cells (Elroy-Stein and Moss, 1990 Proc. Natl. Acad. Sci. U S A, 87, 6743-7; Gao and Huang 1993 Nucleic Acids Res., 21, 2867-72; Lieber et al., 1993 Methods Enzymol., 217, 47-66; Zhou et al., 1990 Mol. Cell. Biol., 10, 4529-37). Several investigators have demonstrated that ribozymes expressed from such promoters can function in mammalian cells (e.g. Kashani-Sabet et al., 1992 Antisense Res. Dev., 2, 3-15; Ojwang et al., 1992 Proc. Natl. Acad. Sci. U S A, 89, 10802-6; Chen et al., 1992 Nucleic Acids Res., 20, 4581-9; Yu et al., 1993 Proc. Natl. Acad. Sci. U S A, 90, 6340-4; L'Huillier et al., 1992 EMBO J. 11, 4411-8; Lisziewicz et al., 1993 Proc. NatI. Acad. Sci. U.S.A., 90, 8000-4). The above ribozyme transcription units can be incorporated into a variety of vectors for introduction into mammalian cells, including but not restricted to, plasmid DNA vectors, viral DNA vectors (such as adenovirus or adeno-associated virus vectors), or viral RNA vectors (such as retroviral, sindbis virus, semliki forest virus vectors).

In a preferred embodiment of the invention, a transcription unit expressing a ribozyme that cleaves TNF-.alpha. RNA is inserted into a plasmid DNA vector or an adenovirus DNA viral vector. Both vectors have been used to transfer genes to the intact vasculature or to joints of live animals (Willard et al., 1992 Circulation, 86,1-473.; Nabel et al., 1990 Science, 249, 1285-1288) and both vectors lead to transient gene expression. The adenovirus vector is delivered as recombinant adenoviral particles. DNA may be delivered alone or complexed with vehicles (as described for RNA above). The DNA, DNA/vehicle complexes, or the recombinant adenovirus particles are locally administered to the site of treatment, e.g., through the use of an injection catheter, stent or infusion pump or are directly added to cells or tissues ex vivo.

In another preferred embodiment of the invention, a transcription unit expressing a ribozyme that cleaves TNF-a RNA is inserted into a retrovirus vector for sustained expression of ribozyme(s).

EXAMPLE 1

TNF-.alpha. Hammerhead ribozymes

By engineering ribozyme motifs we have designed several ribozymes directed against TNF-.alpha. mRNA sequences. These ribozymes are synthesized with modifications that improve their nuclease resistance. The ability of ribozymes to cleave TNF-.alpha. target sequences in vitro is evaluated.

The ribozymes will be tested for function in cells by analyzing bacterial lipopolysaccharide (LPS)-induced TNF-.alpha. expression levels. Ribozymes will be delivered to cells by incorporation into liposomes, by complexing with cationic lipids, by microinjection, or by expression from DNA vectors. TNF-.alpha. expression will be monitored by ELISA, by indirect immunofluoresence, and/or by FACS analysis. TNF-.alpha. mRNA levels will be assessed by Northern analysis, RNAse protection, primer extension analysis or quantitative RT-PCR. Ribozymes that block the induction of TNF-.alpha. activity and/or TNF-.alpha. mRNA by more than 90% will be identified.

RNA ribozymes and/or genes encoding them will be locally delivered to macrophages by intraperitoneal injection. After a period of ribozyme uptake, the peritoneal macrophages are harvested and induced ex vivo with LPS. The ribozymes that significantly reduce TNF-.alpha. secretion are selected. The TNF-.alpha. can also be induced after ribozyme treatment with fixed Streptococcus in the peritoneal cavity instead of ex vivo. In this fashion the ability of TNF-.alpha. ribozymes to block TNF-.alpha. secretion in a localized inflammatory response are evaluated. In addition, we will determine if the ribozymes can block an ongoing inflammatory response by delivering the TNF-.alpha. ribozymes after induction by the injection of fixed Streptococcus.

To examine the effect of anti-TNF-.alpha. ribozymes on systemic inflammation, the ribozymes are delivered by intravenous injection. The ability of the ribozymes to inhibit TNF-.alpha. secretion and lethal shock caused by systemic LPS administration are assessed. Similarly, TNF-.alpha. ribozymes can be introduced into the joints of mice with collagen-induced arthritis. Either free delivery, liposome delivery, cationic lipid delivery, adeno-associated virus vector delivery, adenovirus vector delivery, retrovirus vector delivery or plasmid vector delivery in these animal model experiments can be used to supply ribozymes. One dose (or a few infrequent doses) of a stable anti-TNF-.alpha. ribozyme or a gene construct that constitutively expresses the ribozyme may abrogate tissue damage in these inflammatory diseases.

EXAMPLE 2

Targeting mouse TNF-.alpha. mRNA for cleavage by hairpin ribozymes

Design of Hairpin ribozymes:

As shown in FIG. 7, two hairpin ribozymes were designed to cleave two distinct sites (1393 and 1435) within the mouse TNF-.alpha. mRNA. Corresponding ribozymes were synthesized containing mutations in the catalytic core of the ribozyme which renders the ribozyme inactive (Berzal-Herranz et al., 1993 EMBO J. 12, 2567). To construct these ribozymes, partially overlapping top- and bottom-strand oligonucleotides (.about.50 nucleotides) were designed to include sequences for the T7 promoter and the hairpin ribozyme. The single-strand portions of annealed oligonucleotides were converted to double-strands using Sequenase (U.S. Biochemicals). Transcription reactions containing linear double-stranded templates were carried out essentially as described (Milligan & Uhlenbeck, 1989 supra) using the T7 mega shortscript kit (Ambion, Austin, Tex.).

Macrophage isolation.

To produce responsive macrophages 1 ml of sterile fluid thioglycollate broth (Difco, Detroit, Mich.) was injected i.p. into 6 week old female C57bl/6NCR mice 3 days before peritoneal lavage. Mice were maintained as specific pathogen free in autoclaved cages in a laminar flow hood and given sterilized water to minimize "spontaneous" activation of macrophages. The resulting peritoneal exudate cells (PEC) were obtained by lavage using Hanks balanced salt solution (HBSS) and were plated at 2.5.times.10.sup.5 /well in 96 well plates (Costar, Cambridge, Mass.) with Eagles minimal essential medium (EMEM) containing 10% heat inactivated fetal bovine serum. After adhering for 2 hours the wells were washed to remove non-adherent cells. The resulting cultures were 97% macrophages as determined by morphology and staining for non-specific esterase.

Transfection of ribozymes into macrophages:

The ribozymes were diluted to 2.times.final concentration, mixed with an equal volume of 11 nM lipofectamine (Life Technologies, Gaithersburg, Md.), and vortexed. 100 ml of lipid:ribozyme complex was then added directly to the cells, followed immediately by 10 ml fetal bovine serum. Three hours after ribozyme addition 100 ml of 1 mg/ml bacterial lipopolysaccaride (LPS) was added to each well to stimulate TNF production.

Quantitation of TNF-.alpha. in mouse macrophages:

Supernatants were sampled at 0, 2, 4, 8, and 24 hours post LPS stimulation and stored at -70.degree. C. Quantitation of TNF-.alpha. was done by a specific ELISA. ELISA plates were coated with rabbit anti-mouse TNF-.alpha. serum at 1:1000 dilution (Genzyme) followed by blocking with milk proteins and incubation with TNF-.alpha. containing supernatants. TNF-.alpha. was then detected using a murine TNF-a specific hamster monoclonal antibody (Genzyme). The ELISA was developed with goat anti-hamster IgG coupled to alkaline phosphatase.

Assessment of reagent toxicity:

Following ribozyme/lipid treatment of macrophages and harvesting of supernatants viability of the cells was assessed by incubation of the cells with 5 mg/ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). This compound is reduced by the mitochondrial dihydrogenases, the activity of which correlates well with cell viability. After 12 hours the absorbance of reduced MTT is measured at 585 nm.

Inhibition of TNF-.alpha. expression by hairpin ribozymes in mouse macrophages:

As shown in FIGS. 8 and 9, expression of TNF-.alpha. is significantly inhibited by both hairpin ribozymes 1393 and 1435. The inhibition of TNF-.alpha. expression by the ribozyme 1435 (active) appears to be dependent on the catalytic activity of the ribozyme: a catalytically inactive hairpin ribozyme (1435 dead) does not show appreciable inhibition. In contrast, the inactive version of the 1393 ribozyme does show some inhibition of TNF-.alpha. expression at 162 nM ribozyme concentration. This inhibition may be attributed to ribozyme binding to the target sequence.

Sequences in FIG. 7 are non-limiting examples. Those in the art will recognize that these are but example, and other embodiments can be readily generated using techniques generally known in the art.

Uses

The association between TNF-.alpha. and bacterial sepsis, rheumatoid arthritis, and autoimmune disease make TNF-.alpha. an attractive target for therapeutic intervention �Tracy & Cerami 1992 supra; Williams et al., 1992 Proc. Natl. Acad. Sci. USA 89, 9784-9788; Jacob, 1992 J. Autoimmun. 5 (Supp. A), 133-143!.

Septic Shock

Septic shock is a complication of major surgery, bacterial infection, and polytrauma characterized by high fever, increased cardiac output, reduced blood pressure and a neutrophilic infiltrate into the lungs and other major organs (Parrillo, 1993 supra). Current treatment options are limited to antibiotics to reduce the bacterial load and non-steroidal anti-inflammatories to reduce fever. Despite these treatments in the best intensive care settings, mortality from septic shock averages 50%, due primarily to multiple organ failure and disseminated vascular coagulation. Septic shock, with an incidence of 200,000 cases per year in the United States, is the major cause of death in intensive care units. In septic shock syndrome, tissue injury or bacterial products initiate massive immune activation, resulting in the secretion of pro-inflammatory cytokines which are not normally detected in the serum, such as TNF-.alpha., interleukin-1.beta. (IL-1.beta.), .gamma.-interferon (IFN-.gamma.), interleukin-6 (IL-6), and interleukin-8 (IL-8). Other non-cytokine mediators such as leukotriene b4, prostaglandin E2, C3a and C3d also reach high levels (de Boer et al., 1992 Immunopharmacology 24, 135-148).

TNF-.alpha. is detected early in the course of septic shock in a large fraction of patients (de Boer et al., 1992 supra). In animal models, injection of TNF-.alpha. has been shown to induce shock-like symptoms similar to those induced by LPS injection (Beutler et al., 1985 Science 229, 869-871); in contrast, injection of IL-1.beta., IL-6, or IL-8 does not induce shock. Injection of TNF-.alpha. also causes an elevation of IL-1.beta., IL-6, IL-8, PgE.sub.2, acute phase proteins, and TxA.sub.2 in the serum of experimental animals (de Boer et al., 1992 supra). In animal models the lethal effects of LPS can be blocked by preadministration of anti-TNF-.alpha. antibodies. The cumulative evidence indicates that TNF-.alpha. is a key player in the pathogenesis of septic shock, and therefore a good candidate for therapeutic intervention.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints leading to bone destruction and loss of joint function (Harris, 1990 supra). At the cellular level, autoreactive T-lymphocytes and monocytes are typically present, and the synoviocytes often have altered morphology and immunostaining patterns. RA joints have been shown to contain elevated levels of TNF-.alpha., IL-1.alpha. and IL-1.beta., IL-6, GM-CSF, and TGF-.beta. (Abney et al., 1991 Imm. Rev. 119, 105-123), some or all of which may contribute to the pathological course of the disease.

Cells cultured from RA joints spontaneously secrete all of the pro-inflammatory cytokines detected in vivo. Addition of antisera against TNF-.alpha. to these cultures has been shown to reduce IL-1.alpha./.beta. production by these cells to undetectable levels (Abney et al., 1991 Supra). Thus, TNF-.alpha. may directly induce the production of other cytokines in the RA joint. Addition of the anti-inflammatory cytokine, TGF-.beta., has no effect on cytokine secretion by RA cultures. Immunocytochemical studies of human RA surgical specimens clearly demonstrate the production of TNF-.alpha., IL-1.alpha./.beta., and IL-6 from macrophages near the cartilage/pannus junction when the pannus in invading and overgrowing the cartilage (Chu et al., 1992 Br. J. Rheumatology 31, 653-661). GM-CSF was shown to be produced mainly by vascular endothelium in these samples. Both TNF-.alpha. and TGF-.beta. have been shown to be fibroblast growth factors, and may contribute to the accumulation of scar tissue in the RA joint. TNF-.alpha. has also been shown to increase osteoclast activity and bone resorbtion, and may have a role in the bone erosion commonly found in the RA joint (Cooper et al., 1992 Clin. Exp. Immunol. 89, 244-250).

Elimination of TNF-.alpha. from the rheumatic joint would be predicted to reduce overall inflammation by reducing induction of MHC class II, IL-1.alpha./.beta., II-6, and GM-CSF, and reducing T-cell activation. Osteoclast activity might also fall, reducing the rate of bone erosion at the joint. Finally, elimination of TNF-.alpha. would be expected to reduce accumulation of scar tissue within the joint by removal of a fibroblast growth factor.

Treatment with an anti-TNF-a antibody reduces joint swelling and the histological severity of collagen-induced arthritis in mice (Williams et al., 1992 Proc. Natl. Acad. Sci. USA 89, 9784-9788). In addition, a study of RA patients who have received i.v. infusions of anti-TNF-.alpha. monoclonal antibody reports a reduction in the number and severity of inflamed joints after treatment. The benefit of monoclonal antibody treatment in the long term may be limited by the expense and immunogenicity of the antibody.

Psoriasis

Psoriasis is an inflammatory disorder of the skin characterized by keratinocyte hyperproliferation and immune cell infiltrate (Kupper, 1990 J. Clin. Invest. 86, 1783-1789). It is a fairly common condition, affecting 1.5-2.0% of the population. The disorder ranges in severity from mild, with small flaky patches of skin, to severe, involving inflammation of the entire epidermis. The cellular infiltrate of psoriasis includes T-lymphocytes, neutrophils, macrophages, and dermal dendrocytes. The majority of T-lymphocytes are activated CD4.sup.+ cells of the T.sub.H -1 phenotype, although some CD8.sup.+ and CD4.sup.- /CD8.sup.- are also present. B lymphocytes are typically not found in abundance in psoriatic plaques.

Numerous hypotheses have been offered as to the proximal cause of psoriasis including auto-antibodies and auto-reactive T-cells, overproduction of growth factors, and genetic predisposition. Although there is evidence to support the involvement of each of these factors in psoriasis, they are neither mutually exclusive nor are any of them necessary and sufficient for the pathogenesis of psoriasis (Reeves, 1991 Semin. Dermatol. 10, 217).

The role of cytokines in the pathogenesis of psoriasis has been investigated. Among those cytokines found to be abnormally expressed were TGF-.alpha., IL-1.alpha., IL-1.beta., IL-1ra, IL-6, IL-8, IFN-.gamma., and TNF-.alpha.. In addition to abnormal cytokine production, elevated expression of ICAM-1, ELAM-1, and VCAM has been observed (Reeves, 1991 supra). This cytokine profile is similar to that of normal wound healing, with the notable exception that cytokine levels subside upon healing. Keratinocytes themselves have recently been shown to be capable of secreting EGF, TGF-.alpha., IL-6, and TNF-.alpha., which could increase proliferation in an autocrine fashion (Oxholm et al., 1991 APMIS 99, 58-64).

Nickoloff et al., 1993 (J Dermatol Sci. 6, 127-33) have proposed the following model for the initiation and maintenance of the psoriatic plaque:

Tissue damage induces the wound healing response in the skin. Keratinocytes secrete IL-1.alpha., IL-1.beta., IL-6, IL-8, TNF-.alpha.. These factors activate the endothelium of dermal capillaries, recruiting PMNs, macrophages, and T-cells into the wound site.

Dermal dendrocytes near the dermal/epidermal junction remain activated when they should return to a quiescent state, and subsequently secrete cytokines including TNF-.alpha., IL-6, and IL-8. Cytokine expression, in turn, maintains the activated state of the endothelium, allowing extravasation of additional immunocytes, and the activated state of the keratinocytes which secrete TGF-.alpha. and IL-8. Keratinocyte IL-8 recruits immunocytes from the dermis into the epidermis. During passage through the dermis, T-cells encounter the activated dermal dendrocytes which efficiently activate the T.sub.H -1 phenotype. The activated T-cells continue to migrate into the epidermis, where they are stimulated by keratinocyte-expressed ICAM-1 and MHC class II. IFN-.gamma. secreted by the T-cells synergizes with the TNF-.alpha. from dermal dendrocytes to increase keratinocyte proliferation and the levels of TGF-.alpha., IL-8, and IL-6 production. IFN-.gamma. also feeds back to the dermal dendrocyte, maintaining the activated phenotype and the inflammatory cycle.

Elevated serum titres of IL-6 increases synthesis of acute phase proteins including complement factors by the liver, and antibody production by plasma cells. Increased complement and antibody levels increases the probability of autoimmune reactions.

Maintenance of the psoriatic plaque requires continued expression of all of these processes, but attractive points of therapeutic intervention are TNF-.alpha. expression by the dermal dendrocyte to maintain activated endothelium and keratinocytes, and IFN-.gamma. expression by T-cells to maintain activated dermal dendrocytes.

There are 3 million patients in the United States afflicted with psoriasis. The available treatments for psoriasis are corticosteroids. The most widely prescribed are TEMOVATE (clobetasol propionate), LIDEX (fluocinonide), DIPROLENE (betamethasone propionate), PSORCON (diflorasone diacetate) and TRIAMCINOLONE formulated for topical application. The mechanism of action of corticosteroids is multifactorial. This is a palliative therapy because the underlying cause of the disease remains, and upon discontinuation of the treatment the disease returns. Discontinuation of treatment is often prompted by the appearance of adverse effects such as atrophy, telangiectasias and purpura. Corticosteroids are not recommended for prolonged treatments or when treatment of large and/or inflamed areas is required. Alternative treatments include retinoids, such as etretinate, which has been approved for treatment of severe, refractory psoriasis. Alternative retinoid-based treatments are in advanced clinical trials. Retinoids act by converting keratinocytes to a differentiated state and restoration of normal skin development. Immunosuppressive drugs such as cyclosporine are also in the advanced stages of clinical trials. Due to the nonspecific mechanism of action of corticosteroids, retinoids and immunosuppressives, these treatments exhibit severe side effects and should not be used for extended periods of time unless the condition is life-threatening or disabling. There is a need for a less toxic, effective therapeutic agent in psoriatic patients.

HIV and AIDS

The human immunodeficiency virus (HIV) causes several fundamental changes in the human immune system from the time of infection until the development of full-blown acquired immunodeficiency syndrome (AIDS). These changes include a shift in the ratio of CD4+ to CD8+ T-cells, sustained elevation of IL-4 levels, episodic elevation of TNF-.alpha. and TNF-.beta. levels, hypergammaglobulinemia, and lymphoma/leukemia (Rosenberg & Fauci, 1990 Immun. Today 11, 176; Weiss 1993 Science 260, 1273). Many patients experience a unique tumor, Kaposi's sarcoma and/or unusual opportunistic infections (e.g. Pneumocystis carinii, cytomegalovirus, herpesviruses, hepatitis viruses, papilloma viruses, and tuberculosis). The immunological dysfunction of individuals with AIDS suggests that some of the pathology may be due to cytokine dysregulation.

Levels of serum TNF-.alpha. and IL-6 are often found to be elevated in AIDS patients (Weiss, 1993 supra). In tissue culture, HIV infection of monocytes isolated from healthy individuals stimulates secretion of both TNF-.alpha. and IL-6. This response has been reproduced using purified gp120, the viral coat protein responsible for binding to CD-4 (Buonaguro et al., 1992 J. Virol. 66, 7159). It has also been demonstrated that the viral gene regulator, Tat, can directly induce TNF transcription. The ability of HIV to directly stimulate secretion of TNF-.alpha. and IL-6 may be an adaptive mechanism of the virus. TNF-.alpha. has been shown to upregulate transcription of the LTR of HIV, increasing the number of HIV-specific transcripts in infected cells. IL-6 enhances HIV production, but at a post-transcriptional level, apparently increasing the efficiency with which HIV transcripts are translated into protein. Thus, stimulation of TNF-.alpha. secretion by the HIV virus may promote infection of neighboring CD4+ cells both by enhancing virus production from latently infected cells and by driving replication of the virus in newly infected cells.

The role of TNF-.alpha. in HIV replication has been well established in tissue culture models of infection (Sher et al., 1992 Immun. Rev. 127, 183), suggesting that the mutual induction of HIV replication and TNF-.alpha. replication may create positive feedback in vivo. However, evidence for the presence of such positive feedback in infected patients is not abundant. TNF-.alpha. levels are found to be elevated in some, but not all patients tested. Children with AIDS who were given zidovudine had reduced levels of TNF-.alpha. compared to those not given zidovudine (Cremoni et al., 1993 AIDS 7, 128). This correlation lends support to the hypothesis that reduced viral replication is physiologically linked to TNF-.alpha. levels. Furthermore, recently it has been shown that the polyclonal B cell activation associated with HIV infection is due to membrane-bound TNF-.alpha.. Thus, levels of secreted TNF-.alpha. may not accurately reflect the contribution of this cytokine to AIDS pathogenesis.

Chronic elevation of TNF-.alpha. has been shown to shown to result in cachexia (Tracey et al., 1992 Am. J. Trop. Med. Hyg. 47, 2-7), increased autoimmune disease (Jacob, 1992 supra), lethargy, and immune suppression in animal models (Aderka et al., 1992 Isr. J. Med. Sci. 28, 126-130). The cachexia associated with AIDS may be associated with chronically elevated TNF-.alpha. frequently observed in AIDS patients. Similarly, TNF-.alpha. can stimulate the proliferation of spindle cells isolated from Kaposi's sarcoma lesions of AIDS patients (Barillari et al., 1992 J Immunol 149, 3727).

A therapeutic agent that inhibits cytokine gene expression, inhibits adhesion molecule expression, and mimics the anti-inflammatory effects of glucocorticoids (without inducing steroid-responsive genes) is ideal for the treatment of inflammatory and autoimmune disorders. Disease targets for such a drug are numerous. Target indications and the delivery options each entails are summarized below. In all cases, because of the potential immunosuppressive properties of a ribozyme that cleaves the specified sites in TNF-.alpha. mRNA, uses are limited to local delivery, acute indications, or ex vivo treatment.

.cndot.Septic shock.

Exogenous delivery of ribozymes to macrophages can be achieved by intraperitoneal or intravenous injections. Ribozymes will be delivered by incorporation into liposomes or by complexing with cationic lipids.

.cndot.Rheumatoid arthritis (RA).

Due to the chronic nature of RA, a gene therapy approach is logical. Delivery of a ribozyme to inflamed joints is mediated by adenovirus, retrovirus, or adeno-associated virus vectors. For instance, the appropriate adenovirus vector can be administered by direct injection into the synovium: high efficiency of gene transfer and expression for several months would be expected (B. J. Roessler, E. D. Allen, J. M. Wilson, J. W. Hartman, B. L. Davidson, J. Clin. Invest. 92, 1085-1092 (1993)). It is unlikely that the course of the disease could be reversed by the transient, local administration of an anti-inflammatory agent. Multiple administrations may be necessary. Retrovirus and adeno-associated virus vectors would lead to permanent gene transfer and expression in the joint. However, permanent expression of a potent anti-inflammatory agent may lead to local immune deficiency.

.cndot.Psoriasis

The psoriatic plaque is a particularly good candidate for ribozyme or vector delivery. The stratum corneum of the plaque is thinned, providing access to the proliferating keratinocytes. T-cells and dermal dendrocytes can be efficiently targeted by trans-epidermal diffusion.

Organ culture systems for biopsy specimens of psoriatic and normal skin are described in current literature (Nickoloff et al., 1993 Supra). Primary human keratinocytes are easily obtained and will be grown into epidermal sheets in tissue culture. In addition to these tissue culture models, the flaky skin mouse develops psoriatic skin in response to UV light. This model would allow demonstration of animal efficacy for ribozyme treatments of psoriasis.

.cndot.Gene Therapy.

Immune responses limit the efficacy of many gene transfer techniques. Cells transfected with retrovirus vectors have short lifetimes in immune competent individuals. The length of expression of adenovirus vectors in terminally differentiated cells is longer in neonatal or immune-compromised animals. Insertion of a small ribozyme expression cassette that modulates inflammatory and immune responses into existing adenovirus or retrovirus constructs will greatly enhance their potential.

Thus, ribozymes of the present invention that cleave TNF-.alpha. mRNA and thereby TNF-.alpha. activity have many potential therapeutic uses, and there are reasonable modes of delivering the ribozymes in a number of the possible indications. Development of an effective ribozyme that inhibits TNF-.alpha. function is described above; available cellular and activity assays are number, reproducible, and accurate. Animal models for TNF-.alpha. function and for each of the suggested disease targets exist and can be used to optimize activity.

Diagnostic uses

Ribozymes of this invention may be used as diagnostic tools to examine genetic drift and mutations within diseased cells. The close relationship between ribozyme activity and the structure of the target RNA allows the detection of mutations in any region of the molecule which alters the base-pairing and three-dimensional structure of the target RNA. By using multiple ribozymes described in this invention, one may map nucleotide changes which are important to RNA structure and function in vitro, as well as in cells and tissues. Cleavage of target RNAs with ribozymes may be used to inhibit gene expression and define the role (essentially) of specified gene products in the progression of disease. In this manner, other genetic targets may be defined as important mediators of the disease. These experiments will lead to better treatment of the disease progression by affording the possibility of combinational therapies (e.g., multiple ribozymes targeted to different genes, ribozymes coupled with known small molecule inhibitors, or intermittent treatment with combinations of ribozymes and/or other chemical or biological molecules). Other in vitro uses of ribozymes of this invention are well known in the art, and include detection of the presence of mRNA associated with a TNF-.alpha. related condition. Such RNA is detected by determining the presence of a cleavage product after treatment with a ribozyme using standard methodology.

In a specific example, ribozymes which can cleave only wild-type or mutant forms of the target RNA are used for the assay. The first ribozyme is used to identify wild-type RNA present in the sample and the second ribozyme will be used to identify mutant RNA in the sample. As reaction controls, synthetic substrates of both wild-type and mutant RNA will be cleaved by both ribozymes to demonstrate the relative ribozyme efficiencies in the reactions and the absence of cleavage of the "non-targeted" RNA species. The cleavage products from the synthetic substrates will also serve to generate size markers for the analysis of wild-type and mutant RNAs in the sample population. Thus each analysis will require two ribozymes, two substrates and one unknown sample which will be combined into six reactions. The presence of cleavage products will be determined using an RNAse protection assay so that full-length and cleavage fragments of each RNA can be analyzed in one lane of a polyacrylamide gel. It is not absolutely required to quantify the results to gain insight into the expression of mutant RNAs and putative risk of the desired phenotypic changes in target cells. The expression of mRNA whose protein product is implicated in the development of the phenotype (i.e., TNF-.alpha.) is adequate to establish risk. If probes of comparable specific activity are used for both transcripts, then a qualitative comparison of RNA levels will be adequate and will decrease the cost of the initial diagnosis. Higher mutant form to wild-type ratios will be correlated with higher risk whether RNA levels are compared qualitatively or quantitatively.

A number of other cytokines may also be involved in the activation of inflammation, including platelet activating factor, IL-1, IL-3, IL-4, GM-CSF, gamma interferon, ILAM-1, ELAM-1 and EoCSF. In addition to these cytokines, it is appreciated that any cellular receptors which mediate the activities of the cytokines are also good targets for intervention in inflammatory diseases. These targets include, but are not limited to, the IL-1R and TNF-.alpha.R on keratinocytes, epithelial and endothelial cells in airways. Recent data suggest that certain neuropeptides may play a role in asthmatic symptoms. These peptides include substance P, neurokinin A and calcitonin-gene-related peptides. These target genes may have more general roles in inflammatory diseases, but are currently assumed to have a role only in asthma. Other genes which are considered to play a role in asthma are the c-myb and c-myc genes, which may be triggered to induce endothelial cell proliferation and contribute to blockage of the airways. Those skilled in the art will recognize the other potential targets noted above are also suitable for treatment with ribozymes, which will reduce the risk or occurrence of inflammatory disease, such as the interleukins (1, 3, 4, 6, and 8), glycerol transferase, selectins (E-selectin, MEL-14), cell adhesion molecules (ICAM-1, ELAM-1, VCAM-1, GMP-140, MAM), IL-1R, TGF.beta. R, EoCSF,.alpha.-, .beta.- or .gamma.-interferon, EoCSF, GM-CSF and protein kinase C (PKC)

Other embodiments are within the following claims.

TABLE I

Characteristics of Ribozymes

Group I Introns Size: .about.200 to >1000 nucleotides. Requires a U in the target sequence immediately 5' of the cleavage site. Binds 4-6 nucleotides at 5' side of cleavage site. Over 75 known members of this class. Found in Tetrahymena thermophila rRNA, fungal mitochondria, chloroplasts, phage T4, blue-green algae, and others.

RNAseP RNA (M1 RNA) Size: .about.290 to 400 nucleotides. RNA portion of a ribonucleoprotein enzyme. Cleaves tRNA precursors to form mature tRNA. Roughly 10 known members of this group all are bacterial in origin.

Hammerhead Ribozyme Size: .about.13 to 40 nucleotides. Requires the target sequence UH immediately 5' of the cleavage site. Binds a variable number nucleotides on both sides of the cleavage site. 14 known members of this class. Found in a number of plant pathogens (virusoids) that use RNA as the infectious agent (FIGS. 1 and 2)

Hairpin Ribozyme Size: .about.50 nucleotides. Requires the target sequence GUC immediately 3' of the cleavage site. Binds 4-6 nucleotides at 5' side of the cleavage site and a variable number to the 3' side of the cleavage site. Only 3 known member of this class. Found in three plant pathogen (satellite RNAs of the tobacco ringspot virus, arabis mosaic virus and chicory yellow mottle virus) which uses RNA as the infectious agent (FIG. 3).

Hepatitis Delta Virus (HDV) Ribozyme Size: 50-60 nucleotides (at present). Cleavage of target RNAs recently demonstrated. Sequence requirements not fully determined. Binding sites and structural requirements not fully determined, although no sequences 5' of cleavage site are required. Only 1 known member of this class. Found in human HDV (FIG. 4).

Neurospora VS RNA Ribozyme Size: .about.144 nucleotides (at present) Cleavage of target RNAs recently demonstrated. Sequence requirements not fully determined. Binding sites and structural requirements not fully determined. Only 1 known member of this class. Found in Neurospora VS RNA (FIG. 5).

TABLE II__________________________________________________________________________Human TNF-a HH Ribozyme Target Sequencent. Sequence nt. SequencePosition HH Target Sequence ID No. Position HH Target Sequence ID No.__________________________________________________________________________ 28 GGCAGGU U CUCUUCC 15 29 GCAGGUU C UCUUCCU 16 321 GUCAGAU C AUCUUCU 54 31 AGGUUCU C UUCCUCU 17 324 AGAUCAU C UUCUCGA 55 33 GUUCUCU U CCUCUCA 18 326 AUCAUCU U CUCGAAC 56 34 UUCUCUU C CUCUCAC 19 327 UCAUCUU C UCGAACC 57 37 UCUUCCU C UCACAUA 20 329 AUCUUCU C GAACCCC 58 39 UUCCUCU C ACAUACU 21 352 AGCCUGU A GCCCAUG 59 44 CUCACAU A CUGACCC 22 361 CCCAUGU U GUAGCAA 60 58 CACGGCU C CACCCUC 23 364 AUGUUGU A GCAAACC 61 65 CCACCCU C UCUCCCC 24 374 AAACCCU C AAGCUGA 62 67 ACCCUCU C UCCCCUG 25 391 GGCAGCU C CAGUGGC 63 69 CCUCUCU C CCCUGGA 26 421 AUGCCCU C CUGGCCA 64 106 GCAUGAU C CGGGACG 27 449 GAGAGAU A ACCAGCU 65 136 AGGCGCU C CCCAAGA 28 468 GUGCCAU C AGAGGGC 66 165 CAGGGCU C CAGGCGG 29 480 GGCCUGU A CCUCAUC 67 177 CGGUGCU U GUUCCUC 30 484 UGUACCU C AUCUACU 68 180 UGCUUGU U CCUCAGC 31 487 ACCUCAU C UACUCCC 69 181 GCUUGUU C CUCAGCC 32 489 CUCAUCU A CUCCCAG 70 184 UGUUCCU C AGCCUCU 33 492 AUCUACU C CCAGGUC 71 190 UCAGCCU C UUCUCCU 34 499 CCCAGGU C CUCUUCA 72 192 AGCCUCU U CUCCUUC 35 502 AGGUCCU C UUCAAGG 73 193 GCCUCUU C UCCUUCC 36 504 GUCCUCU U CAAGGGC 74 195 CUCUUCU C CUUCCUG 37 505 UCCUCUU C AAGGGCC 75 198 UUCUCCU U CCUGAUC 38 525 UGCCCCU C CACCCAU 76 199 UCUCCUU C CUGAUCG 39 538 AUGUGCU C CUCACCC 77 205 UCCUGAU C GUGGCAG 40 541 UGCUCCU C ACCCACA 78 226 CCACGCU C UUCUGCC 41 553 ACACCAU C AGCCGCA 79 228 ACGCUCU U CUGCCUG 42 562 GCCGCAU C GCCGUCU 80 229 CGCUCUU C UGCCUGC 43 568 UCGCCGU C UCCUACC 81 243 CUGCACU U UGGAGUG 44 570 GCCGUCU C CUACCAG 82 244 UGCACUU U GGAGUGA 45 573 GUCUCCU A CCAGACC 83 253 GAGUGAU C GGCCCCC 46 586 CCAAGGU C AACCUCC 84 273 GAAGAGU C CCCCAGG 47 592 UCAACCU C CUCUCUG 85 286 GGGACCU C UCUCUAA 48 595 ACCUCCU C UCUGCCA 86 288 GACCUCU C UCUAAUC 49 597 CUCCUCU C UGCCAUC 87 290 CCUCUCU C UAAUCAG 50 604 CUGCCAU C AAGAGCC 88 292 UCUCUCU A AUCAGCC 51 657 CCCUGGU A UGAGCCC 89 295 CUCUAAU C AGCCCUC 52 667 AGCCCAU C UAUCUGG 90 302 CAGCCCU C UGGCCCA 53 669 CCCAUCU A UCUGGGA 91 671 CAUCUAU C UGGGAGG 92 960 UGGGAUU C AGGAAUG 141 682 GAGGGGU C UUCCAGC 93 1001 AACCACU A AGAAUUC 142 684 GGGGUCU U CCAGCUG 94 1007 UAAGAAU U CAAACUG 143 685 GGGUCUU C CAGCUGG 95 1008 AAGAAUU C AAACUGG 144 709 ACCGACU C AGCGCUG 96 1021 GGGGCCU C CAGAACU 145 721 CUGAGAU C AAUCGGC 97 1029 CAGAACU C ACUGGGG 146 725 GAUCAAU C GGCCCGA 98 1040 GGGGCCU A CAGCUUU 147 735 CCCGACU A UCUCGAC 99 1046 UACAGCU U UGAUCCC 148 737 CGACUAU C UCGACUU 100 1047 ACAGCUU U GAUCCCU 149 739 ACUAUCU C GACUUUG 101 1051 CUUUGAU C CCUGACA 150 744 CUCGACU U UGCCGAG 102 1060 CUGACAU C UGGAAUC 151 745 UCGACUU U GCCGAGU 103 1067 CUGGAAU C UGGAGAC 152 753 GCCGAGU C UGGGCAG 104 1085 GGAGCCU U UGGUUCU 153 763 GGCAGGU C UACUUUG 105 1086 GAGCCUU U GGUUCUG 154 765 CAGGUCU A CUUUGGG 106 1090 CUUUGGU U CUGGCCA 155 768 GUCUACU U UGGGAUC 107 1091 UUUGGUU C UGGCCAG 156 769 UCUACUU U GGGAUCA 108 1113 CAGGACU U GAGAAGA 157 775 UUGGGAU C AUUGCCC 109 1124 AAGACCU C ACCUAGA 158 778 GGAUCAU U GCCCUGU 110 1129 CUCACCU A GAAAUUG 159 801 CGAACAU C CAACCUU 111 1135 UAGAAAU U GACACAA 160 808 CCAACCU U CCCAAAC 112 1151 UGGACCU U AGGCCUU 161 809 CAACCUU C CCAAACG 113 1152 GGACCUU A GGCCUUC 162 820 AACGCCU C CCCUGCC 114 1158 UAGGCCU U CCUCUCU 163 833 CCCCAAU C CCUUUAU 115 1159 AGGCCUU C CUCUCUC 164 837 AAUCCCU U UAUUACC 116 1162 CCUUCCU C UCUCCAG 165 838 AUCCCUU U AUUACCC 117 1164 UUCCUCU C UCCAGAU 166 839 UCCCUUU A UUACCCC 118 1166 CCUCUCU C CAGAUGU 167 841 CCUUUAU U ACCCCCU 119 1174 CAGAUGU U UCCAGAC 168 842 CUUUAUU A CCCCCUC 120 1175 AGAUGUU U CCAGACU 169 849 ACCCCCU C CUUCAGA 121 1176 GAUGUUU C CAGACUU 170 852 CCCUCCU U CAGACAC 122 1183 CCAGACU U CCUUGAG 171 853 CCUCCUU C AGACACC 123 1184 CAGACUU C CUUGAGA 172 863 ACACCCU C AACCUCU 124 1187 ACUUCCU U GAGACAC 173 869 UCAACCU C UUCUGGC 125 1208 CAGCCCU C CCCAUGG 174 871 AACCUCU U CUGGCUC 126 1224 GCCAGCU C CCUCUAU 175 872 ACCUCUU C UGGCUCA 127 1228 GCUCCCU C UAUUUAU 176 878 UCUGGCU C AAAAAGA 128 1230 UCCCUCU A UUUAUGU 177 890 AGAGAAU U GGGGGCU 129 1232 CCUCUAU U UAUGUUU 178 898 GGGGGCU U AGGGUCG 130 1233 CUCUAUU U AUGUUUG 179 899 GGGGCUU A GGGUCGG 131 1234 UCUAUUU A UGUUUGC 180 904 UUAGGGU C GGAACCC 132 1238 UUUAUGU U UGCACUU 181 917 CCAAGCU U AGAACUU 133 1239 UUAUGUU U GCACUUG 182 918 CAAGCUU A GAACUUU 134 1245 UUGCACU U GUGAUUA 183 924 UAGAACU U UAAGCAA 135 1251 UUGUGAU U AUUUAUU 184 925 AGAACUU U AAGCAAC 136 1252 UGUGAUU A UUUAUUA 185 926 GAACUUU A AGCAACA 137 1254 UGAUUAU U UAUUAUU 186 945 CACCACU U CGAAACC 138 1255 GAUUAUU U AUUAUUU 187 946 ACCACUU C GAAACCU 139 1256 AUUAUUU A UUAUUUA 188 959 CUGGGAU U CAGGAAU 140 1258 UAUUUAU U AUUUAUU 1891259 AUUUAUU A UUUAUUU 190 1440 UGUUUUU U AAAAUAU 2381261 UUAUUAU U UAUUUAU 191 1441 GUUUUUU A AAAUAUU 2391262 UAUUAUU U AUUUAUU 192 1446 UUAAAAU A UUAUCUG 2401263 AUUAUUU A UUUAUUA 193 1448 AAAAUAU U AUCUGAU 2411265 UAUUUAU U UAUUAUU 194 1449 AAAUAUU A UCUGAUU 2421266 AUUUAUU U AUUAUUU 195 1451 AUAUUAU C UGAUUAA 2431267 UUUAUUU A UUAUUUA 196 1456 AUCUGAU U AAGUUGU 2441269 UAUUUAU U AUUUAUU 197 1457 UCUGAUU A AGUUGUC 2451270 AUUUAUU A UUUAUUU 198 1461 AUUAAGU U GUCUAAA 2461272 UUAUUAU U UAUUUAU 199 1464 AAGUUGU C UAAACAA 2471273 UAUUAUU U AUUUAUU 200 1466 GUUGUCU A AACAAUG 2481274 AUUAUUU A UUUAUUU 201 1479 UGCUGAU U UGGUGAC 2491276 UAUUUAU U UAUUUAC 202 1480 GCUGAUU U GGUGACC 2501277 AUUUAUU U AUUUACA 203 1494 CAACUGU C ACUCAUU 2511278 UUUAUUU A UUUACAG 204 1498 UGUCACU C AUUGCUG 2521280 UAUUUAU U UACAGAU 205 1501 CACUCAU U GCUGAGG 2531281 AUUUAUU U ACAGAUG 206 1512 GAGGCCU C UGCUCCC 2541282 UUUAUUU A CAGAUGA 207 1517 CUCUGCU C CCCAGGG 2551294 UGAAUGU A UUUAUUU 208 1528 AGGGAGU U GUGUCUG 2561296 AAUGUAU U UAUUUGG 209 1533 GUUGUGU C UGUAAUC 2571297 AUGUAUU U AUUUGGG 210 1537 UGUCUGU A AUCGGCC 2581298 UGUAUUU A UUUGGGA 211 1540 CUGUAAU C GGCCUAC 2591300 UAUUUAU U UGGGAGA 212 1546 UCGGCCU A CUAUUCA 2601301 AUUUAUU U GGGAGAC 213 1549 GCCUACU A UUCAGUG 2611315 CCGGGGU A UCCUGGG 214 1551 CUACUAU U CAGUGGC 2621317 GGGGUAU C CUGGGGG 215 1552 UACUAUU C AGUGGCG 2631334 CCAAUGU A GGAGCUG 216 1566 GAGAAAU A AAGGUUG 2641345 GCUGCCU U GGCUCAG 217 1572 UAAAGGU U GCUUAGG 2651350 CUUGGCU C AGACAUG 218 1576 GGUUGCU U AGGAAAG 2661359 GACAUGU U UUCCGUG 219 1577 GUUGCUU A GGAAAGA 2671360 ACAUGUU U UCCGUGA 2201361 CAUGUUU U CCGUGAA 2211362 AUGUUUU C CGUGAAA 2221386 GAACAAU A GGCUGUU 2231393 AGGCUGU U CCCAUGU 2241394 GGCUGUU C CCAUGUA 2251401 CCCAUGU A GCCCCCU 2261414 CUGGCCU C UGUGCCU 2271422 UGUGCCU U CUUUUGA 2281423 GUGCCUU C UUUUGAU 2291425 GCCUUCU U UUGAUUA 2301426 CCUUCUU U UGAUUAU 2311427 CUUCUUU U GAUUAUG 2321431 UUUUGAU U AUGUUUU 2331432 UUUGAUU A UGUUUUU 2341436 AUUAUGU U UUUUAAA 2351437 UUAUGUU U UUUAAAA 2361438 UAUGUUU U UUAAAAU 237__________________________________________________________________________ TABLE III__________________________________________________________________________Human TNF-a Hammerhead Ribozyme Sequencesnt. SequencePosition HH Ribozyme Sequence ID No.__________________________________________________________________________ 28 GGAAGAG CUGAUGAGGCCGAAAGGCCGAA ACCUGCC 268 29 AGGAAGA CUGAUGAGGCCGAAAGGCCGAA AACCUGC 269 31 AGAGGAA CUGAUGAGGCCGAAAGGCCGAA AGAACCU 270 33 UGAGAGG CUGAUGAGGCCGAAAGGCCGAA AGAGAAC 271 34 GUGAGAG CUGAUGAGGCCGAAAGGCCGAA AAGAGAA 271 37 UAUGUGA CUGAUGAGGCCGAAAGGCCGAA AGGAAGA 273 39 AGUAUGU CUGAUGAGGCCGAAAGGCCGAA AGAGGAA 274 44 GGGUCAG CUGAUGAGGCCGAAAGGCCGAA AUGUGAG 275 58 GAGGGUG CUGAUGAGGCCGAAAGGCCGAA AGCCGUG 276 65 GGGGAGA CUGAUGAGGCCGAAAGGCCGAA AGGGUGG 277 67 CAGGGGA CUGAUGAGGCCGAAAGGCCGAA AGAGGGU 278 69 UCCAGGG CUGAUGAGGCCGAAAGGCCGAA AGAGAGG 279 106 CGUCCCG CUGAUGAGGCCGAAAGGCCGAA AUCAUGC 280 136 UCUUGGG CUGAUGAGGCCGAAAGGCCGAA AGCGCCU 281 165 CCGCCUG CUGAUGAGGCCGAAAGGCCGAA AGCCCUG 282 177 GAGGAAC CUGAUGAGGCCGAAAGGCCGAA AGCACCG 283 180 GCUGAGG CUGAUGAGGCCGAAAGGCCGAA ACAAGCA 284 181 GGCUGAG CUGAUGAGGCCGAAAGGCCGAA AACAAGC 285 184 AGAGGCU CUGAUGAGGCCGAAAGGCCGAA AGGAACA 286 190 AGGAGAA CUGAUGAGGCCGAAAGGCCGAA AGGCUGA 287 192 GAAGGAG CUGAUGAGGCCGAAAGGCCGAA AGAGGCU 288 193 GGAAGGA CUGAUGAGGCCGAAAGGCCGAA AAGAGGC 289 195 CAGGAAG CUGAUGAGGCCGAAAGGCCGAA AGAAGAG 290 198 GAUCAGG CUGAUGAGGCCGAAAGGCCGAA AGGAGAA 291 199 CGAUCAG CUGAUGAGGCCGAAAGGCCGAA AAGGAGA 292 205 CUGCCAC CUGAUGAGGCCGAAAGGCCGAA AUCAGGA 293 226 GCCAGAA CUGAUGAGGCCGAAAGGCCGAA AGCGUGG 294 228 CAGGCAG CUGAUGAGGCCGAAAGGCCGAA AGAGCGU 295 229 GCAGGCA CUGAUGAGGCCGAAAGGCCGAA AAGAGCG 296 243 CACUCCA CUGAUGAGGCCGAAAGGCCGAA AGUGCAG 297 244 UCACUCC CUGAUGAGGCCGAAAGGCCGAA AAGUGCA 298 253 GGGGGCC CUGAUGAGGCCGAAAGGCCGAA AUCACUC 299 273 CCUGGGG CUGAUGAGGCCGAAAGGCCGAA ACUCUUC 300 286 UUAGAGA CUGAUGAGGCCGAAAGGCCGAA AGGUCCC 301 288 GAUUAGA CUGAUGAGGCCGAAAGGCCGAA AGAGGUC 302 290 CUGAUUA CUGAUGAGGCCGAAAGGCCGAA AGAGAGG 303 292 GGCUGAU CUGAUGAGGCCGAAAGGCCGAA AGAGAGA 304 295 GAGGGCU CUGAUGAGGCCGAAAGGCCGAA AUUAGAG 305 302 UGGGCCA CUGAUGAGGCCGAAAGGCCGAA AGGGCUG 306 321 AGAAGAU CUGAUGAGGCCGAAAGGCCGAA AUCUGAC 307 324 UCGAGAA CUGAUGAGGCCGAAAGGCCGAA AUGAUCU 308 326 GUUCGAG CUGAUGAGGCCGAAAGGCCGAA AGAUGAU 309 327 GGUUCGA CUGAUGAGGCCGAAAGGCCGAA AAGAUGA 310 329 GGGGUUC CUGAUGAGGCCGAAAGGCCGAA AGAAGAU 311 352 CAUGGGC CUGAUGAGGCCGAAAGGCCGAA ACAGGCU 312 361 UUGCUAC CUGAUGAGGCCGAAAGGCCGAA ACAUGGG 313 364 GGUUUGC CUGAUGAGGCCGAAAGGCCGAA ACAACAU 314 374 UCAGCUU CUGAUGAGGCCGAAAGGCCGAA AGGGUUU 315 391 GCCACUG CUGAUGAGGCCGAAAGGCCGAA AGCUGCC 316 421 UGGCCAG CUGAUGAGGCCGAAAGGCCGAA AGGGCAU 317 449 AGCUGGU CUGAUGAGGCCGAAAGGCCGAA AUCUCUC 318 468 GCCCUCU CUGAUGAGGCCGAAAGGCCGAA AUGGCAC 319 480 GAUGAGG CUGAUGAGGCCGAAAGGCCGAA ACAGGCC 320 484 AGUAGAU CUGAUGAGGCCGAAAGGCCGAA AGGUACA 321 487 GGGAGUA CUGAUGAGGCCGAAAGGCCGAA AUGAGGU 322 489 CUGGGAG CUGAUGAGGCCGAAAGGCCGAA AGAUGAG 323 492 GACCUGG CUGAUGAGGCCGAAAGGCCGAA AGUAGAU 324 499 UGAAGAG CUGAUGAGGCCGAAAGGCCGAA ACCUGGG 325 502 CCUUGAA CUGAUGAGGCCGAAAGGCCGAA AGGACCU 326 504 GCCCUUG CUGAUGAGGCCGAAAGGCCGAA AGAGGAC 327 505 GGCCCUU CUGAUGAGGCCGAAAGGCCGAA AAGAGGA 328 525 AUGGGUG CUGAUGAGGCCGAAAGGCCGAA AGGGGCA 329 538 GGGUGAG CUGAUGAGGCCGAAAGGCCGAA AGCACAU 330 541 UGUGGGU CUGAUGAGGCCGAAAGGCCGAA AGGAGCA 331 553 UGCCGCU CUGAUGAGGCCGAAAGGCCGAA AUGGUGU 332 562 AGACGGC CUGAUGAGGCCGAAAGGCCGAA AUGCGGC 333 568 GGUAGGA CUGAUGAGGCCGAAAGGCCGAA ACGGCGA 334 570 CUGGUAG CUGAUGAGGCCGAAAGGCCGAA AGACGGC 335 573 GGUCUGG CUGAUGAGGCCGAAAGGCCGAA AGGAGAC 336 586 GGAGGUU CUGAUGAGGCCGAAAGGCCGAA ACCUUGG 337 592 CAGAGAG CUGAUGAGGCCGAAAGGCCGAA AGGUUGA 338 595 UGGCAGA CUGAUGAGGCCGAAAGGCCGAA AGGAGGU 339 597 GAUGGCA CUGAUGAGGCCGAAAGGCCGAA AGAGGAG 340 604 GGCUCUU CUGAUGAGGCCGAAAGGCCGAA AUGGCAG 341 657 GGGCUCA CUGAUGAGGCCGAAAGGCCGAA ACCAGGG 342 667 CCAGAUA CUGAUGAGGCCGAAAGGCCGAA AUGGGCU 343 669 UCCCAGA CUGAUGAGGCCGAAAGGCCGAA AGAUGGG 344 671 CCUCCCA CUGAUGAGGCCGAAAGGCCGAA AUAGAUG 345 682 GCUGGAA CUGAUGAGGCCGAAAGGCCGAA ACCCCUC 346 684 CAGCUGG CUGAUGAGGCCGAAAGGCCGAA AGACCCC 347 685 CCAGCUG CUGAUGAGGCCGAAAGGCCGAA AAGACCC 348 709 CAGCGCU CUGAUGAGGCCGAAAGGCCGAA AGUCGGU 349 721 GCCGAUU CUGAUGAGGCCGAAAGGCCGAA AUCUCAG 350 725 UCGGGCC CUGAUGAGGCCGAAAGGCCGAA AUUGAUC 351 735 GUCGAGA CUGAUGAGGCCGAAAGGCCGAA AGUCGGG 352 737 AAGUCGA CUGAUGAGGCCGAAAGGCCGAA AUAGUCG 353 739 CAAAGUC CUGAUGAGGCCGAAAGGCCGAA AGAUAGU 354 744 CUCGGCA CUGAUGAGGCCGAAAGGCCGAA AGUCGAG 355 745 ACUCGGC CUGAUGAGGCCGAAAGGCCGAA AAGUCGA 356 753 CUGCCCA CUGAUGAGGCCGAAAGGCCGAA ACUCGGC 357 763 CAAAGUA CUGAUGAGGCCGAAAGGCCGAA ACCUGCC 358 765 CCCAAAG CUGAUGAGGCCGAAAGGCCGAA AGACCUG 359 768 GAUCCCA CUGAUGAGGCCGAAAGGCCGAA AGUAGAC 360 769 UGAUCCC CUGAUGAGGCCGAAAGGCCGAA AAGUAGA 361 775 GGGCAAU CUGAUGAGGCCGAAAGGCCGAA AUCCCAA 362 778 ACAGGGC CUGAUGAGGCCGAAAGGCCGAA AUGAUCC 363 801 AAGGUUG CUGAUGAGGCCGAAAGGCCGAA AUGUUCG 364 808 GUUUGGG CUGAUGAGGCCGAAAGGCCGAA AGGUUGG 365 809 CGUUUGG CUGAUGAGGCCGAAAGGCCGAA AAGGUUG 366 820 GGCAGGG CUGAUGAGGCCGAAAGGCCGAA AGGCGUU 367 833 AUAAAGG CUGAUGAGGCCGAAAGGCCGAA AUUGGGG 368 837 GGUAAUA CUGAUGAGGCCGAAAGGCCGAA AGGGAUU 369 838 GGGUAAU CUGAUGAGGCCGAAAGGCCGAA AAGGGAU 370 839 GGGGUAA CUGAUGAGGCCGAAAGGCCGAA AAAGGGA 371 841 AGGGGGU CUGAUGAGGCCGAAAGGCCGAA AUAAAGG 372 842 GAGGGGG CUGAUGAGGCCGAAAGGCCGAA AAUAAAG 373 849 UCUGAAG CUGAUGAGGCCGAAAGGCCGAA AGGGGGU 374 852 GUGUCUG CUGAUGAGGCCGAAAGGCCGAA AGGAGGG 375 853 GGUGUCU CUGAUGAGGCCGAAAGGCCGAA AAGGAGG 376 863 AGAGGUU CUGAUGAGGCCGAAAGGCCGAA AGGGUGU 377 869 GCCAGAA CUGAUGAGGCCGAAAGGCCGAA AGGUUGA 378 871 GAGCCAG CUGAUGAGGCCGAAAGGCCGAA AGAGGUU 379 872 UGAGCCA CUGAUGAGGCCGAAAGGCCGAA AAGAGGU 380 878 UCUUUUU CUGAUGAGGCCGAAAGGCCGAA AGCCAGA 381 890 AGCCCCC CUGAUGAGGCCGAAAGGCCGAA AUUCUCU 382 898 CGACCCU CUGAUGAGGCCGAAAGGCCGAA AGCCCCC 383 899 CCGACCC CUGAUGAGGCCGAAAGGCCGAA AAGCCCC 384 904 GGGUUCC CUGAUGAGGCCGAAAGGCCGAA ACCCUAA 385 917 AAGUUCU CUGAUGAGGCCGAAAGGCCGAA AGCUUGG 386 918 AAAGUUC CUGAUGAGGCCGAAAGGCCGAA AAGCUUG 387 924 UUGCUUA CUGAUGAGGCCGAAAGGCCGAA AGUUCUA 388 925 GUUGCUU CUGAUGAGGCCGAAAGGCCGAA AAGUUCU 389 926 UGUUGCU CUGAUGAGGCCGAAAGGCCGAA AAAGUUC 390 945 GGUUUCG CUGAUGAGGCCGAAAGGCCGAA AGUGGUG 391 946 AGGUUUC CUGAUGAGGCCGAAAGGCCGAA AAGUGGU 392 959 AUUCCUG CUGAUGAGGCCGAAAGGCCGAA AUCCCAG 393 960 CAUUCCU CUGAUGAGGCCGAAAGGCCGAA AAUCCCA 3941001 GAAUUCU CUGAUGAGGCCGAAAGGCCGAA AGUGGUU 3951007 CAGUUUG CUGAUGAGGCCGAAAGGCCGAA AUUCUUA 3961008 CCAGUUU CUGAUGAGGCCGAAAGGCCGAA AAUUCUU 3971021 AGUUCUG CUGAUGAGGCCGAAAGGCCGAA AGGCCCC 3981029 CCCCAGU CUGAUGAGGCCGAAAGGCCGAA AGUUCUG 3991040 AAAGCUG CUGAUGAGGCCGAAAGGCCGAA AGGCCCC 4001046 GGGAUCA CUGAUGAGGCCGAAAGGCCGAA AGCUGUA 4011047 AGGGAUC CUGAUGAGGCCGAAAGGCCGAA AAGCUGU 4021051 UGUCAGG CUGAUGAGGCCGAAAGGCCGAA AUCAAAG 4031060 GAUUCCA CUGAUGAGGCCGAAAGGCCGAA AUGUCAG 4041067 GUCUCCA CUGAUGAGGCCGAAAGGCCGAA AUUCCAG 4051085 AGAACCA CUGAUGAGGCCGAAAGGCCGAA AGGCUCC 4061086 CAGAACC CUGAUGAGGCCGAAAGGCCGAA AAGGCUC 4071090 UGGCCAG CUGAUGAGGCCGAAAGGCCGAA ACCAAAG 4081091 CUGGCCA CUGAUGAGGCCGAAAGGCCGAA AACCAAA 4091113 UCUUCUC CUGAUGAGGCCGAAAGGCCGAA AGUCCUG 4101124 UCUAGGU CUGAUGAGGCCGAAAGGCCGAA AGGUCUU 4111129 CAAUUUC CUGAUGAGGCCGAAAGGCCGAA AGGUGAG 4121135 UUGUGUC CUGAUGAGGCCGAAAGGCCGAA AUUUCUA 4131151 AAGGCCU CUGAUGAGGCCGAAAGGCCGAA AGGUCCA 4141152 GAAGGCC CUGAUGAGGCCGAAAGGCCGAA AAGGUCC 4151158 AGAGAGG CUGAUGAGGCCGAAAGGCCGAA AGGCCUA 4161159 GAGAGAG CUGAUGAGGCCGAAAGGCCGAA AAGGCCU 4171162 CUGGAGA CUGAUGAGGCCGAAAGGCCGAA AGGAAGG 4181164 AUCUGGA CUGAUGAGGCCGAAAGGCCGAA AGAGGAA 4191166 ACAUCUG CUGAUGAGGCCGAAAGGCCGAA AGAGAGG 4201174 GUCUGGA CUGAUGAGGCCGAAAGGCCGAA ACAUCUG 4211175 AGUCUGG CUGAUGAGGCCGAAAGGCCGAA AACAUCU 4221176 AAGUCUG CUGAUGAGGCCGAAAGGCCGAA AAACAUC 4231183 CUCAAGG CUGAUGAGGCCGAAAGGCCGAA AGUCUGG 4241184 UCUCAAG CUGAUGAGGCCGAAAGGCCGAA AAGUCUG 4251187 GUGUCUC CUGAUGAGGCCGAAAGGCCGAA AGGAAGU 4261208 CCAUGGG CUGAUGAGGCCGAAAGGCCGAA AGGGCUG 4271224 AUAGAGG CUGAUGAGGCCGAAAGGCCGAA AGCUGGC 4281228 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AGGGAGC 4291230 ACAUAAA CUGAUGAGGCCGAAAGGCCGAA AGAGGGA 4301232 AAACAUA CUGAUGAGGCCGAAAGGCCGAA AUAGAGG 4311233 CAAACAU CUGAUGAGGCCGAAAGGCCGAA AAUAGAG 4321234 GCAAACA CUGAUGAGGCCGAAAGGCCGAA AAAUAGA 4331238 AAGUGCA CUGAUGAGGCCGAAAGGCCGAA ACAUAAA 4341239 CAAGUGC CUGAUGAGGCCGAAAGGCCGAA AACAUAA 4351245 UAAUCAC CUGAUGAGGCCGAAAGGCCGAA AGUGCAA 4361251 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUCACAA 4371252 UAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUCACA 4381254 AAUAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUCA 4391255 AAAUAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUC 4401256 UAAAUAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAU 4411258 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 4421259 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 4431261 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUAA 4441262 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUA 4451263 UAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAU 4461265 AAUAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 4471266 AAAUAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 4481267 UAAAUAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAA 4491269 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 4501270 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 4511272 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUAA 4521273 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUA 4531274 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAU 4541276 GUAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 4551277 UGUAAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 4561278 CUGUAAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAA 4571280 AUCUGUA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 4581281 CAUCUGU CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 4591282 UCAUCUG CUGAUGAGGCCGAAAGGCCGAA AAAUAAA 4601294 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA ACAUUCA 4611296 CCAAAUA CUGAUGAGGCCGAAAGGCCGAA AUACAUU 4621297 CCCAAAU CUGAUGAGGCCGAAAGGCCGAA AAUACAU 4631298 UCCCAAA CUGAUGAGGCCGAAAGGCCGAA AAAUACA 4641300 UCUCCCA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 4651301 GUCUCCC CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 4661315 CCCAGGA CUGAUGAGGCCGAAAGGCCGAA ACCCCGG 4671317 CCCCCAG CUGAUGAGGCCGAAAGGCCGAA AUACCCC 4681334 CAGCUCC CUGAUGAGGCCGAAAGGCCGAA ACAUUGG 4691345 CUGAGCC CUGAUGAGGCCGAAAGGCCGAA AGGCAGC 4701350 CAUGUCU CUGAUGAGGCCGAAAGGCCGAA AGCCAAG 4711359 CACGGAA CUGAUGAGGCCGAAAGGCCGAA ACAUGUC 4721360 UCACGGA CUGAUGAGGCCGAAAGGCCGAA AACAUGU 4731361 UUCACGG CUGAUGAGGCCGAAAGGCCGAA AAACAUG 4741362 UUUCACG CUGAUGAGGCCGAAAGGCCGAA AAAACAU 4751386 AACAGCC CUGAUGAGGCCGAAAGGCCGAA AUUGUUC 4761393 ACAUGGG CUGAUGAGGCCGAAAGGCCGAA ACAGCCU 4771394 UACAUGG CUGAUGAGGCCGAAAGGCCGAA AACAGCC 4781401 AGGGGGC CUGAUGAGGCCGAAAGGCCGAA ACAUGGG 4791414 AGGCACA CUGAUGAGGCCGAAAGGCCGAA AGGCCAG 4801422 UCAAAAG CUGAUGAGGCCGAAAGGCCGAA AGGCACA 4811423 AUCAAAA CUGAUGAGGCCGAAAGGCCGAA AAGGCAC 4821425 UAAUCAA CUGAUGAGGCCGAAAGGCCGAA AGAAGGC 4831426 AUAAUCA CUGAUGAGGCCGAAAGGCCGAA AAGAAGG 4841427 CAUAAUC CUGAUGAGGCCGAAAGGCCGAA AAAGAAG 4851431 AAAACAU CUGAUGAGGCCGAAAGGCCGAA AUCAAAA 4861432 AAAAACA CUGAUGAGGCCGAAAGGCCGAA AAUCAAA 4871436 UUUAAAA CUGAUGAGGCCGAAAGGCCGAA ACAUAAU 4881437 UUUUAAA CUGAUGAGGCCGAAAGGCCGAA AACAUAA 4891438 AUUUUAA CUGAUGAGGCCGAAAGGCCGAA AAACAUA 4901439 UAUUUUA CUGAUGAGGCCGAAAGGCCGAA AAAACAU 4911440 AUAUUUU CUGAUGAGGCCGAAAGGCCGAA AAAAACA 4921441 AAUAUUU CUGAUGAGGCCGAAAGGCCGAA AAAAAAC 4931446 CAGAUAA CUGAUGAGGCCGAAAGGCCGAA AUUUUAA 4941448 AUCAGAU CUGAUGAGGCCGAAAGGCCGAA AUAUUUU 4951449 AAUCAGA CUGAUGAGGCCGAAAGGCCGAA AAUAUUU 4961451 UUAAUCA CUGAUGAGGCCGAAAGGCCGAA AUAAUAU 4971456 ACAACUU CUGAUGAGGCCGAAAGGCCGAA AUCAGAU 4981457 GACAACU CUGAUGAGGCCGAAAGGCCGAA AAUCAGA 4991461 UUUAGAC CUGAUGAGGCCGAAAGGCCGAA ACUUAAU 5001464 UUGUUUA CUGAUGAGGCCGAAAGGCCGAA ACAACUU 5011466 CAUUGUU CUGAUGAGGCCGAAAGGCCGAA AGACAAC 5021479 GUCACCA CUGAUGAGGCCGAAAGGCCGAA AUCAGCA 5031480 GGUCACC CUGAUGAGGCCGAAAGGCCGAA AAUCAGC 5041494 AAUGAGU CUGAUGAGGCCGAAAGGCCGAA ACAGUUG 5051498 CAGCAAU CUGAUGAGGCCGAAAGGCCGAA AGUGACA 5061501 CCUCAGC CUGAUGAGGCCGAAAGGCCGAA AUGAGUG 5071512 GGGAGCA CUGAUGAGGCCGAAAGGCCGAA AGGCCUC 5081517 CCCUGGG CUGAUGAGGCCGAAAGGCCGAA AGCAGAG 5091528 CAGACAC CUGAUGAGGCCGAAAGGCCGAA ACUCCCU 5101533 GAUUACA CUGAUGAGGCCGAAAGGCCGAA ACACAAC 5111537 GGCCGAU CUGAUGAGGCCGAAAGGCCGAA ACAGACA 5121540 GUAGGCC CUGAUGAGGCCGAAAGGCCGAA AUUACAG 5131546 UGAAUAG CUGAUGAGGCCGAAAGGCCGAA AGGCCGA 5141549 CACUGAA CUGAUGAGGCCGAAAGGCCGAA AGUAGGC 5151551 GCCACUG CUGAUGAGGCCGAAAGGCCGAA AUAGUAG 5161552 CGCCACU CUGAUGAGGCCGAAAGGCCGAA AAUAGUA 5171566 CAACCUU CUGAUGAGGCCGAAAGGCCGAA AUUUCUC 5181572 CCUAAGC CUGAUGAGGCCGAAAGGCCGAA ACCUUUA 5191576 CUUUCCU CUGAUGAGGCCGAAAGGCCGAA AGCAACC 5201577 UCUUUCC CUGAUGAGGCCGAAAGGCCGAA AAGCAAC 521__________________________________________________________________________ TABLE IV__________________________________________________________________________Mouse TNF-a HH Target Sequencesnt. Sequence nt. SequencePosition HH Target Sequence ID No. Position HH Target Sequence ID No.__________________________________________________________________________ 66 UgGAAAU a GcucCcA 522 324 GgGUGAU C GGuCCCC 562 101 GGCAGGU U CUgUcCC 523 347 GAGAagU u cCCAaaU 563 101 GGCAGgU u CUGUccC 524 364 CCUCcCU C UcAUCAG 564 102 GCAGGUU C UgUcCCU 525 366 UCcCUCU c AUCAGuu 565 102 gCAGgUU c ugUCCCU 526 366 UcCCUCU C auCAGuU 566 106 GUUCUgU c CCUuUCA 527 369 CUCUcAU C AGuuCUa 567 110 UgUcCCU u UCACucA 528 376 CAGuuCU a UGGCCCA 568 111 gUCcCUU u CaCUCAC 529 390 AgACCCU C AcaCUcA 569 111 guCCCuU u CACuCAc 530 396 ucaCAcU C AGAUCAU 570 112 UcCCUuU C ACucACU 531 401 cUCAGAU C AUCUUCU 571 116 UuUCACU C AcUGgcc 532 404 AGAUCAU C UUCUCaA 572 137 GCCaCAU C uCCcUCc 533 406 AUCAUCU U CUCaAAa 573 139 caCAuCU C CCUCcAg 534 406 AUcAUcU U cUcaAAA 574 177 GCAUGAU C CGcGACG 535 407 UCAUCUU C UCaAAau 575 207 AGGCaCU C CCCcAaA 536 409 AUCUUCU C aAAauuC 576 228 GGGGCuU C CAGAACU 537 409 AuCuuCU c AaAAUUC 577 228 GGGGCuU c CAGaacU 538 409 aUcUUcU c AAAauUc 578 236 CAGaaCU C CAGGCGG 539 432 ACCCUGU A GCCCAcG 579 236 CAGaACU c cAGgcGg 540 249 GGugCCU a UgUCUcA 541 249 GGuGCCU a UGucUCa 542 444 AcGUcGU A GCAAACC 580 501 AcGCCCU C CUGGCCA 581 261 UCAGCCU C UUCUCaU 543 560 gGgUUGU a CCUuguC 582 261 UCAgCCU C UUCUcau 544 560 GGguUGU A CCUugUC 583 263 AGCCUCU U CUCaUUC 545 564 UGUACCU u gUCUACU 584 263 AgCCUCU U CUcauUC 546 567 ACCUugU C UACUCCC 585 264 GCCUCUU C UCaUUCC 547 569 CUugUCU A CUCCCAG 586 264 gCCUCUU C UcauUCc 548 572 gUCUACU C CCAGGUu 587 266 CUCUUCU C aUUCCUG 549 572 GUCUaCU c CCAGguu 588 269 UUCUCaU U CCUGcUu 550 572 GuCUacU C CCAgGUu 589 270 UCUCaUU C CUGcUuG 551 579 CCCAGGU u CUCUUCA 590 276 UCCUGcU u GUGGCAG 552 580 CCAGguU c uCUUcAa 591 297 CCACGCU C UUCUGuC 553 580 CCaGGuU c UCuUcaa 592 299 ACGCUCU U CUGuCUa 554 582 AGGUUCU C UUCaagg 593 300 CGCUCUU C UGuCUaC 555 582 AGGUuCU C UUCAAGG 594 304 CUuCUgU c uAcUGaa 556 584 GUuCUCU U CAAGGGa 595 306 UcUGUcU a cUgAAcU 557 585 UuCUCUU C AAGGGaC 596 314 CUGaACU U cGGgGUG 558 608 CcCGaCU a CgugCUC 597 315 UGaACUU c GGgGUGA 559 615 aCgUGcU C CUCAcCC 598 315 uGaaCUU c GGGguGa 560 615 AcGUGCU C CUCACCC 599 324 gGGUGaU c GgUCCcC 561 618 UGCUCCU C ACCCACA 600 630 ACACCgU C AGCCGau 601 940 GuCUACU c cUCAGaG 650 630 ACACCgU C AgCCgaU 602 943 UACUccU C AGaGcCc 651 638 agcCgAU u uGCUaUc 603 972 UCUaaCU u AgAAAGg 652 643 aUUUGcU a uCUcAuA 604 972 ucUaaCU u AGAaAgG 653 645 UuGCuaU C UCaUACC 605 973 CUaACuU A GAAAggG 654 647 GCuaUCU C aUACCAG 606 984 AGgGgAU U auGGcuc 655 663 agAAaGU C AACCUCC 607 984 AGGGgaU U aUGgCUc 656 669 UCAACCU C CUCUCUG 608 985 GGGGauU a uGGcUCa 657 669 UcAAccU c cUcUCUG 609 997 UcAGAgU c CAAcucu 658 672 ACCUCCU C UCUGCCg 610 1010 CuguGCU c AGAgCUU 659 674 CUCCUCU C UGCCgUC 611 1017 cAGAgCU U UcAaCAA 660 681 cUGCCgU C AagaGcC 612 1018 AGAgCUU U cAaCAAC 661 681 CUGCCgU C AAGAGCC 613 1019 GAgCUUU c AaCAACu 662 681 CUGcCgU C aaGAgcC 614 1073 UgGGCCU c ucAUgCA 663 734 CCCUGGU A UGAGCCC 615 1096 AAGgAcU C AAAugGG 664 734 CccUGGU a ugaGCCc 616 1106 aUGGGcU U uccGAAU 665 744 AGCCCAU a UAcCUGG 617 1107 UGGGcUU u ccGAAUu 666 746 CCCAUaU A cCUGGGA 618 1108 GGgCuUU c cGaaUUC 667 759 GAgGAGU C uuCCAGc 619 1115 CcGAAuU C ACUGGaG 668 759 GAGGaGU C UUCCAGC 620 1133 CGAAugU C CAuuCcU 669 761 GGaGUCU U CCAGCUG 621 1164 gagUGgU c AgGUUGc 670 762 GaGUCUU C CAGCUGG 622 1180 UcUgUcU c agaAUGA 671 786 ACCaACU C AGCGCUG 623 1203 aaGAuCU c AGGCCUU 672 798 CUGAGgU C AAUCuGC 624 1210 cAGGCCU U CCUacCU 673 802 GgUCAAU C uGCCCaA 625 1211 AGGCCUU C CUacCUu 674 812 CCCaAgU A cuUaGAC 626 1214 CCUUCCU a cCUuCAG 675 816 AgUAcuU a GACUUUG 627 1218 CcuACcU u CaGACCu 676 821 uUaGACU U UGCgGAG 628 1218 CCuaCCU U CAGACcu 677 822 UaGACUU U GCgGAGU 629 1218 cCuACcU u cAgACCU 678 830 GCgGAGU C cGGGCAG 630 1218 CCUacCU u CAGAccU 679 840 GGCAGGU C UACUUUG 631 1219 CuaCCUU C AGACcuu 680 842 CAGGUCU A CUUUGGa 632 1219 CuAcCUU c agACcUU 681 842 CAGgucU a CUUugGA 633 1226 CagACCU U uCCAgAC 682 842 cagGuCU a CUUUgGA 634 1226 CAGAccU U UCCAGAC 683 845 GUCUACU U UGGagUC 635 1227 agACCUU u CCAgACu 684 846 UCUACUU U GGagUCA 636 1227 GAccUUU C CCAGACU 685 852 UUGGagU C AUUGCuC 637 1228 GAccUUU C CAGACUc 686 855 GagUCAU U GCuCUGU 638 1238 gACUCuU c cCUGAGG 687 887 AUCCaUU c ucUACCC 639 1262 CAGCCuU C CuCAcaG 688 891 AuucuCU a CCCaGCC 640 1283 CCCCccU C uaUUUAU 689 905 CCcCaCU C UgaCCCC 641 1283 cCcCCCU C UAUUUAU 690 905 cCCCacU c UgACCCC 642 1285 cCCCUCU A UUUAUaU 691 905 CcCCACU c uGAccCC 643 1287 CcuCUAU u UauAuUU 692 914 GAcCCcU U uacUCUG 644 1287 CCUCUAU U UAUaUUU 693 915 ACCCCuU u acUCuGA 645 1288 CUCUAUU U AUaUUUG 694 919 CUUUAcU c ugaCCcC 646 1289 UCUAUUU A UaUUUGC 695 928 GACCcCU u UaUugUC 647 1293 UUUAUaU U UGCACUU 696 928 gAcCCCU U UAUUguC 648 1293 uUUaUaU u UGcAcUu 697 932 CCUUUAU U guCuaCU 649 1294 UUAUaUU U GCACUUa 6981300 UUGCACU U aUuAUUu 699 1462 aCCuUGU u GCCuCCU 7471303 CAcuUaU u AuUuAUU 700 1470 GccuCcU C UUUUGcU 7481304 acUuAUU A UUUAUUA 701 1472 cuCcUCU U UUGcUUA 7491306 UuAUUAU U UAUUAUU 702 1473 uCcUCUU U UGcUUAU 7501307 uAUUAUU U AUUAUUU 703 1474 CcUCUUU U GcUUAUG 7511307 UaUUaUU U AuuAUuU 704 1478 UUUUGcU U AUGUUUa 7521308 UUAUUU A UUAUUUA 705 1479 UUUGcUU a UGuuuAa 7531310 UauUuAU U AUUUAUU 706 1479 UUUGcUU A UGUUUaa 7541310 UAUUUAU U AUUUAUU 707 1484 UUAUGUU U aaaAcAA 7551310 UAUUUAU U AUUUAUU 708 1498 AAAuauU U AUCUaAc 7561311 AUUUAUU A UUUAUUU 709 1511 AcccAaU U GUCUuAA 7571311 AUUUAUU A UUUAUUU 710 1514 cAaUUGU C UuAAuAA 7581311 AuuUAUU A UuUauUU 711 1516 aUUGUCU u AAuAAcG 7591313 UUAUUAU U UAUUUAU 712 1529 CgcugAU u UGGuGAC 7601313 UUAUUAU U UAUUUAU 713 1529 cGCUGAU U UGGUGAC 7611313 uUAUUAU u UauUUAu 714 1530 gCUGAUU u gGUgacC 7621314 UAUUAUU U AUUUAUU 715 1530 GCUGAUU U GGUGACC 7631314 UAUUAUU U AUUUAUU 716 1563 UgaAcCU c UGcUCCC 7641315 AUUAUUU A UUUAUUA 717 1563 ugaaCCU C UGCUCCC 7651317 UAUUUAU U UAUUAUU 718 1568 CUCUGCU C CCCAcGG 7661318 AUUUAUU U AUUAUUU 719 1589 UGaCUGU A AUuGcCC 7671319 UUUAUUU A UUAUUUA 720 1592 CUGUAAU u GcCCUAC 7681326 AUUAUUU A UUUAUUU 721 1617 GAGAAAU A AAGaUcG 7691328 UAUUUAU U UAUUUgC 722 1623 UAAAGaU c GCUUAaa 7701329 AUUUAUU U AUUUgCu 723 1633 UUAaaaU a aaAAaCC 7711330 UUUAUUU A UUUgCuu 724 25 AgGgaCU a gCCagGA 7721332 UAUUUAU U UgCuuAU 7251333 AUUUAUU U gCuuAUG 7261337 auUUGCU U AuGAAuG 7271338 uUUGCUU A uGAAuGu 7281346 UGAAUGU A UUUAUUU 7291348 AAUGUAU U UAUUUGG 7301349 AUGUAUU U AUUUGGa 7311350 UGUAUUU A UUUGGaA 7321352 uAUuUAU u UGGaAGG 7331352 UAUUUAU U UGGaAGg 7341353 AUUUAUU U GGaAGgC 7351369 GGGGUgU C CUGGaGG 7361398 gCUguCU U cAGACAg 7371398 GCUGuCU U cagaCAG 7381412 GACAUGU U UUCuGUG 7391413 ACAUGUU U UCuGUGA 7401414 CAUGUUU U CuGUGAA 7411415 AUGUUUU C uGUGAAA 7421415 AUGUUUU c UgugAaA 7431438 gaGCUGU c CCCAccU 7441451 CUGGCCU C UcUaCCU 7451453 ggCCUCU C UaCCuUG 746__________________________________________________________________________ TABLE V__________________________________________________________________________Mouse TNF-a Hammerhead Ribozyme Sequencesnt. SequencePosition Mouse HH Ribozyme Sequence ID No.__________________________________________________________________________ 25 UCCUGGC CUGAUGAGGCCGAAAGGCCGAA AGUCCCU 773 66 UGGGAGC CUGAUGAGGCCGAAAGGCCGAA AUUUCCA 774 101 GGGACAG CUGAUGAGGCCGAAAGGCCGAA ACCUGCC 775 101 GGGACAG CUGAUGAGGCCGAAAGGCCGAA ACCUGCC 776 102 AGGGACA CUGAUGAGGCCGAAAGGCCGAA AACCUGC 777 102 AGGGACA CUGAUGAGGCCGAAAGGCCGAA AACCUGC 778 106 UGAAAGG CUGAUGAGGCCGAAAGGCCGAA ACAGAAC 779 110 UGAGUGA CUGAUGAGGCCGAAAGGCCGAA AGGGACA 780 111 GUGAGUG CUGAUGAGGCCGAAAGGCCGAA AAGGGAC 781 111 GUGAGUG CUGAUGAGGCCGAAAGGCCGAA AAGGGAC 782 112 AGUGAGU CUGAUGAGGCCGAAAGGCCGAA AAAGGGA 783 116 GGCCAGU CUGAUGAGGCCGAAAGGCCGAA AGUGAAA 784 137 GGAGGGA CUGAUGAGGCCGAAAGGCCGAA AUGUGGC 785 139 CUGGAGG CUGAUGAGGCCGAAAGGCCGAA AGAUGUG 786 177 CGUCGCG CUGAUGAGGCCGAAAGGCCGAA AUCAUGC 787 207 UUUGGGG CUGAUGAGGCCGAAAGGCCGAA AGUGCCU 788 228 AGUUCUG CUGAUGAGGCCGAAAGGCCGAA AAGCCCC 789 228 AGUUCUG CUGAUGAGGCCGAAAGGCCGAA AAGCCCC 790 236 CCGCCUG CUGAUGAGGCCGAAAGGCCGAA AGUUCUG 791 236 CCGCCUG CUGAUGAGGCCGAAAGGCCGAA AGUUCUG 792 249 UGAGACA CUGAUGAGGCCGAAAGGCCGAA AGGCACC 793 249 UGAGACA CUGAUGAGGCCGAAAGGCCGAA AGGCACC 794 261 AUGAGAA CUGAUGAGGCCGAAAGGCCGAA AGGCUGA 795 261 AUGAGAA CUGAUGAGGCCGAAAGGCCGAA AGGCUGA 796 263 GAAUGAG CUGAUGAGGCCGAAAGGCCGAA AGAGGCU 797 263 GAAUGAG CUGAUGAGGCCGAAAGGCCGAA AGAGGCU 798 264 GGAAUGA CUGAUGAGGCCGAAAGGCCGAA AAGAGGC 799 264 GGAAUGA CUGAUGAGGCCGAAAGGCCGAA AAGAGGC 800 266 CAGGAAU CUGAUGAGGCCGAAAGGCCGAA AGAAGAG 801 269 AAGCAGG CUGAUGAGGCCGAAAGGCCGAA AUGAGAA 802 270 CAAGCAG CUGAUGAGGCCGAAAGGCCGAA AAUGAGA 803 276 CUGCCAC CUGAUGAGGCCGAAAGGCCGAA AGCAGGA 804 297 GACAGAA CUGAUGAGGCCGAAAGGCCGAA AGCGUGG 805 299 UAGACAG CUGAUGAGGCCGAAAGGCCGAA AGAGCGU 806 300 GUAGACA CUGAUGAGGCCGAAAGGCCGAA AAGAGCG 807 304 UUCAGUA CUGAUGAGGCCGAAAGGCCGAA ACAGAAG 808 306 AGUUCAG CUGAUGAGGCCGAAAGGCCGAA AGACAGA 809 314 CACCCCG CUGAUGAGGCCGAAAGGCCGAA AGUUCAG 810 315 UCACCCC CUGAUGAGGCCGAAAGGCCGAA AAGUUCA 811 315 UCACCCC CUGAUGAGGCCGAAAGGCCGAA AAGUUCA 812 324 GGGGACC CUGAUGAGGCCGAAAGGCCGAA AUCACCC 813 324 GGGGACC CUGAUGAGGCCGAAAGGCCGAA AUCACCC 814 347 AUUUGGG CUGAUGAGGCCGAAAGGCCGAA ACUUCUC 815 364 CUGAUGA CUGAUGAGGCCGAAAGGCCGAA AGGGAGG 816 366 AACUGAU CUGAUGAGGCCGAAAGGCCGAA AGAGGGA 817 366 AACUGAU CUGAUGAGGCCGAAAGGCCGAA AGAGGGA 818 369 UAGAACU CUGAUGAGGCCGAAAGGCCGAA AUGAGAG 819 376 UGGGCCA CUGAUGAGGCCGAAAGGCCGAA AGAACUG 820 390 UGAGUGU CUGAUGAGGCCGAAAGGCCGAA AGGGUCU 821 396 AUGAUCU CUGAUGAGGCCGAAAGGCCGAA AGUGUGA 822 401 AGAAGAU CUGAUGAGGCCGAAAGGCCGAA AUCUGAG 823 404 UUGAGAA CUGAUGAGGCCGAAAGGCCGAA AUGAUCU 824 406 UUUUGAG CUGAUGAGGCCGAAAGGCCGAA AGAUGAU 825 406 UUUUGAG CUGAUGAGGCCGAAAGGCCGAA AGAUGAU 826 407 AUUUUGA CUGAUGAGGCCGAAAGGCCGAA AAGAUGA 827 409 GAAUUUU CUGAUGAGGCCGAAAGGCCGAA AGAAGAU 828 409 GAAUUUU CUGAUGAGGCCGAAAGGCCGAA AGAAGAU 829 409 GAAUUUU CUGAUGAGGCCGAAAGGCCGAA AGAAGAU 830 432 CGUGGGC CUGAUGAGGCCGAAAGGCCGAA ACAGGCU 831 444 GGUUUGC CUGAUGAGGCCGAAAGGCCGAA ACGACGU 832 501 UGGCCAG CUGAUGAGGCCGAAAGGCCGAA AGGGCGU 833 560 GACAAGG CUGAUGAGGCCGAAAGGCCGAA ACAACCC 834 560 GACAAGG CUGAUGAGGCCGAAAGGCCGAA ACAACCC 835 564 AGUAGAC CUGAUGAGGCCGAAAGGCCGAA AGGUACA 836 567 GGGAGUA CUGAUGAGGCCGAAAGGCCGAA ACAAGGU 837 569 CUGGGAG CUGAUGAGGCCGAAAGGCCGAA AGACAAG 838 572 AACCUGG CUGAUGAGGCCGAAAGGCCGAA AGUAGAC 839 572 AACCUGG CUGAUGAGGCCGAAAGGCCGAA AGUAGAC 840 572 AACCUGG CUGAUGAGGCCGAAAGGCCGAA AGUAGAC 841 579 UGAAGAG CUGAUGAGGCCGAAAGGCCGAA ACCUGGG 842 580 UUGAAGA CUGAUGAGGCCGAAAGGCCGAA AACCUGG 843 580 UUGAAGA CUGAUGAGGCCGAAAGGCCGAA AACCUGG 844 582 CCUUGAA CUGAUGAGGCCGAAAGGCCGAA AGAACCU 845 582 CCUUGAA CUGAUGAGGCCGAAAGGCCGAA AGAACCU 846 584 UCCCUUG CUGAUGAGGCCGAAAGGCCGAA AGAGAAC 847 585 GUCCCUU CUGAUGAGGCCGAAAGGCCGAA AAGAGAA 848 608 GAGCACG CUGAUGAGGCCGAAAGGCCGAA AGUCGGG 849 615 GGGUGAG CUGAUGAGGCCGAAAGGCCGAA AGCACGU 850 615 GGGUGAG CUGAUGAGGCCGAAAGGCCGAA AGCACGU 851 618 UGUGGGU CUGAUGAGGCCGAAAGGCCGAA AGGAGCA 852 630 AUCGGCU CUGAUGAGGCCGAAAGGCCGAA ACGGUGU 853 630 AUCGGCU CUGAUGAGGCCGAAAGGCCGAA ACGGUGU 854 638 GAUAGCA CUGAUGAGGCCGAAAGGCCGAA AUCGGCU 855 643 UAUGAGA CUGAUGAGGCCGAAAGGCCGAA AGCAAAU 856 645 GGUAUGA CUGAUGAGGCCGAAAGGCCGAA AUAGCAA 857 647 CUGGUAU CUGAUGAGGCCGAAAGGCCGAA AGAUAGC 858 663 GGAGGUU CUGAUGAGGCCGAAAGGCCGAA ACUUUCU 859 669 CAGAGAG CUGAUGAGGCCGAAAGGCCGAA AGGUUGA 860 669 CAGAGAG CUGAUGAGGCCGAAAGGCCGAA AGGUUGA 861 672 CGGCAGA CUGAUGAGGCCGAAAGGCCGAA AGGAGGU 862 674 GACGGCA CUGAUGAGGCCGAAAGGCCGAA AGAGGAG 863 681 GGCUCUU CUGAUGAGGCCGAAAGGCCGAA ACGGCAG 864 681 GGCUCUU CUGAUGAGGCCGAAAGGCCGAA ACGGCAG 865 681 GGCUCUU CUGAUGAGGCCGAAAGGCCGAA ACGGCAG 866 734 GGGCUCA CUGAUGAGGCCGAAAGGCCGAA ACCAGGG 867 734 GGGCUCA CUGAUGAGGCCGAAAGGCCGAA ACCAGGG 868 744 CCAGGUA CUGAUGAGGCCGAAAGGCCGAA AUGGGCU 869 746 UCCCAGG CUGAUGAGGCCGAAAGGCCGAA AUAUGGG 870 759 GCUGGAA CUGAUGAGGCCGAAAGGCCGAA ACUCCUC 871 759 GCUGGAA CUGAUGAGGCCGAAAGGCCGAA ACUCCUC 872 761 CAGCUGG CUGAUGAGGCCGAAAGGCCGAA AGACUCC 873 762 CCAGCUG CUGAUGAGGCCGAAAGGCCGAA AAGACUC 874 786 CAGCGCU CUGAUGAGGCCGAAAGGCCGAA AGUUGGU 875 798 GCAGAUU CUGAUGAGGCCGAAAGGCCGAA ACCUCAG 876 802 UUGGGCA CUGAUGAGGCCGAAAGGCCGAA AUUGACC 877 812 GUCUAAG CUGAUGAGGCCGAAAGGCCGAA ACUUGGG 878 816 CAAAGUC CUGAUGAGGCCGAAAGGCCGAA AAGUACU 879 821 CUCCGCA CUGAUGAGGCCGAAAGGCCGAA AGUCUAA 880 822 ACUCCGC CUGAUGAGGCCGAAAGGCCGAA AAGUCUA 881 830 CUGCCCG CUGAUGAGGCCGAAAGGCCGAA ACUCCGC 882 840 CAAAGUA CUGAUGAGGCCGAAAGGCCGAA ACCUGCC 883 842 UCCAAAG CUGAUGAGGCCGAAAGGCCGAA AGACCUG 884 842 UCCAAAG CUGAUGAGGCCGAAAGGCCGAA AGACCUG 885 842 UCCAAAG CUGAUGAGGCCGAAAGGCCGAA AGACCUG 886 845 GACUCCA CUGAUGAGGCCGAAAGGCCGAA AGUAGAC 887 846 UGACUCC CUGAUGAGGCCGAAAGGCCGAA AAGUAGA 888 852 GAGCAAU CUGAUGAGGCCGAAAGGCCGAA ACUCCAA 889 855 ACAGAGC CUGAUGAGGCCGAAAGGCCGAA AUGACUC 890 887 GGGUAGA CUGAUGAGGCCGAAAGGCCGAA AAUGGAU 891 891 GGCUGGG CUGAUGAGGCCGAAAGGCCGAA AGAGAAU 892 905 GGGGUCA CUGAUGAGGCCGAAAGGCCGAA AGUGGGG 893 905 GGGGUCA CUGAUGAGGCCGAAAGGCCGAA AGUGGGG 894 905 GGGGUCA CUGAUGAGGCCGAAAGGCCGAA AGUGGGG 895 914 CAGAGUA CUGAUGAGGCCGAAAGGCCGAA AGGGGUC 896 915 UCAGAGU CUGAUGAGGCCGAAAGGCCGAA AAGGGGU 897 919 GGGGUCA CUGAUGAGGCCGAAAGGCCGAA AGUAAAG 898 928 GACAAUA CUGAUGAGGCCGAAAGGCCGAA AGGGGUC 899 928 GACAAUA CUGAUGAGGCCGAAAGGCCGAA AGGGGUC 900 932 AGUAGAC CUGAUGAGGCCGAAAGGCCGAA AUAAAGG 901 940 CUCUGAG CUGAUGAGGCCGAAAGGCCGAA AGUAGAC 902 943 GGGCUCU CUGAUGAGGCCGAAAGGCCGAA AGGAGUA 903 972 CCUUUCU CUGAUGAGGCCGAAAGGCCGAA AGUUAGA 904 972 CCUUUCU CUGAUGAGGCCGAAAGGCCGAA AGUUAGA 905 973 CCCUUUC CUGAUGAGGCCGAAAGGCCGAA AAGUUAG 906 984 GAGCCAU CUGAUGAGGCCGAAAGGCCGAA AUCCCCU 907 984 GAGCCAU CUGAUGAGGCCGAAAGGCCGAA AUCCCCU 908 985 UGAGCCA CUGAUGAGGCCGAAAGGCCGAA AAUCCCC 909 997 AGAGUUG CUGAUGAGGCCGAAAGGCCGAA ACUCUGA 9101010 AAGCUCU CUGAUGAGGCCGAAAGGCCGAA AGCACAG 9111017 UUUUUGA CUGAUGAGGCCGAAAGGCCGAA AGCUCUG 9121018 GUUGUUG CUGAUGAGGCCGAAAGGCCGAA AAGCUCU 9131019 AGUUGUU CUGAUGAGGCCGAAAGGCCGAA AAAGCUC 9141073 UGCAUGA CUGAUGAGGCCGAAAGGCCGAA AGGCCCA 9151096 CCCAUUU CUGAUGAGGCCGAAAGGCCGAA AGUCCUU 9161106 AUUCGGA CUGAUGAGGCCGAAAGGCCGAA AGCCCAU 9171107 AAUUCGG CUGAUGAGGCCGAAAGGCCGAA AAGCCCA 9181108 GAAUUCG CUGAUGAGGCCGAAAGGCCGAA AAAGCCC 9191115 CUCCAGU CUGAUGAGGCCGAAAGGCCGAA AAUUCGG 9201133 AGGAAUG CUGAUGAGGCCGAAAGGCCGAA ACAUUCG 9211164 GCAACCU CUGAUGAGGCCGAAAGGCCGAA ACCACUC 9221180 UCAUUCU CUGAUGAGGCCGAAAGGCCGAA AGACAGA 9231203 AAGGCCU CUGAUGAGGCCGAAAGGCCGAA AGAUCUU 9241210 AGGUAGG CUGAUGAGGCCGAAAGGCCGAA AGGCCUG 9251211 AAGGUAG CUGAUGAGGCCGAAAGGCCGAA AAGGCCU 9261214 CUGAAGG CUGAUGAGGCCGAAAGGCCGAA AGGAAGG 9271218 AGGUCUG CUGAUGAGGCCGAAAGGCCGAA AGGUAGG 9281218 AGGUCUG CUGAUGAGGCCGAAAGGCCGAA AGGUAGG 9291218 AGGUCUG CUGAUGAGGCCGAAAGGCCGAA AGGUAGG 9301218 AGGUCUG CUGAUGAGGCCGAAAGGCCGAA AGGUAGG 9311219 AAGGUCU CUGAUGAGGCCGAAAGGCCGAA AAGGUAG 9321219 AAGGUCU CUGAUGAGGCCGAAAGGCCGAA AAGGUAG 9331226 GUCUGGA CUGAUGAGGCCGAAAGGCCGAA AGGUCUG 9341226 GUCUGGA CUGAUGAGGCCGAAAGGCCGAA AGGUCUG 9351227 AGUCUGG CUGAUGAGGCCGAAAGGCCGAA AAGGUCU 9361227 AGUCUGG CUGAUGAGGCCGAAAGGCCGAA AAGGUCU 9371228 GAGUCUG CUGAUGAGGCCGAAAGGCCGAA AAAGGUC 9381238 CCUCAGG CUGAUGAGGCCGAAAGGCCGAA AAGAGUC 9391262 CUGUGAG CUGAUGAGGCCGAAAGGCCGAA AAGGCUG 9401283 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AGGGGGG 9411283 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AGGGGGG 9421285 AUAUAAA CUGAUGAGGCCGAAAGGCCGAA AGAGGGG 9431287 AAAUAUA CUGAUGAGGCCGAAAGGCCGAA AUAGAGG 9441287 AAAUAUA CUGAUGAGGCCGAAAGGCCGAA AUAGAGG 9451288 CAAAUAU CUGAUGAGGCCGAAAGGCCGAA AAUAGAG 9461289 GCAAAUA CUGAUGAGGCCGAAAGGCCGAA AAAUAGA 9471293 AAGUGCA CUGAUGAGGCCGAAAGGCCGAA AUAUAAA 9481293 AAGUGCA CUGAUGAGGCCGAAAGGCCGAA AUAUAAA 9491294 UAAGUGC CUGAUGAGGCCGAAAGGCCGAA AAUAUAA 9501300 AAAUAAU CUGAUGAGGCCGAAAGGCCGAA AGUGCAA 9511303 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUAAGUG 9521304 UAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUAAGU 9531306 AAUAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUAA 9541307 AAAUAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUA 9551307 AAAUAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUA 9561308 UAAAUAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAU 9571310 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9581310 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9591310 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9601311 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9611311 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9621311 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9631313 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUAA 9641313 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUAA 9651313 AUAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAUAA 9661314 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUA 9671314 AAUAAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAUA 9681315 UAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAU 9691317 AAUAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9701318 AAAUAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9711319 UAAAUAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAA 9721326 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAU 9731328 GCAAAUA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9741329 AGCAAAU CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9751330 AAGCAAA CUGAUGAGGCCGAAAGGCCGAA AAAUAAA 9761332 AUAAGCA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9771333 CAUAAGC CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9781337 CAUUCAU CUGAUGAGGCCGAAAGGCCGAA AGCAAAU 9791338 ACAUUCA CUGAUGAGGCCGAAAGGCCGAA AAGCAAA 9801346 AAAUAAA CUGAUGAGGCCGAAAGGCCGAA ACAUUCA 9811348 CCAAAUA CUGAUGAGGCCGAAAGGCCGAA AUACAUU 9821349 UCCAAAU CUGAUGAGGCCGAAAGGCCGAA AAUACAU 9831350 UUCCAAA CUGAUGAGGCCGAAAGGCCGAA AAAUACA 9841352 CCUUCCA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9851352 CCUUCCA CUGAUGAGGCCGAAAGGCCGAA AUAAAUA 9861353 GCCUUCC CUGAUGAGGCCGAAAGGCCGAA AAUAAAU 9871369 CCUCCAG CUGAUGAGGCCGAAAGGCCGAA ACACCCC 9881398 CUGUCUG CUGAUGAGGCCGAAAGGCCGAA AGACAGC 9891398 CUGUCUG CUGAUGAGGCCGAAAGGCCGAA AGACAGC 9901412 CACAGAA CUGAUGAGGCCGAAAGGCCGAA ACAUGUC 9911413 UCACAGA CUGAUGAGGCCGAAAGGCCGAA AACAUGU 9921414 UUCACAG CUGAUGAGGCCGAAAGGCCGAA AAACAUG 9931415 UUUCACA CUGAUGAGGCCGAAAGGCCGAA AAAACAU 9941415 UUUCACA CUGAUGAGGCCGAAAGGCCGAA AAAACAU 9951438 AGGUGGG CUGAUGAGGCCGAAAGGCCGAA ACAGCUC 9961451 AGGUAGA CUGAUGAGGCCGAAAGGCCGAA AGGCCAG 9971453 CAAGGUA CUGAUGAGGCCGAAAGGCCGAA AGAGGCC 9981455 AACAAGG CUGAUGAGGCCGAAAGGCCGAA AGAGAGG 9991462 AGGAGGC CUGAUGAGGCCGAAAGGCCGAA ACAAGGU 10001470 AGCAAAA CUGAUGAGGCCGAAAGGCCGAA AGGAGGC 10011472 UAAGCAA CUGAUGAGGCCGAAAGGCCGAA AGAGGAG 10021473 AUAAGCA CUGAUGAGGCCGAAAGGCCGAA AAGAGGA 10031474 CAUAAGC CUGAUGAGGCCGAAAGGCCGAA AAAGAGG 10041478 UAAACAU CUGAUGAGGCCGAAAGGCCGAA AGCAAAA 10051479 UUAAACA CUGAUGAGGCCGAAAGGCCGAA AAGCAAA 10061479 UUAAACA CUGAUGAGGCCGAAAGGCCGAA AAGCAAA 10071484 UUGUUUU CUGAUGAGGCCGAAAGGCCGAA AACAUAA 10081498 GUUAGAU CUGAUGAGGCCGAAAGGCCGAA AAUAUUU 10091511 UUAAGAC CUGAUGAGGCCGAAAGGCCGAA AUUGGGU 10101514 UUAUUAA CUGAUGAGGCCGAAAGGCCGAA ACAAUUG 10111516 CGUUAUU CUGAUGAGGCCGAAAGGCCGAA AGACAAU 10121529 GUCACCA CUGAUGAGGCCGAAAGGCCGAA AUCAGCG 10131529 GUCACCA CUGAUGAGGCCGAAAGGCCGAA AUCAGCG 10141530 GGUCACC CUGAUGAGGCCGAAAGGCCGAA AAUCAGC 10151530 GGUCACC CUGAUGAGGCCGAAAGGCCGAA AAUCAGC 10161563 GGGAGCA CUGAUGAGGCCGAAAGGCCGAA AGGUUCA 10171563 GGGAGCA CUGAUGAGGCCGAAAGGCCGAA AGGUUCA 10181568 CCGUGGG CUGAUGAGGCCGAAAGGCCGAA AGCAGAG 10191589 GGGCAAU CUGAUGAGGCCGAAAGGCCGAA ACAGUCA 10201592 GUAGGGC CUGAUGAGGCCGAAAGGCCGAA AUUACAG 10211617 CGAUCUU CUGAUGAGGCCGAAAGGCCGAA AUUUCUC 10221623 UUUAAGC CUGAUGAGGCCGAAAGGCCGAA AUCUUUA 10231633 GGUUUUU CUGAUGAGGCCGAAAGGCCGAA AUUUUAA 1024__________________________________________________________________________ TABLE VI__________________________________________________________________________Human TNF-a Hairpin Ribozyme Sequencesnt. Sequence SequencePosition Hairpin Ribozyme Sequence ID No. Substrate ID__________________________________________________________________________ No. 46 AGCCGUGG AGAA GUAUGU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1025 ACAUACU 1058 CCACGGCU 54 GAGGGUGG AGAA GUGGGU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1026 ACCCACG 1059 CCACCCUC 185 GGAGAAGA AGAA GAGGAA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1027 UUCCUCA 1060 UCUUCUCC 201 CUGCCACG AGAA GGAAGG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1028 CCUUCCU 1061 CGUGGCAG 230 GUGCAGCA AGAA GAAGAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1029 CUCUUCU 1062 UGCUGCAC 234 CAAAGUGC AGAA GGCAGA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1030 UCUGCCU 1063 GCACUUUG 254 CCUCUGGG AGAA GAUCAC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1031 GUGAUCG 1064 CCCAGAGG 296 GGCCAGAG AGAA GAUUAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1032 CUAAUCA 1065 CUCUGGCC 317 AGAAGAUG AGAA GACUGC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1033 GCAGUCA 1066 CAUCUUCU 387 GCCACUGG AGAA GCCCCU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1034 AGGGGCA 1067 CCAGUGGC 404 AUUGGCCC AGAA GUUCAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1035 CUGAACC 1068 GGGCCAAU 453 GCACCACC AGAA GGUUAU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1036 AUAACCA 1069 GGUGGUGC 518 GGUGGAGG AGAA GCCUUG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1037 CAAGGCU 1070 CCUCCACC 554 GGCGAUGC AGAA GAUGGU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1038 ACCAUCA 1071 GCAUCGCC 565 UGGUAGGA AGAA GCGAUG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1039 CAUCGCC 1072 UCCUACCA 576 UGACCUUG AGAA GGUAGG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1040 CCUACCA 1073 CAAGGUCA 687 CCUUCUCC AGAA GGAAGA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1041 UCUUCCA 1074 GGAGAAGG 704 AGCGCUGA AGAA GUCACC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1042 GGUGACC 1075 UCAGCGCU 726 GAUAGUCG AGAA GAUUGA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1043 UCAAUCG 1076 CGACUAUC 730 UCGAGAUA AGAA GGCCGA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1044 UCGGCCC 1077 UAUCUCGA 824 GGGAUUGG AGAA GGGGAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1045 CUCCCCU 1078 CCAAUCCC1042 GGGAUCAA AGAA GUAGGC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1046 GCCUACA 1079 UUGAUCCC1168 CUGGAAAC AGAA GGAGAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1047 CUCUCCA 1080 GUUUCCAG1178 UCAAGGAA AGGA GGAAAC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1048 GUUUCCA 1081 UUCCUUGA1202 AUGGGGAG AGAA GGGCUC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1049 GAGCCCA 1082 CUCCCCAU1220 AUAGAGGG AGAA GGCUCC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1050 GGAGCCA 1083 CCCUCUAU1284 AUACAUUC AGAA GUAAAU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1051 AUUUACA 1084 GAAUGUAU1340 UGAGCCAA AGAA GCUCCU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1052 AGGAGCU 1085 UUGGCUCA1390 UACAUGGG AGAA GCCUAU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1053 AUAGGCU 1086 CCCAUGUA1452 ACAACUUA AGAA GAUAAU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1054 AUUAUCU 1087 UAAGUUGU1475 GUCACCAA AGAA GCAUUG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1055 CAAUGCU 1088 UUGGUGAC1513 CCCUGGGG AGAA GAGGCC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1056 GGCCUCU 1089 CCCCAGGG1541 GAAUAGUA AGAA GAUUAC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1057 GUAAUCG 1090 UACUAUUC__________________________________________________________________________ TABLE VII__________________________________________________________________________Mouse TNF-a Hairpin Ribozyme Sequences Sequence Sequencent. Hairpin Ribozyme Sequence ID No. Substrate ID__________________________________________________________________________ No. 103 GUGAAAGG AGAA GAACCU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1091 AGGUUCU 1124 CCUUUCAC 256 UGAGAAGA AGAA GAGACA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1092 UGUCUCA 1125 UCUUCUCA 272 CUGCCACA AGAA GGAAUG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1093 CAUUCCU 1126 UGUGGCAG 301 GUUCAGUA AGAA GAAGAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1094 CUCUUCU 1127 UACUGAAC 325 CCUUUGGG AGAA GAUCAC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1095 GUGAUCG 1128 CCCAAAGG 370 GGCCAUAG AGAA GAUGAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1096 CUCAUCA 1129 CUAUGGCC 383 GUGUGAGG AGAA GGGCCA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1097 UGGCCCA 1130 CCUCACAC 397 AGAAGAUG AGAA GAGUGU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1098 ACACUCA 1131 CAUCUUCU 467 GCCACUCC AGAA GCUCCU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1099 AGGAGCA 1132 GGAGUGGC 546 AACCCAUC AGAA GGCACC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1100 GGUGCCA 1133 GAUGGGUU 549 UACAACCC AGAA GCUGGC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1101 GCCAGCC 1134 GGGUUGUA 598 GUAGUCGG AGAA GCCUUG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1102 CAAGGCU 1135 CCGACUAC 603 AGCACGUA AGAA GGGCAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1103 CUGCCCC 1136 UACGUGCU 631 AGCAAAUC AGAA GACGGU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1104 ACCGUCA 1137 GAUUUGCU 634 GAUAGCAA AGAA GCUGAC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1105 GUCAGCC 1138 UUGCUAUC 675 CUCUUGAC AGAA GAGAGG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1106 CCUCUCU 1139 GUCAAGAG 691 GUCCUUGG AGAA GGGGCU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1107 AGCCCCU 1140 CCAAGGAC 764 CCUUCUCC AGAA GGAAGA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1108 UCUUCCA 1141 GGAGAAGG 803 AGUACUUG AGAA GAUUGA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1109 UCAAUCU 1142 CAAGUACU 895 AGAGUGGG AGAA GGGUAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1110 CUACCCA 1143 CCCACUCU 906 GUAAAGGG AGAA GAGUGG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1111 CCACUCU 1144 CCCUUUAC 920 AUAAAGGG AGAA GAGUAA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1112 UUACUCU 1145 CCCUUUAU 953 AGGACACA AGAA GGGGGC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1113 GCCCCCA 1146 UGUGUCCU1175 CAUUCUGA AGAA GAGGCA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1114 UGCCUCU 1147 UCAGAAUG1220 CUGGAAAG AGAA GAAGGU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1115 ACCUUCA 1148 CUUUCCAG1230 AGGGAAGA AGAA GGAAAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1116 CUUUCCA 1149 UCUUCCCU1256 GUGAGGAA AGAA GUGCAU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1117 AUGCACA 1150 UUCCUCAC1274 UAGAGGGG AGAA GGCUCU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1118 AGAGCCA 1151 CCCCUCUA1393 UGUCUGAA AGAA GCUUCC ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1119 GGAAGCU 1152 UUCAGACA1435 CAGGUGGG AGAA GCUCAG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1120 CUGAGCU 1153 CCCACCUG1525 GUCACCAA AGAA GCGUUA ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1121 UAACGCU 1154 UUGGUGAC1542 GAUGUAGC AGAA GCCUGG ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1122 CCAGGCU 1155 GCUACAUC1564 CCGUGGGG AGAA GAGGUU ACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA 1123 AACCUCU 1156 CCCCACGG__________________________________________________________________________ __________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 1157(2) INFORMATION FOR SEQ ID NO: 1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 11(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ix) FEATURE:(D) OTHER INFORMATION: The letter "N"stands forany base. "H"representsnucleotide C, A, or U.(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:NNNNUHNNNNN11(2) INFORMATION FOR SEQ ID NO: 2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 28(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ix) FEATURE:(D) OTHER INFORMATION: The letter "N"stands forany base.(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:NNNNNCUGANGAGNNNNNNCGAAANNNN28(2) INFORMATION FOR SEQ ID NO: 3:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 14(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ix) FEATURE:(D) OTHER INFORMATION: The letter "N"stands forany base. The leter "Y"isU or C. The letter "H"isA, U, or C.(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:NNNYNGHYNNNNNN14(2) INFORMATION FOR SEQ ID NO: 4:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 50(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ix) FEATURE:(D) OTHER INFORMATION: The letter "N"stands forany base.(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4:NNNNNNNGAAGNNNNNNNNNNAAACANNNNNNNNNNNACAUUACNNNNNN50(2) INFORMATION FOR SEQ ID NO: 5:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 85(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:UGGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACAUUCCGAGGGGACCG60UCCCCUCGGUAAUGGCGAAUGGGAC85(2) INFORMATION FOR SEQ ID NO: 6:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 176(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:GGGAAAGCUUGCGAAGGGCGUCGUCGCCCCGAGCGGUAGUAAGCAGGGAACUCACCUCCA60AUUUCAGUACUGAAAUUGUCGUAGCAGUUGACUACUGUUAUGUGAUUGGUAGAGGCUAAG120UGACGGUAUUGGCGUAAGUCAGUAUUGCAGCACAGCACAAGCCCGCUUGCGAGAAU176(2) INFORMATION FOR SEQ ID NO: 7:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7:GGAAGCUGUCUUCAGACA18(2) INFORMATION FOR SEQ ID NO: 8:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:UGUCUGAAAGAAGCUUCCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO: 9:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:GGAAGCUGUCUUCAGACA18(2) INFORMATION FOR SEQ ID NO: 10:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:UGUCUGAAAUAAGCUUCCACCAGAGAAAGACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO: 11:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:CUGAGCUGUCCCCACCUG18(2) INFORMATION FOR SEQ ID NO: 12:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12:CAGGUGGGAGAAGCUCAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO: 13:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13:CUGAGCUGUCCCCACCUG18(2) INFORMATION FOR SEQ ID NO: 14:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14:CAGGUGGGAUAAGCUCAGACCAGAGAAAGACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:15:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:GGCAGGUUCUCUUCC15(2) INFORMATION FOR SEQ ID NO:16:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:GCAGGUUCUCUUCCU15(2) INFORMATION FOR SEQ ID NO:17:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:AGGUUCUCUUCCUCU15(2) INFORMATION FOR SEQ ID NO:18:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:GUUCUCUUCCUCUCA15(2) INFORMATION FOR SEQ ID NO:19:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:UUCUCUUCCUCUCAC15(2) INFORMATION FOR SEQ ID NO:20:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:UCUUCCUCUCACAUA15(2) INFORMATION FOR SEQ ID NO:21:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:UUCCUCUCACAUACU15(2) INFORMATION FOR SEQ ID NO:22:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:CUCACAUACUGACCC15(2) INFORMATION FOR SEQ ID NO:23:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:CACGGCUCCACCCUC15(2) INFORMATION FOR SEQ ID NO:24:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:CCACCCUCUCUCCCC15(2) INFORMATION FOR SEQ ID NO:25:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:ACCCUCUCUCCCCUG15(2) INFORMATION FOR SEQ ID NO:26:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:CCUCUCUCCCCUGGA15(2) INFORMATION FOR SEQ ID NO:27:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:GCAUGAUCCGGGACG15(2) INFORMATION FOR SEQ ID NO:28:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:AGGCGCUCCCCAAGA15(2) INFORMATION FOR SEQ ID NO:29:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:CAGGGCUCCAGGCGG15(2) INFORMATION FOR SEQ ID NO:30:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:30:CGGUGCUUGUUCCUC15(2) INFORMATION FOR SEQ ID NO:31:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:31:UGCUUGUUCCUCAGC15(2) INFORMATION FOR SEQ ID NO:32:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:GCUUGUUCCUCAGCC15(2) INFORMATION FOR SEQ ID NO:33:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:UGUUCCUCAGCCUCU15(2) INFORMATION FOR SEQ ID NO:34:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:UCAGCCUCUUCUCCU15(2) INFORMATION FOR SEQ ID NO:35:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:AGCCUCUUCUCCUUC15(2) INFORMATION FOR SEQ ID NO:36:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:GCCUCUUCUCCUUCC15(2) INFORMATION FOR SEQ ID NO:37:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:CUCUUCUCCUUCCUG15(2) INFORMATION FOR SEQ ID NO:38:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:UUCUCCUUCCUGAUC15(2) INFORMATION FOR SEQ ID NO:39:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:UCUCCUUCCUGAUCG15(2) INFORMATION FOR SEQ ID NO:40:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:40:UCCUGAUCGUGGCAG15(2) INFORMATION FOR SEQ ID NO:41:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:CCACGCUCUUCUGCC15(2) INFORMATION FOR SEQ ID NO:42:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:ACGCUCUUCUGCCUG15(2) INFORMATION FOR SEQ ID NO:43:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:CGCUCUUCUGCCUGC15(2) INFORMATION FOR SEQ ID NO:44:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:CUGCACUUUGGAGUG15(2) INFORMATION FOR SEQ ID NO:45:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:UGCACUUUGGAGUGA15(2) INFORMATION FOR SEQ ID NO:46:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:GAGUGAUCGGCCCCC15(2) INFORMATION FOR SEQ ID NO:47:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:47:GAAGAGUCCCCCAGG15(2) INFORMATION FOR SEQ ID NO:48:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:48:GGGACCUCUCUCUAA15(2) INFORMATION FOR SEQ ID NO:49:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:49:GACCUCUCUCUAAUC15(2) INFORMATION FOR SEQ ID NO:50:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:50:CCUCUCUCUAAUCAG15(2) INFORMATION FOR SEQ ID NO:51:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:51:UCUCUCUAAUCAGCC15(2) INFORMATION FOR SEQ ID NO:52:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:52:CUCUAAUCAGCCCUC15(2) INFORMATION FOR SEQ ID NO:53:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:53:CAGCCCUCUGGCCCA15(2) INFORMATION FOR SEQ ID NO:54:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:54:GUCAGAUCAUCUUCU15(2) INFORMATION FOR SEQ ID NO:55:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:55:AGAUCAUCUUCUCGA15(2) INFORMATION FOR SEQ ID NO:56:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:56:AUCAUCUUCUCGAAC15(2) INFORMATION FOR SEQ ID NO:57:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:57:UCAUCUUCUCGAACC15(2) INFORMATION FOR SEQ ID NO:58:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:58:AUCUUCUCGAACCCC15(2) INFORMATION FOR SEQ ID NO:59:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:59:AGCCUGUAGCCCAUG15(2) INFORMATION FOR SEQ ID NO:60:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:60:CCCAUGUUGUAGCAA15(2) INFORMATION FOR SEQ ID NO:61:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:61:AUGUUGUAGCAAACC15(2) INFORMATION FOR SEQ ID NO:62:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:62:AAACCCUCAAGCUGA15(2) INFORMATION FOR SEQ ID NO:63:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:63:GGCAGCUCCAGUGGC15(2) INFORMATION FOR SEQ ID NO:64:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:64:AUGCCCUCCUGGCCA15(2) INFORMATION FOR SEQ ID NO:65:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:65:GAGAGAUAACCAGCU15(2) INFORMATION FOR SEQ ID NO:66:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:66:GUGCCAUCAGAGGGC15(2) INFORMATION FOR SEQ ID NO:67:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:67:GGCCUGUACCUCAUC15(2) INFORMATION FOR SEQ ID NO:68:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:68:UGUACCUCAUCUACU15(2) INFORMATION FOR SEQ ID NO:69:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:69:ACCUCAUCUACUCCC15(2) INFORMATION FOR SEQ ID NO:70:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:70:CUCAUCUACUCCCAG15(2) INFORMATION FOR SEQ ID NO:71:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:71:AUCUACUCCCAGGUC15(2) INFORMATION FOR SEQ ID NO:72:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:72:CCCAGGUCCUCUUCA15(2) INFORMATION FOR SEQ ID NO:73:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:73:AGGUCCUCUUCAAGG15(2) INFORMATION FOR SEQ ID NO:74:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:74:GUCCUCUUCAAGGGC15(2) INFORMATION FOR SEQ ID NO:75:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:75:UCCUCUUCAAGGGCC15(2) INFORMATION FOR SEQ ID NO:76:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:76:UGCCCCUCCACCCAU15(2) INFORMATION FOR SEQ ID NO:77:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:77:AUGUGCUCCUCACCC15(2) INFORMATION FOR SEQ ID NO:78:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:78:UGCUCCUCACCCACA15(2) INFORMATION FOR SEQ ID NO:79:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:79:ACACCAUCAGCCGCA15(2) INFORMATION FOR SEQ ID NO:80:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:80:GCCGCAUCGCCGUCU15(2) INFORMATION FOR SEQ ID NO:81:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:81:UCGCCGUCUCCUACC15(2) INFORMATION FOR SEQ ID NO:82:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:82:GCCGUCUCCUACCAG15(2) INFORMATION FOR SEQ ID NO:83:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:83:GUCUCCUACCAGACC15(2) INFORMATION FOR SEQ ID NO:84:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:84:CCAAGGUCAACCUCC15(2) INFORMATION FOR SEQ ID NO:85:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:85:UCAACCUCCUCUCUG15(2) INFORMATION FOR SEQ ID NO:86:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:86:ACCUCCUCUCUGCCA15(2) INFORMATION FOR SEQ ID NO:87:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:87:CUCCUCUCUGCCAUC15(2) INFORMATION FOR SEQ ID NO:88:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:88:CUGCCAUCAAGAGCC15(2) INFORMATION FOR SEQ ID NO:89:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:89:CCCUGGUAUGAGCCC15(2) INFORMATION FOR SEQ ID NO:90:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:90:AGCCCAUCUAUCUGG15(2) INFORMATION FOR SEQ ID NO:91:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:91:CCCAUCUAUCUGGGA15(2) INFORMATION FOR SEQ ID NO:92:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:92:CAUCUAUCUGGGAGG15(2) INFORMATION FOR SEQ ID NO:93:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:93:GAGGGGUCUUCCAGC15(2) INFORMATION FOR SEQ ID NO:94:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:94:GGGGUCUUCCAGCUG15(2) INFORMATION FOR SEQ ID NO:95:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:95:GGGUCUUCCAGCUGG15(2) INFORMATION FOR SEQ ID NO:96:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:96:ACCGACUCAGCGCUG15(2) INFORMATION FOR SEQ ID NO:97:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:97:CUGAGAUCAAUCGGC15(2) INFORMATION FOR SEQ ID NO:98:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:98:GAUCAAUCGGCCCGA15(2) INFORMATION FOR SEQ ID NO:99:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:99:CCCGACUAUCUCGAC15(2) INFORMATION FOR SEQ ID NO:100:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:100:CGACUAUCUCGACUU15(2) INFORMATION FOR SEQ ID NO:101:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:101:ACUAUCUCGACUUUG15(2) INFORMATION FOR SEQ ID NO:102:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:102:CUCGACUUUGCCGAG15(2) INFORMATION FOR SEQ ID NO:103:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:103:UCGACUUUGCCGAGU15(2) INFORMATION FOR SEQ ID NO:104:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:104:GCCGAGUCUGGGCAG15(2) INFORMATION FOR SEQ ID NO:105:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:105:GGCAGGUCUACUUUG15(2) INFORMATION FOR SEQ ID NO:106:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:106:CAGGUCUACUUUGGG15(2) INFORMATION FOR SEQ ID NO:107:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:107:GUCUACUUUGGGAUC15(2) INFORMATION FOR SEQ ID NO:108:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:108:UCUACUUUGGGAUCA15(2) INFORMATION FOR SEQ ID NO:109:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:109:UUGGGAUCAUUGCCC15(2) INFORMATION FOR SEQ ID NO:110:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:110:GGAUCAUUGCCCUGU15(2) INFORMATION FOR SEQ ID NO:111:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:111:CGAACAUCCAACCUU15(2) INFORMATION FOR SEQ ID NO:112:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:112:CCAACCUUCCCAAAC15(2) INFORMATION FOR SEQ ID NO:113:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:113:CAACCUUCCCAAACG15(2) INFORMATION FOR SEQ ID NO:114:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:114:AACGCCUCCCCUGCC15(2) INFORMATION FOR SEQ ID NO:115:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:115:CCCCAAUCCCUUUAU15(2) INFORMATION FOR SEQ ID NO:116:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:116:AAUCCCUUUAUUACC15(2) INFORMATION FOR SEQ ID NO:117:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:117:AUCCCUUUAUUACCC15(2) INFORMATION FOR SEQ ID NO:118:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:118:UCCCUUUAUUACCCC15(2) INFORMATION FOR SEQ ID NO:119:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:119:CCUUUAUUACCCCCU15(2) INFORMATION FOR SEQ ID NO:120:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:120:CUUUAUUACCCCCUC15(2) INFORMATION FOR SEQ ID NO:121:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:121:ACCCCCUCCUUCAGA15(2) INFORMATION FOR SEQ ID NO:122:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:122:CCCUCCUUCAGACAC15(2) INFORMATION FOR SEQ ID NO:123:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:123:CCUCCUUCAGACACC15(2) INFORMATION FOR SEQ ID NO:124:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:124:ACACCCUCAACCUCU15(2) INFORMATION FOR SEQ ID NO:125:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:125:UCAACCUCUUCUGGC15(2) INFORMATION FOR SEQ ID NO:126:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:126:AACCUCUUCUGGCUC15(2) INFORMATION FOR SEQ ID NO:127:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:127:ACCUCUUCUGGCUCA15(2) INFORMATION FOR SEQ ID NO:128:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:128:UCUGGCUCAAAAAGA15(2) INFORMATION FOR SEQ ID NO:129:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:129:AGAGAAUUGGGGGCU15(2) INFORMATION FOR SEQ ID NO:130:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:130:GGGGGCUUAGGGUCG15(2) INFORMATION FOR SEQ ID NO:131:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:131:GGGGCUUAGGGUCGG15(2) INFORMATION FOR SEQ ID NO:132:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:132:UUAGGGUCGGAACCC15(2) INFORMATION FOR SEQ ID NO:133:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:133:CCAAGCUUAGAACUU15(2) INFORMATION FOR SEQ ID NO:134:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:134:CAAGCUUAGAACUUU15(2) INFORMATION FOR SEQ ID NO:135:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:135:UAGAACUUUAAGCAA15(2) INFORMATION FOR SEQ ID NO:136:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:136:AGAACUUUAAGCAAC15(2) INFORMATION FOR SEQ ID NO:137:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:137:GAACUUUAAGCAACA15(2) INFORMATION FOR SEQ ID NO:138:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:138:CACCACUUCGAAACC15(2) INFORMATION FOR SEQ ID NO:139:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:139:ACCACUUCGAAACCU15(2) INFORMATION FOR SEQ ID NO:140:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:140:CUGGGAUUCAGGAAU15(2) INFORMATION FOR SEQ ID NO:141:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:141:UGGGAUUCAGGAAUG15(2) INFORMATION FOR SEQ ID NO:142:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:142:AACCACUAAGAAUUC15(2) INFORMATION FOR SEQ ID NO:143:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:143:UAAGAAUUCAAACUG15(2) INFORMATION FOR SEQ ID NO:144:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:144:AAGAAUUCAAACUGG15(2) INFORMATION FOR SEQ ID NO:145:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:145:GGGGCCUCCAGAACU15(2) INFORMATION FOR SEQ ID NO:146:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:146:CAGAACUCACUGGGG15(2) INFORMATION FOR SEQ ID NO:147:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:147:GGGGCCUACAGCUUU15(2) INFORMATION FOR SEQ ID NO:148:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:148:UACAGCUUUGAUCCC15(2) INFORMATION FOR SEQ ID NO:149:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:149:ACAGCUUUGAUCCCU15(2) INFORMATION FOR SEQ ID NO:150:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:150:CUUUGAUCCCUGACA15(2) INFORMATION FOR SEQ ID NO:151:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:151:CUGACAUCUGGAAUC15(2) INFORMATION FOR SEQ ID NO:152:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:152:CUGGAAUCUGGAGAC15(2) INFORMATION FOR SEQ ID NO:153:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:153:GGAGCCUUUGGUUCU15(2) INFORMATION FOR SEQ ID NO:154:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:154:GAGCCUUUGGUUCUG15(2) INFORMATION FOR SEQ ID NO:155:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:155:CUUUGGUUCUGGCCA15(2) INFORMATION FOR SEQ ID NO:156:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:156:UUUGGUUCUGGCCAG15(2) INFORMATION FOR SEQ ID NO:157:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:157:CAGGACUUGAGAAGA15(2) INFORMATION FOR SEQ ID NO:158:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:158:AAGACCUCACCUAGA15(2) INFORMATION FOR SEQ ID NO:159:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:159:CUCACCUAGAAAUUG15(2) INFORMATION FOR SEQ ID NO:160:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:160:UAGAAAUUGACACAA15(2) INFORMATION FOR SEQ ID NO:161:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:161:UGGACCUUAGGCCUU15(2) INFORMATION FOR SEQ ID NO:162:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:162:GGACCUUAGGCCUUC15(2) INFORMATION FOR SEQ ID NO:163:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:163:UAGGCCUUCCUCUCU15(2) INFORMATION FOR SEQ ID NO:164:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:164:AGGCCUUCCUCUCUC15(2) INFORMATION FOR SEQ ID NO:165:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:165:CCUUCCUCUCUCCAG15(2) INFORMATION FOR SEQ ID NO:166:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:166:UUCCUCUCUCCAGAU15(2) INFORMATION FOR SEQ ID NO:167:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:167:CCUCUCUCCAGAUGU15(2) INFORMATION FOR SEQ ID NO:168:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:168:CAGAUGUUUCCAGAC15(2) INFORMATION FOR SEQ ID NO:169:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:169:AGAUGUUUCCAGACU15(2) INFORMATION FOR SEQ ID NO:170:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:170:GAUGUUUCCAGACUU15(2) INFORMATION FOR SEQ ID NO:171:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:171:CCAGACUUCCUUGAG15(2) INFORMATION FOR SEQ ID NO:172:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:172:CAGACUUCCUUGAGA15(2) INFORMATION FOR SEQ ID NO:173:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:173:ACUUCCUUGAGACAC15(2) INFORMATION FOR SEQ ID NO:174:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:174:CAGCCCUCCCCAUGG15(2) INFORMATION FOR SEQ ID NO:175:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:175:GCCAGCUCCCUCUAU15(2) INFORMATION FOR SEQ ID NO:176:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:176:GCUCCCUCUAUUUAU15(2) INFORMATION FOR SEQ ID NO:177:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:177:UCCCUCUAUUUAUGU15(2) INFORMATION FOR SEQ ID NO:178:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:178:CCUCUAUUUAUGUUU15(2) INFORMATION FOR SEQ ID NO:179:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:179:CUCUAUUUAUGUUUG15(2) INFORMATION FOR SEQ ID NO:180:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:180:UCUAUUUAUGUUUGC15(2) INFORMATION FOR SEQ ID NO:181:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:181:UUUAUGUUUGCACUU15(2) INFORMATION FOR SEQ ID NO:182:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:182:UUAUGUUUGCACUUG15(2) INFORMATION FOR SEQ ID NO:183:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:183:UUGCACUUGUGAUUA15(2) INFORMATION FOR SEQ ID NO:184:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:184:UUGUGAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:185:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:185:UGUGAUUAUUUAUUA15(2) INFORMATION FOR SEQ ID NO:186:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:186:UGAUUAUUUAUUAUU15(2) INFORMATION FOR SEQ ID NO:187:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:187:GAUUAUUUAUUAUUU15(2) INFORMATION FOR SEQ ID NO:188:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:188:AUUAUUUAUUAUUUA15(2) INFORMATION FOR SEQ ID NO:189:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:189:UAUUUAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:190:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:190:AUUUAUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:191:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:191:UUAUUAUUUAUUUAU15(2) INFORMATION FOR SEQ ID NO:192:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:192:UAUUAUUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:193:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:193:AUUAUUUAUUUAUUA15(2) INFORMATION FOR SEQ ID NO:194:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:194:UAUUUAUUUAUUAUU15(2) INFORMATION FOR SEQ ID NO:195:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:195:AUUUAUUUAUUAUUU15(2) INFORMATION FOR SEQ ID NO:196:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:196:UUUAUUUAUUAUUUA15(2) INFORMATION FOR SEQ ID NO:197:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:197:UAUUUAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:198:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:198:AUUUAUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:199:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:199:UUAUUAUUUAUUUAU15(2) INFORMATION FOR SEQ ID NO:200:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:200:UAUUAUUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:201:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:201:AUUAUUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:202:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:202:UAUUUAUUUAUUUAC15(2) INFORMATION FOR SEQ ID NO:203:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:203:AUUUAUUUAUUUACA15(2) INFORMATION FOR SEQ ID NO:204:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:204:UUUAUUUAUUUACAG15(2) INFORMATION FOR SEQ ID NO:205:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:205:UAUUUAUUUACAGAU15(2) INFORMATION FOR SEQ ID NO:206:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:206:AUUUAUUUACAGAUG15(2) INFORMATION FOR SEQ ID NO:207:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:207:UUUAUUUACAGAUGA15(2) INFORMATION FOR SEQ ID NO:208:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:208:UGAAUGUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:209:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:209:AAUGUAUUUAUUUGG15(2) INFORMATION FOR SEQ ID NO:210:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:210:AUGUAUUUAUUUGGG15(2) INFORMATION FOR SEQ ID NO:211:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:211:UGUAUUUAUUUGGGA15(2) INFORMATION FOR SEQ ID NO:212:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:212:UAUUUAUUUGGGAGA15(2) INFORMATION FOR SEQ ID NO:213:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:213:AUUUAUUUGGGAGAC15(2) INFORMATION FOR SEQ ID NO:214:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:214:CCGGGGUAUCCUGGG15(2) INFORMATION FOR SEQ ID NO:215:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:215:GGGGUAUCCUGGGGG15(2) INFORMATION FOR SEQ ID NO:216:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:216:CCAAUGUAGGAGCUG15(2) INFORMATION FOR SEQ ID NO:217:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:217:GCUGCCUUGGCUCAG15(2) INFORMATION FOR SEQ ID NO:218:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:218:CUUGGCUCAGACAUG15(2) INFORMATION FOR SEQ ID NO:219:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:219:GACAUGUUUUCCGUG15(2) INFORMATION FOR SEQ ID NO:220:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:220:ACAUGUUUUCCGUGA15(2) INFORMATION FOR SEQ ID NO:221:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:221:CAUGUUUUCCGUGAA15(2) INFORMATION FOR SEQ ID NO:222:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:222:AUGUUUUCCGUGAAA15(2) INFORMATION FOR SEQ ID NO:223:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:223:GAACAAUAGGCUGUU15(2) INFORMATION FOR SEQ ID NO:224:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:224:AGGCUGUUCCCAUGU15(2) INFORMATION FOR SEQ ID NO:225:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:225:GGCUGUUCCCAUGUA15(2) INFORMATION FOR SEQ ID NO:226:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:226:CCCAUGUAGCCCCCU15(2) INFORMATION FOR SEQ ID NO:227:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:227:CUGGCCUCUGUGCCU15(2) INFORMATION FOR SEQ ID NO:228:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:228:UGUGCCUUCUUUUGA15(2) INFORMATION FOR SEQ ID NO:229:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:229:GUGCCUUCUUUUGAU15(2) INFORMATION FOR SEQ ID NO:230:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:230:GCCUUCUUUUGAUUA15(2) INFORMATION FOR SEQ ID NO:231:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:231:CCUUCUUUUGAUUAU15(2) INFORMATION FOR SEQ ID NO:232:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:232:CUUCUUUUGAUUAUG15(2) INFORMATION FOR SEQ ID NO:233:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:233:UUUUGAUUAUGUUUU15(2) INFORMATION FOR SEQ ID NO:234:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:234:UUUGAUUAUGUUUUU15(2) INFORMATION FOR SEQ ID NO:235:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:235:AUUAUGUUUUUUAAA15(2) INFORMATION FOR SEQ ID NO:236:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:236:UUAUGUUUUUUAAAA15(2) INFORMATION FOR SEQ ID NO:237:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:237:UAUGUUUUUUAAAAU15(2) INFORMATION FOR SEQ ID NO:238:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:238:UGUUUUUUAAAAUAU15(2) INFORMATION FOR SEQ ID NO:239:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:239:GUUUUUUAAAAUAUU15(2) INFORMATION FOR SEQ ID NO:240:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:240:UUAAAAUAUUAUCUG15(2) INFORMATION FOR SEQ ID NO:241:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:241:AAAAUAUUAUCUGAU15(2) INFORMATION FOR SEQ ID NO:242:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:242:AAAUAUUAUCUGAUU15(2) INFORMATION FOR SEQ ID NO:243:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:243:AUAUUAUCUGAUUAA15(2) INFORMATION FOR SEQ ID NO:244:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:244:AUCUGAUUAAGUUGU15(2) INFORMATION FOR SEQ ID NO:245:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:245:UCUGAUUAAGUUGUC15(2) INFORMATION FOR SEQ ID NO:246:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:246:AUUAAGUUGUCUAAA15(2) INFORMATION FOR SEQ ID NO:247:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:247:AAGUUGUCUAAACAA15(2) INFORMATION FOR SEQ ID NO:248:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:248:GUUGUCUAAACAAUG15(2) INFORMATION FOR SEQ ID NO:249:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:249:UGCUGAUUUGGUGAC15(2) INFORMATION FOR SEQ ID NO:250:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:250:GCUGAUUUGGUGACC15(2) INFORMATION FOR SEQ ID NO:251:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:251:CAACUGUCACUCAUU15(2) INFORMATION FOR SEQ ID NO:252:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:252:UGUCACUCAUUGCUG15(2) INFORMATION FOR SEQ ID NO:253:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:253:CACUCAUUGCUGAGG15(2) INFORMATION FOR SEQ ID NO:254:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:254:GAGGCCUCUGCUCCC15(2) INFORMATION FOR SEQ ID NO:255:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:255:CUCUGCUCCCCAGGG15(2) INFORMATION FOR SEQ ID NO:256:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:256:AGGGAGUUGUGUCUG15(2) INFORMATION FOR SEQ ID NO:257:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:257:GUUGUGUCUGUAAUC15(2) INFORMATION FOR SEQ ID NO:258:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:258:UGUCUGUAAUCGGCC15(2) INFORMATION FOR SEQ ID NO:259:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:259:CUGUAAUCGGCCUAC15(2) INFORMATION FOR SEQ ID NO:260:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:260:UCGGCCUACUAUUCA15(2) INFORMATION FOR SEQ ID NO:261:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:261:GCCUACUAUUCAGUG15(2) INFORMATION FOR SEQ ID NO:262:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:262:CUACUAUUCAGUGGC15(2) INFORMATION FOR SEQ ID NO:263:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:263:UACUAUUCAGUGGCG15(2) INFORMATION FOR SEQ ID NO:264:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:264:GAGAAAUAAAGGUUG15(2) INFORMATION FOR SEQ ID NO:265:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:265:UAAAGGUUGCUUAGG15(2) INFORMATION FOR SEQ ID NO:266:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:266:GGUUGCUUAGGAAAG15(2) INFORMATION FOR SEQ ID NO:267:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:267:GUUGCUUAGGAAAGA15(2) INFORMATION FOR SEQ ID NO:268:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:268:GGAAGAGCUGAUGAGGCCGAAAGGCCGAAACCUGCC36(2) INFORMATION FOR SEQ ID NO:269:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:269:AGGAAGACUGAUGAGGCCGAAAGGCCGAAAACCUGC36(2) INFORMATION FOR SEQ ID NO:270:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:270:AGAGGAACUGAUGAGGCCGAAAGGCCGAAAGAACCU36(2) INFORMATION FOR SEQ ID NO:271:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:271:UGAGAGGCUGAUGAGGCCGAAAGGCCGAAAGAGAAC36(2) INFORMATION FOR SEQ ID NO:272:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:272:GUGAGAGCUGAUGAGGCCGAAAGGCCGAAAAGAGAA36(2) INFORMATION FOR SEQ ID NO:273:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:273:UAUGUGACUGAUGAGGCCGAAAGGCCGAAAGGAAGA36(2) INFORMATION FOR SEQ ID NO:274:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:274:AGUAUGUCUGAUGAGGCCGAAAGGCCGAAAGAGGAA36(2) INFORMATION FOR SEQ ID NO:275:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:275:GGGUCAGCUGAUGAGGCCGAAAGGCCGAAAUGUGAG36(2) INFORMATION FOR SEQ ID NO:276:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:276:GAGGGUGCUGAUGAGGCCGAAAGGCCGAAAGCCGUG36(2) INFORMATION FOR SEQ ID NO:277:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:277:GGGGAGACUGAUGAGGCCGAAAGGCCGAAAGGGUGG36(2) INFORMATION FOR SEQ ID NO:278:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:278:CAGGGGACUGAUGAGGCCGAAAGGCCGAAAGAGGGU36(2) INFORMATION FOR SEQ ID NO:279:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:279:UCCAGGGCUGAUGAGGCCGAAAGGCCGAAAGAGAGG36(2) INFORMATION FOR SEQ ID NO:280:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:280:CGUCCCGCUGAUGAGGCCGAAAGGCCGAAAUCAUGC36(2) INFORMATION FOR SEQ ID NO:281:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:281:UCUUGGGCUGAUGAGGCCGAAAGGCCGAAAGCGCCU36(2) INFORMATION FOR SEQ ID NO:282:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:282:CCGCCUGCUGAUGAGGCCGAAAGGCCGAAAGCCCUG36(2) INFORMATION FOR SEQ ID NO:283:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:283:GAGGAACCUGAUGAGGCCGAAAGGCCGAAAGCACCG36(2) INFORMATION FOR SEQ ID NO:284:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:284:GCUGAGGCUGAUGAGGCCGAAAGGCCGAAACAAGCA36(2) INFORMATION FOR SEQ ID NO:285:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:285:GGCUGAGCUGAUGAGGCCGAAAGGCCGAAAACAAGC36(2) INFORMATION FOR SEQ ID NO:286:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:286:AGAGGCUCUGAUGAGGCCGAAAGGCCGAAAGGAACA36(2) INFORMATION FOR SEQ ID NO:287:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:287:AGGAGAACUGAUGAGGCCGAAAGGCCGAAAGGCUGA36(2) INFORMATION FOR SEQ ID NO:288:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:288:GAAGGAGCUGAUGAGGCCGAAAGGCCGAAAGAGGCU36(2) INFORMATION FOR SEQ ID NO:289:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:289:GGAAGGACUGAUGAGGCCGAAAGGCCGAAAAGAGGC36(2) INFORMATION FOR SEQ ID NO:290:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:290:CAGGAAGCUGAUGAGGCCGAAAGGCCGAAAGAAGAG36(2) INFORMATION FOR SEQ ID NO:291:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:291:GAUCAGGCUGAUGAGGCCGAAAGGCCGAAAGGAGAA36(2) INFORMATION FOR SEQ ID NO:292:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:292:CGAUCAGCUGAUGAGGCCGAAAGGCCGAAAAGGAGA36(2) INFORMATION FOR SEQ ID NO:293:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:293:CUGCCACCUGAUGAGGCCGAAAGGCCGAAAUCAGGA36(2) INFORMATION FOR SEQ ID NO:294:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:294:GGCAGAACUGAUGAGGCCGAAAGGCCGAAAGCGUGG36(2) INFORMATION FOR SEQ ID NO:295:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:295:CAGGCAGCUGAUGAGGCCGAAAGGCCGAAAGAGCGU36(2) INFORMATION FOR SEQ ID NO:296:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:296:GCAGGCACUGAUGAGGCCGAAAGGCCGAAAAGAGCG36(2) INFORMATION FOR SEQ ID NO:297:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:297:CACUCCACUGAUGAGGCCGAAAGGCCGAAAGUGCAG36(2) INFORMATION FOR SEQ ID NO:298:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:298:UCACUCCCUGAUGAGGCCGAAAGGCCGAAAAGUGCA36(2) INFORMATION FOR SEQ ID NO:299:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:299:GGGGGCCCUGAUGAGGCCGAAAGGCCGAAAUCACUC36(2) INFORMATION FOR SEQ ID NO:300:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:300:CCUGGGGCUGAUGAGGCCGAAAGGCCGAAACUCUUC36(2) INFORMATION FOR SEQ ID NO:301:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:301:UUAGAGACUGAUGAGGCCGAAAGGCCGAAAGGUCCC36(2) INFORMATION FOR SEQ ID NO:302:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:302:GAUUAGACUGAUGAGGCCGAAAGGCCGAAAGAGGUC36(2) INFORMATION FOR SEQ ID NO:303:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:303:CUGAUUACUGAUGAGGCCGAAAGGCCGAAAGAGAGG36(2) INFORMATION FOR SEQ ID NO:304:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:304:GGCUGAUCUGAUGAGGCCGAAAGGCCGAAAGAGAGA36(2) INFORMATION FOR SEQ ID NO:305:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:305:GAGGGCUCUGAUGAGGCCGAAAGGCCGAAAUUAGAG36(2) INFORMATION FOR SEQ ID NO:306:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:306:UGGGCCACUGAUGAGGCCGAAAGGCCGAAAGGGCUG36(2) INFORMATION FOR SEQ ID NO:307:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:307:AGAAGAUCUGAUGAGGCCGAAAGGCCGAAAUCUGAC36(2) INFORMATION FOR SEQ ID NO:308:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:308:UCGAGAACUGAUGAGGCCGAAAGGCCGAAAUGAUCU36(2) INFORMATION FOR SEQ ID NO:309:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:309:GUUCGAGCUGAUGAGGCCGAAAGGCCGAAAGAUGAU36(2) INFORMATION FOR SEQ ID NO:310:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:310:GGUUCGACUGAUGAGGCCGAAAGGCCGAAAAGAUGA36(2) INFORMATION FOR SEQ ID NO:311:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:311:GGGGUUCCUGAUGAGGCCGAAAGGCCGAAAGAAGAU36(2) INFORMATION FOR SEQ ID NO:312:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:312:CAUGGGCCUGAUGAGGCCGAAAGGCCGAAACAGGCU36(2) INFORMATION FOR SEQ ID NO:313:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:313:UUGCUACCUGAUGAGGCCGAAAGGCCGAAACAUGGG36(2) INFORMATION FOR SEQ ID NO:314:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:314:GGUUUGCCUGAUGAGGCCGAAAGGCCGAAACAACAU36(2) INFORMATION FOR SEQ ID NO:315:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:315:UCAGCUUCUGAUGAGGCCGAAAGGCCGAAAGGGUUU36(2) INFORMATION FOR SEQ ID NO:316:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:316:GCCACUGCUGAUGAGGCCGAAAGGCCGAAAGCUGCC36(2) INFORMATION FOR SEQ ID NO:317:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:317:UGGCCAGCUGAUGAGGCCGAAAGGCCGAAAGGGCAU36(2) INFORMATION FOR SEQ ID NO:318:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:318:AGCUGGUCUGAUGAGGCCGAAAGGCCGAAAUCUCUC36(2) INFORMATION FOR SEQ ID NO:319:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:319:GCCCUCUCUGAUGAGGCCGAAAGGCCGAAAUGGCAC36(2) INFORMATION FOR SEQ ID NO:320:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:320:GAUGAGGCUGAUGAGGCCGAAAGGCCGAAACAGGCC36(2) INFORMATION FOR SEQ ID NO:321:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:321:AGUAGAUCUGAUGAGGCCGAAAGGCCGAAAGGUACA36(2) INFORMATION FOR SEQ ID NO:322:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:322:GGGAGUACUGAUGAGGCCGAAAGGCCGAAAUGAGGU36(2) INFORMATION FOR SEQ ID NO:323:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:323:CUGGGAGCUGAUGAGGCCGAAAGGCCGAAAGAUGAG36(2) INFORMATION FOR SEQ ID NO:324:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:324:GACCUGGCUGAUGAGGCCGAAAGGCCGAAAGUAGAU36(2) INFORMATION FOR SEQ ID NO:325:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:325:UGAAGAGCUGAUGAGGCCGAAAGGCCGAAACCUGGG36(2) INFORMATION FOR SEQ ID NO:326:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:326:CCUUGAACUGAUGAGGCCGAAAGGCCGAAAGGACCU36(2) INFORMATION FOR SEQ ID NO:327:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:327:GCCCUUGCUGAUGAGGCCGAAAGGCCGAAAGAGGAC36(2) INFORMATION FOR SEQ ID NO:328:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:328:GGCCCUUCUGAUGAGGCCGAAAGGCCGAAAAGAGGA36(2) INFORMATION FOR SEQ ID NO:329:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:329:AUGGGUGCUGAUGAGGCCGAAAGGCCGAAAGGGGCA36(2) INFORMATION FOR SEQ ID NO:330:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:330:GGGUGAGCUGAUGAGGCCGAAAGGCCGAAAGCACAU36(2) INFORMATION FOR SEQ ID NO:331:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:331:UGUGGGUCUGAUGAGGCCGAAAGGCCGAAAGGAGCA36(2) INFORMATION FOR SEQ ID NO:332:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:332:UGCGGCUCUGAUGAGGCCGAAAGGCCGAAAUGGUGU36(2) INFORMATION FOR SEQ ID NO:333:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:333:AGACGGCCUGAUGAGGCCGAAAGGCCGAAAUGCGGC36(2) INFORMATION FOR SEQ ID NO:334:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:334:GGUAGGACUGAUGAGGCCGAAAGGCCGAAACGGCGA36(2) INFORMATION FOR SEQ ID NO:335:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:335:CUGGUAGCUGAUGAGGCCGAAAGGCCGAAAGACGGC36(2) INFORMATION FOR SEQ ID NO:336:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:336:GGUCUGGCUGAUGAGGCCGAAAGGCCGAAAGGAGAC36(2) INFORMATION FOR SEQ ID NO:337:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:337:GGAGGUUCUGAUGAGGCCGAAAGGCCGAAACCUUGG36(2) INFORMATION FOR SEQ ID NO:338:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:338:CAGAGAGCUGAUGAGGCCGAAAGGCCGAAAGGUUGA36(2) INFORMATION FOR SEQ ID NO:339:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:339:UGGCAGACUGAUGAGGCCGAAAGGCCGAAAGGAGGU36(2) INFORMATION FOR SEQ ID NO:340:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:340:GAUGGCACUGAUGAGGCCGAAAGGCCGAAAGAGGAG36(2) INFORMATION FOR SEQ ID NO:341:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:341:GGCUCUUCUGAUGAGGCCGAAAGGCCGAAAUGGCAG36(2) INFORMATION FOR SEQ ID NO:342:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:342:GGGCUCACUGAUGAGGCCGAAAGGCCGAAACCAGGG36(2) INFORMATION FOR SEQ ID NO:343:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:343:CCAGAUACUGAUGAGGCCGAAAGGCCGAAAUGGGCU36(2) INFORMATION FOR SEQ ID NO:344:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:344:UCCCAGACUGAUGAGGCCGAAAGGCCGAAAGAUGGG36(2) INFORMATION FOR SEQ ID NO:345:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:345:CCUCCCACUGAUGAGGCCGAAAGGCCGAAAUAGAUG36(2) INFORMATION FOR SEQ ID NO:346:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:346:GCUGGAACUGAUGAGGCCGAAAGGCCGAAACCCCUC36(2) INFORMATION FOR SEQ ID NO:347:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:347:CAGCUGGCUGAUGAGGCCGAAAGGCCGAAAGACCCC36(2) INFORMATION FOR SEQ ID NO:348:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:348:CCAGCUGCUGAUGAGGCCGAAAGGCCGAAAAGACCC36(2) INFORMATION FOR SEQ ID NO:349:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:349:CAGCGCUCUGAUGAGGCCGAAAGGCCGAAAGUCGGU36(2) INFORMATION FOR SEQ ID NO:350:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:350:GCCGAUUCUGAUGAGGCCGAAAGGCCGAAAUCUCAG36(2) INFORMATION FOR SEQ ID NO:351:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:351:UCGGGCCCUGAUGAGGCCGAAAGGCCGAAAUUGAUC36(2) INFORMATION FOR SEQ ID NO:352:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:352:GUCGAGACUGAUGAGGCCGAAAGGCCGAAAGUCGGG36(2) INFORMATION FOR SEQ ID NO:353:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:353:AAGUCGACUGAUGAGGCCGAAAGGCCGAAAUAGUCG36(2) INFORMATION FOR SEQ ID NO:354:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:354:CAAAGUCCUGAUGAGGCCGAAAGGCCGAAAGAUAGU36(2) INFORMATION FOR SEQ ID NO:355:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:355:CUCGGCACUGAUGAGGCCGAAAGGCCGAAAGUCGAG36(2) INFORMATION FOR SEQ ID NO:356:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:356:ACUCGGCCUGAUGAGGCCGAAAGGCCGAAAAGUCGA36(2) INFORMATION FOR SEQ ID NO:357:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:357:CUGCCCACUGAUGAGGCCGAAAGGCCGAAACUCGGC36(2) INFORMATION FOR SEQ ID NO:358:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:358:CAAAGUACUGAUGAGGCCGAAAGGCCGAAACCUGCC36(2) INFORMATION FOR SEQ ID NO:359:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:359:CCCAAAGCUGAUGAGGCCGAAAGGCCGAAAGACCUG36(2) INFORMATION FOR SEQ ID NO:360:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:360:GAUCCCACUGAUGAGGCCGAAAGGCCGAAAGUAGAC36(2) INFORMATION FOR SEQ ID NO:361:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:361:UGAUCCCCUGAUGAGGCCGAAAGGCCGAAAAGUAGA36(2) INFORMATION FOR SEQ ID NO:362:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:362:GGGCAAUCUGAUGAGGCCGAAAGGCCGAAAUCCCAA36(2) INFORMATION FOR SEQ ID NO:363:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:363:ACAGGGCCUGAUGAGGCCGAAAGGCCGAAAUGAUCC36(2) INFORMATION FOR SEQ ID NO:364:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:364:AAGGUUGCUGAUGAGGCCGAAAGGCCGAAAUGUUCG36(2) INFORMATION FOR SEQ ID NO:365:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:365:GUUUGGGCUGAUGAGGCCGAAAGGCCGAAAGGUUGG36(2) INFORMATION FOR SEQ ID NO:366:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:366:CGUUUGGCUGAUGAGGCCGAAAGGCCGAAAAGGUUG36(2) INFORMATION FOR SEQ ID NO:367:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:367:GGCAGGGCUGAUGAGGCCGAAAGGCCGAAAGGCGUU36(2) INFORMATION FOR SEQ ID NO:368:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:368:AUAAAGGCUGAUGAGGCCGAAAGGCCGAAAUUGGGG36(2) INFORMATION FOR SEQ ID NO:369:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:369:GGUAAUACUGAUGAGGCCGAAAGGCCGAAAGGGAUU36(2) INFORMATION FOR SEQ ID NO:370:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:370:GGGUAAUCUGAUGAGGCCGAAAGGCCGAAAAGGGAU36(2) INFORMATION FOR SEQ ID NO:371:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:371:GGGGUAACUGAUGAGGCCGAAAGGCCGAAAAAGGGA36(2) INFORMATION FOR SEQ ID NO:372:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:372:AGGGGGUCUGAUGAGGCCGAAAGGCCGAAAUAAAGG36(2) INFORMATION FOR SEQ ID NO:373:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:373:GAGGGGGCUGAUGAGGCCGAAAGGCCGAAAAUAAAG36(2) INFORMATION FOR SEQ ID NO:374:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:374:UCUGAAGCUGAUGAGGCCGAAAGGCCGAAAGGGGGU36(2) INFORMATION FOR SEQ ID NO:375:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:375:GUGUCUGCUGAUGAGGCCGAAAGGCCGAAAGGAGGG36(2) INFORMATION FOR SEQ ID NO:376:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:376:GGUGUCUCUGAUGAGGCCGAAAGGCCGAAAAGGAGG36(2) INFORMATION FOR SEQ ID NO:377:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:377:AGAGGUUCUGAUGAGGCCGAAAGGCCGAAAGGGUGU36(2) INFORMATION FOR SEQ ID NO:378:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:378:GCCAGAACUGAUGAGGCCGAAAGGCCGAAAGGUUGA36(2) INFORMATION FOR SEQ ID NO:379:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:379:GAGCCAGCUGAUGAGGCCGAAAGGCCGAAAGAGGUU36(2) INFORMATION FOR SEQ ID NO:380:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:380:UGAGCCACUGAUGAGGCCGAAAGGCCGAAAAGAGGU36(2) INFORMATION FOR SEQ ID NO:381:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:381:UCUUUUUCUGAUGAGGCCGAAAGGCCGAAAGCCAGA36(2) INFORMATION FOR SEQ ID NO:382:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:382:AGCCCCCCUGAUGAGGCCGAAAGGCCGAAAUUCUCU36(2) INFORMATION FOR SEQ ID NO:383:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:383:CGACCCUCUGAUGAGGCCGAAAGGCCGAAAGCCCCC36(2) INFORMATION FOR SEQ ID NO:384:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:384:CCGACCCCUGAUGAGGCCGAAAGGCCGAAAAGCCCC36(2) INFORMATION FOR SEQ ID NO:385:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:385:GGGUUCCCUGAUGAGGCCGAAAGGCCGAAACCCUAA36(2) INFORMATION FOR SEQ ID NO:386:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:386:AAGUUCUCUGAUGAGGCCGAAAGGCCGAAAGCUUGG36(2) INFORMATION FOR SEQ ID NO:387:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:387:AAAGUUCCUGAUGAGGCCGAAAGGCCGAAAAGCUUG36(2) INFORMATION FOR SEQ ID NO:388:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:388:UUGCUUACUGAUGAGGCCGAAAGGCCGAAAGUUCUA36(2) INFORMATION FOR SEQ ID NO:389:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:389:GUUGCUUCUGAUGAGGCCGAAAGGCCGAAAAGUUCU36(2) INFORMATION FOR SEQ ID NO:390:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:390:UGUUGCUCUGAUGAGGCCGAAAGGCCGAAAAAGUUC36(2) INFORMATION FOR SEQ ID NO:391:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:391:GGUUUCGCUGAUGAGGCCGAAAGGCCGAAAGUGGUG36(2) INFORMATION FOR SEQ ID NO:392:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:392:AGGUUUCCUGAUGAGGCCGAAAGGCCGAAAAGUGGU36(2) INFORMATION FOR SEQ ID NO:393:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:393:AUUCCUGCUGAUGAGGCCGAAAGGCCGAAAUCCCAG36(2) INFORMATION FOR SEQ ID NO:394:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:394:CAUUCCUCUGAUGAGGCCGAAAGGCCGAAAAUCCCA36(2) INFORMATION FOR SEQ ID NO:395:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:395:GAAUUCUCUGAUGAGGCCGAAAGGCCGAAAGUGGUU36(2) INFORMATION FOR SEQ ID NO:396:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:396:CAGUUUGCUGAUGAGGCCGAAAGGCCGAAAUUCUUA36(2) INFORMATION FOR SEQ ID NO:397:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:397:CCAGUUUCUGAUGAGGCCGAAAGGCCGAAAAUUCUU36(2) INFORMATION FOR SEQ ID NO:398:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:398:AGUUCUGCUGAUGAGGCCGAAAGGCCGAAAGGCCCC36(2) INFORMATION FOR SEQ ID NO:399:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:399:CCCCAGUCUGAUGAGGCCGAAAGGCCGAAAGUUCUG36(2) INFORMATION FOR SEQ ID NO:400:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:400:AAAGCUGCUGAUGAGGCCGAAAGGCCGAAAGGCCCC36(2) INFORMATION FOR SEQ ID NO:401:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:401:GGGAUCACUGAUGAGGCCGAAAGGCCGAAAGCUGUA36(2) INFORMATION FOR SEQ ID NO:402:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:402:AGGGAUCCUGAUGAGGCCGAAAGGCCGAAAAGCUGU36(2) INFORMATION FOR SEQ ID NO:403:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:403:UGUCAGGCUGAUGAGGCCGAAAGGCCGAAAUCAAAG36(2) INFORMATION FOR SEQ ID NO:404:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:404:GAUUCCACUGAUGAGGCCGAAAGGCCGAAAUGUCAG36(2) INFORMATION FOR SEQ ID NO:405:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:405:GUCUCCACUGAUGAGGCCGAAAGGCCGAAAUUCCAG36(2) INFORMATION FOR SEQ ID NO:406:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:406:AGAACCACUGAUGAGGCCGAAAGGCCGAAAGGCUCC36(2) INFORMATION FOR SEQ ID NO:407:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:407:CAGAACCCUGAUGAGGCCGAAAGGCCGAAAAGGCUC36(2) INFORMATION FOR SEQ ID NO:408:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:408:UGGCCAGCUGAUGAGGCCGAAAGGCCGAAACCAAAG36(2) INFORMATION FOR SEQ ID NO:409:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:409:CUGGCCACUGAUGAGGCCGAAAGGCCGAAAACCAAA36(2) INFORMATION FOR SEQ ID NO:410:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:410:UCUUCUCCUGAUGAGGCCGAAAGGCCGAAAGUCCUG36(2) INFORMATION FOR SEQ ID NO:411:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:411:UCUAGGUCUGAUGAGGCCGAAAGGCCGAAAGGUCUU36(2) INFORMATION FOR SEQ ID NO:412:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:412:CAAUUUCCUGAUGAGGCCGAAAGGCCGAAAGGUGAG36(2) INFORMATION FOR SEQ ID NO:413:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:413:UUGUGUCCUGAUGAGGCCGAAAGGCCGAAAUUUCUA36(2) INFORMATION FOR SEQ ID NO:414:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:414:AAGGCCUCUGAUGAGGCCGAAAGGCCGAAAGGUCCA36(2) INFORMATION FOR SEQ ID NO:415:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:415:GAAGGCCCUGAUGAGGCCGAAAGGCCGAAAAGGUCC36(2) INFORMATION FOR SEQ ID NO:416:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:416:AGAGAGGCUGAUGAGGCCGAAAGGCCGAAAGGCCUA36(2) INFORMATION FOR SEQ ID NO:417:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:417:GAGAGAGCUGAUGAGGCCGAAAGGCCGAAAAGGCCU36(2) INFORMATION FOR SEQ ID NO:418:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:418:CUGGAGACUGAUGAGGCCGAAAGGCCGAAAGGAAGG36(2) INFORMATION FOR SEQ ID NO:419:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:419:AUCUGGACUGAUGAGGCCGAAAGGCCGAAAGAGGAA36(2) INFORMATION FOR SEQ ID NO:420:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:420:ACAUCUGCUGAUGAGGCCGAAAGGCCGAAAGAGAGG36(2) INFORMATION FOR SEQ ID NO:421:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:421:GUCUGGACUGAUGAGGCCGAAAGGCCGAAACAUCUG36(2) INFORMATION FOR SEQ ID NO:422:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:422:AGUCUGGCUGAUGAGGCCGAAAGGCCGAAAACAUCU36(2) INFORMATION FOR SEQ ID NO:423:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:423:AAGUCUGCUGAUGAGGCCGAAAGGCCGAAAAACAUC36(2) INFORMATION FOR SEQ ID NO:424:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:424:CUCAAGGCUGAUGAGGCCGAAAGGCCGAAAGUCUGG36(2) INFORMATION FOR SEQ ID NO:425:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:425:UCUCAAGCUGAUGAGGCCGAAAGGCCGAAAAGUCUG36(2) INFORMATION FOR SEQ ID NO:426:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:426:GUGUCUCCUGAUGAGGCCGAAAGGCCGAAAGGAAGU36(2) INFORMATION FOR SEQ ID NO:427:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:427:CCAUGGGCUGAUGAGGCCGAAAGGCCGAAAGGGCUG36(2) INFORMATION FOR SEQ ID NO:428:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:428:AUAGAGGCUGAUGAGGCCGAAAGGCCGAAAGCUGGC36(2) INFORMATION FOR SEQ ID NO:429:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:429:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAGGGAGC36(2) INFORMATION FOR SEQ ID NO:430:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:430:ACAUAAACUGAUGAGGCCGAAAGGCCGAAAGAGGGA36(2) INFORMATION FOR SEQ ID NO:431:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:431:AAACAUACUGAUGAGGCCGAAAGGCCGAAAUAGAGG36(2) INFORMATION FOR SEQ ID NO:432:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:432:CAAACAUCUGAUGAGGCCGAAAGGCCGAAAAUAGAG36(2) INFORMATION FOR SEQ ID NO:433:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:433:GCAAACACUGAUGAGGCCGAAAGGCCGAAAAAUAGA36(2) INFORMATION FOR SEQ ID NO:434:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:434:AAGUGCACUGAUGAGGCCGAAAGGCCGAAACAUAAA36(2) INFORMATION FOR SEQ ID NO:435:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:435:CAAGUGCCUGAUGAGGCCGAAAGGCCGAAAACAUAA36(2) INFORMATION FOR SEQ ID NO:436:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:436:UAAUCACCUGAUGAGGCCGAAAGGCCGAAAGUGCAA36(2) INFORMATION FOR SEQ ID NO:437:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:437:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUCACAA36(2) INFORMATION FOR SEQ ID NO:438:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:438:UAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUCACA36(2) INFORMATION FOR SEQ ID NO:439:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:439:AAUAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUCA36(2) INFORMATION FOR SEQ ID NO:440:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:440:AAAUAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUC36(2) INFORMATION FOR SEQ ID NO:441:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:441:UAAAUAACUGAUGAGGCCGAAAGGCCGAAAAAUAAU36(2) INFORMATION FOR SEQ ID NO:442:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:442:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:443:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:443:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:444:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:444:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUAA36(2) INFORMATION FOR SEQ ID NO:445:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:445:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUA36(2) INFORMATION FOR SEQ ID NO:446:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:446:UAAUAAACUGAUGAGGCCGAAAGGCCGAAAAAUAAU36(2) INFORMATION FOR SEQ ID NO:447:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:447:AAUAAUACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:448:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:448:AAAUAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:449:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:449:UAAAUAACUGAUGAGGCCGAAAGGCCGAAAAAUAAA36(2) INFORMATION FOR SEQ ID NO:450:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:450:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:451:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:451:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:452:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:452:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUAA36(2) INFORMATION FOR SEQ ID NO:453:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:453:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUA36(2) INFORMATION FOR SEQ ID NO:454:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:454:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAAUAAU36(2) INFORMATION FOR SEQ ID NO:455:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:455:GUAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:456:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:456:UGUAAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:457:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:457:CUGUAAACUGAUGAGGCCGAAAGGCCGAAAAAUAAA36(2) INFORMATION FOR SEQ ID NO:458:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:458:AUCUGUACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:459:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:459:CAUCUGUCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:460:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:460:UCAUCUGCUGAUGAGGCCGAAAGGCCGAAAAAUAAA36(2) INFORMATION FOR SEQ ID NO:461:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:461:AAAUAAACUGAUGAGGCCGAAAGGCCGAAACAUUCA36(2) INFORMATION FOR SEQ ID NO:462:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:462:CCAAAUACUGAUGAGGCCGAAAGGCCGAAAUACAUU36(2) INFORMATION FOR SEQ ID NO:463:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:463:CCCAAAUCUGAUGAGGCCGAAAGGCCGAAAAUACAU36(2) INFORMATION FOR SEQ ID NO:464:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:464:UCCCAAACUGAUGAGGCCGAAAGGCCGAAAAAUACA36(2) INFORMATION FOR SEQ ID NO:465:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:465:UCUCCCACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:466:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:466:GUCUCCCCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:467:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:467:CCCAGGACUGAUGAGGCCGAAAGGCCGAAACCCCGG36(2) INFORMATION FOR SEQ ID NO:468:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:468:CCCCCAGCUGAUGAGGCCGAAAGGCCGAAAUACCCC36(2) INFORMATION FOR SEQ ID NO:469:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:469:CAGCUCCCUGAUGAGGCCGAAAGGCCGAAACAUUGG36(2) INFORMATION FOR SEQ ID NO:470:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:470:CUGAGCCCUGAUGAGGCCGAAAGGCCGAAAGGCAGC36(2) INFORMATION FOR SEQ ID NO:471:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:471:CAUGUCUCUGAUGAGGCCGAAAGGCCGAAAGCCAAG36(2) INFORMATION FOR SEQ ID NO:472:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:472:CACGGAACUGAUGAGGCCGAAAGGCCGAAACAUGUC36(2) INFORMATION FOR SEQ ID NO:473:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:473:UCACGGACUGAUGAGGCCGAAAGGCCGAAAACAUGU36(2) INFORMATION FOR SEQ ID NO:474:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:474:UUCACGGCUGAUGAGGCCGAAAGGCCGAAAAACAUG36(2) INFORMATION FOR SEQ ID NO:475:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:475:UUUCACGCUGAUGAGGCCGAAAGGCCGAAAAAACAU36(2) INFORMATION FOR SEQ ID NO:476:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:476:AACAGCCCUGAUGAGGCCGAAAGGCCGAAAUUGUUC36(2) INFORMATION FOR SEQ ID NO:477:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:477:ACAUGGGCUGAUGAGGCCGAAAGGCCGAAACAGCCU36(2) INFORMATION FOR SEQ ID NO:478:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:478:UACAUGGCUGAUGAGGCCGAAAGGCCGAAAACAGCC36(2) INFORMATION FOR SEQ ID NO:479:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:479:AGGGGGCCUGAUGAGGCCGAAAGGCCGAAACAUGGG36(2) INFORMATION FOR SEQ ID NO:480:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:480:AGGCACACUGAUGAGGCCGAAAGGCCGAAAGGCCAG36(2) INFORMATION FOR SEQ ID NO:481:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:481:UCAAAAGCUGAUGAGGCCGAAAGGCCGAAAGGCACA36(2) INFORMATION FOR SEQ ID NO:482:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:482:AUCAAAACUGAUGAGGCCGAAAGGCCGAAAAGGCAC36(2) INFORMATION FOR SEQ ID NO:483:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:483:UAAUCAACUGAUGAGGCCGAAAGGCCGAAAGAAGGC36(2) INFORMATION FOR SEQ ID NO:484:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:484:AUAAUCACUGAUGAGGCCGAAAGGCCGAAAAGAAGG36(2) INFORMATION FOR SEQ ID NO:485:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:485:CAUAAUCCUGAUGAGGCCGAAAGGCCGAAAAAGAAG36(2) INFORMATION FOR SEQ ID NO:486:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:486:AAAACAUCUGAUGAGGCCGAAAGGCCGAAAUCAAAA36(2) INFORMATION FOR SEQ ID NO:487:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:487:AAAAACACUGAUGAGGCCGAAAGGCCGAAAAUCAAA36(2) INFORMATION FOR SEQ ID NO:488:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:488:UUUAAAACUGAUGAGGCCGAAAGGCCGAAACAUAAU36(2) INFORMATION FOR SEQ ID NO:489:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:489:UUUUAAACUGAUGAGGCCGAAAGGCCGAAAACAUAA36(2) INFORMATION FOR SEQ ID NO:490:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:490:AUUUUAACUGAUGAGGCCGAAAGGCCGAAAAACAUA36(2) INFORMATION FOR SEQ ID NO:491:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:491:UAUUUUACUGAUGAGGCCGAAAGGCCGAAAAAACAU36(2) INFORMATION FOR SEQ ID NO:492:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:492:AUAUUUUCUGAUGAGGCCGAAAGGCCGAAAAAAACA36(2) INFORMATION FOR SEQ ID NO:493:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:493:AAUAUUUCUGAUGAGGCCGAAAGGCCGAAAAAAAAC36(2) INFORMATION FOR SEQ ID NO:494:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:494:CAGAUAACUGAUGAGGCCGAAAGGCCGAAAUUUUAA36(2) INFORMATION FOR SEQ ID NO:495:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:495:AUCAGAUCUGAUGAGGCCGAAAGGCCGAAAUAUUUU36(2) INFORMATION FOR SEQ ID NO:496:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:496:AAUCAGACUGAUGAGGCCGAAAGGCCGAAAAUAUUU36(2) INFORMATION FOR SEQ ID NO:497:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:497:UUAAUCACUGAUGAGGCCGAAAGGCCGAAAUAAUAU36(2) INFORMATION FOR SEQ ID NO:498:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:498:ACAACUUCUGAUGAGGCCGAAAGGCCGAAAUCAGAU36(2) INFORMATION FOR SEQ ID NO:499:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:499:GACAACUCUGAUGAGGCCGAAAGGCCGAAAAUCAGA36(2) INFORMATION FOR SEQ ID NO:500:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:500:UUUAGACCUGAUGAGGCCGAAAGGCCGAAACUUAAU36(2) INFORMATION FOR SEQ ID NO:501:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:501:UUGUUUACUGAUGAGGCCGAAAGGCCGAAACAACUU36(2) INFORMATION FOR SEQ ID NO:502:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:502:CAUUGUUCUGAUGAGGCCGAAAGGCCGAAAGACAAC36(2) INFORMATION FOR SEQ ID NO:503:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:503:GUCACCACUGAUGAGGCCGAAAGGCCGAAAUCAGCA36(2) INFORMATION FOR SEQ ID NO:504:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:504:GGUCACCCUGAUGAGGCCGAAAGGCCGAAAAUCAGC36(2) INFORMATION FOR SEQ ID NO:505:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:505:AAUGAGUCUGAUGAGGCCGAAAGGCCGAAACAGUUG36(2) INFORMATION FOR SEQ ID NO:506:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:506:CAGCAAUCUGAUGAGGCCGAAAGGCCGAAAGUGACA36(2) INFORMATION FOR SEQ ID NO:507:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:507:CCUCAGCCUGAUGAGGCCGAAAGGCCGAAAUGAGUG36(2) INFORMATION FOR SEQ ID NO:508:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:508:GGGAGCACUGAUGAGGCCGAAAGGCCGAAAGGCCUC36(2) INFORMATION FOR SEQ ID NO:509:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:509:CCCUGGGCUGAUGAGGCCGAAAGGCCGAAAGCAGAG36(2) INFORMATION FOR SEQ ID NO:510:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:510:CAGACACCUGAUGAGGCCGAAAGGCCGAAACUCCCU36(2) INFORMATION FOR SEQ ID NO:511:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:511:GAUUACACUGAUGAGGCCGAAAGGCCGAAACACAAC36(2) INFORMATION FOR SEQ ID NO:512:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:512:GGCCGAUCUGAUGAGGCCGAAAGGCCGAAACAGACA36(2) INFORMATION FOR SEQ ID NO:513:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:513:GUAGGCCCUGAUGAGGCCGAAAGGCCGAAAUUACAG36(2) INFORMATION FOR SEQ ID NO:514:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:514:UGAAUAGCUGAUGAGGCCGAAAGGCCGAAAGGCCGA36(2) INFORMATION FOR SEQ ID NO:515:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:515:CACUGAACUGAUGAGGCCGAAAGGCCGAAAGUAGGC36(2) INFORMATION FOR SEQ ID NO:516:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:516:GCCACUGCUGAUGAGGCCGAAAGGCCGAAAUAGUAG36(2) INFORMATION FOR SEQ ID NO:517:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:517:CGCCACUCUGAUGAGGCCGAAAGGCCGAAAAUAGUA36(2) INFORMATION FOR SEQ ID NO:518:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:518:CAACCUUCUGAUGAGGCCGAAAGGCCGAAAUUUCUC36(2) INFORMATION FOR SEQ ID NO:519:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:519:CCUAAGCCUGAUGAGGCCGAAAGGCCGAAACCUUUA36(2) INFORMATION FOR SEQ ID NO:520:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:520:CUUUCCUCUGAUGAGGCCGAAAGGCCGAAAGCAACC36(2) INFORMATION FOR SEQ ID NO:521:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:521:UCUUUCCCUGAUGAGGCCGAAAGGCCGAAAAGCAAC36(2) INFORMATION FOR SEQ ID NO:522:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:522:UGGAAAUAGCUCCCA15(2) INFORMATION FOR SEQ ID NO:523:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:523:GGCAGGUUCUGUCCC15(2) INFORMATION FOR SEQ ID NO:524:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:524:GGCAGGUUCUGUCCC15(2) INFORMATION FOR SEQ ID NO:525:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:525:GCAGGUUCUGUCCCU15(2) INFORMATION FOR SEQ ID NO:526:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:526:GCAGGUUCUGUCCCU15(2) INFORMATION FOR SEQ ID NO:527:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:527:GUUCUGUCCCUUUCA15(2) INFORMATION FOR SEQ ID NO:528:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:528:UGUCCCUUUCACUCA15(2) INFORMATION FOR SEQ ID NO:529:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:529:GUCCCUUUCACUCAC15(2) INFORMATION FOR SEQ ID NO:530:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:530:GUCCCUUUCACUCAC15(2) INFORMATION FOR SEQ ID NO:531:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:531:UCCCUUUCACUCACU15(2) INFORMATION FOR SEQ ID NO:532:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:532:UUUCACUCACUGGCC15(2) INFORMATION FOR SEQ ID NO:533:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:533:GCCACAUCUCCCUCC15(2) INFORMATION FOR SEQ ID NO:534:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:534:CACAUCUCCCUCCAG15(2) INFORMATION FOR SEQ ID NO:535:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:535:GCAUGAUCCGCGACG15(2) INFORMATION FOR SEQ ID NO:536:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:536:AGGCACUCCCCCAAA15(2) INFORMATION FOR SEQ ID NO:537:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:537:GGGGCUUCCAGAACU15(2) INFORMATION FOR SEQ ID NO:538:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:538:GGGGCUUCCAGAACU15(2) INFORMATION FOR SEQ ID NO:539:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:539:CAGAACUCCAGGCGG15(2) INFORMATION FOR SEQ ID NO:540:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:540:CAGAACUCCAGGCGG15(2) INFORMATION FOR SEQ ID NO:541:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:541:GGUGCCUAUGUCUCA15(2) INFORMATION FOR SEQ ID NO:542:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:542:GGUGCCUAUGUCUCA15(2) INFORMATION FOR SEQ ID NO:543:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:543:UCAGCCUCUUCUCAU15(2) INFORMATION FOR SEQ ID NO:544:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:544:UCAGCCUCUUCUCAU15(2) INFORMATION FOR SEQ ID NO:545:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:545:AGCCUCUUCUCAUUC15(2) INFORMATION FOR SEQ ID NO:546:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:546:AGCCUCUUCUCAUUC15(2) INFORMATION FOR SEQ ID NO:547:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:547:GCCUCUUCUCAUUCC15(2) INFORMATION FOR SEQ ID NO:548:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:548:GCCUCUUCUCAUUCC15(2) INFORMATION FOR SEQ ID NO:549:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:549:CUCUUCUCAUUCCUG15(2) INFORMATION FOR SEQ ID NO:550:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:550:UUCUCAUUCCUGCUU15(2) INFORMATION FOR SEQ ID NO:551:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:551:UCUCAUUCCUGCUUG15(2) INFORMATION FOR SEQ ID NO:552:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:552:UCCUGCUUGUGGCAG15(2) INFORMATION FOR SEQ ID NO:553:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:553:CCACGCUCUUCUGUC15(2) INFORMATION FOR SEQ ID NO:554:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:554:ACGCUCUUCUGUCUA15(2) INFORMATION FOR SEQ ID NO:555:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:555:CGCUCUUCUGUCUAC15(2) INFORMATION FOR SEQ ID NO:556:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:556:CUUCUGUCUACUGAA15(2) INFORMATION FOR SEQ ID NO:557:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:557:UCUGUCUACUGAACU15(2) INFORMATION FOR SEQ ID NO:558:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:558:CUGAACUUCGGGGUG15(2) INFORMATION FOR SEQ ID NO:559:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:559:UGAACUUCGGGGUGA15(2) INFORMATION FOR SEQ ID NO:560:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:560:UGAACUUCGGGGUGA15(2) INFORMATION FOR SEQ ID NO:561:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:561:GGGUGAUCGGUCCCC15(2) INFORMATION FOR SEQ ID NO:562:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:562:GGGUGAUCGGUCCCC15(2) INFORMATION FOR SEQ ID NO:563:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:563:GAGAAGUUCCCAAAU15(2) INFORMATION FOR SEQ ID NO:564:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:564:CCUCCCUCUCAUCAG15(2) INFORMATION FOR SEQ ID NO:565:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:565:UCCCUCUCAUCAGUU15(2) INFORMATION FOR SEQ ID NO:566:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:566:UCCCUCUCAUCAGUU15(2) INFORMATION FOR SEQ ID NO:567:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:567:CUCUCAUCAGUUCUA15(2) INFORMATION FOR SEQ ID NO:568:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:568:CAGUUCUAUGGCCCA15(2) INFORMATION FOR SEQ ID NO:569:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:569:AGACCCUCACACUCA15(2) INFORMATION FOR SEQ ID NO:570:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:570:UCACACUCAGAUCAU15(2) INFORMATION FOR SEQ ID NO:571:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:571:CUCAGAUCAUCUUCU15(2) INFORMATION FOR SEQ ID NO:572:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:572:AGAUCAUCUUCUCAA15(2) INFORMATION FOR SEQ ID NO:573:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:573:AUCAUCUUCUCAAAA15(2) INFORMATION FOR SEQ ID NO:574:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:574:AUCAUCUUCUCAAAA15(2) INFORMATION FOR SEQ ID NO:575:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:575:UCAUCUUCUCAAAAU15(2) INFORMATION FOR SEQ ID NO:576:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:576:AUCUUCUCAAAAUUC15(2) INFORMATION FOR SEQ ID NO:577:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:577:AUCUUCUCAAAAUUC15(2) INFORMATION FOR SEQ ID NO:578:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:578:AUCUUCUCAAAAUUC15(2) INFORMATION FOR SEQ ID NO:579:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:579:AGCCUGUAGCCCACG15(2) INFORMATION FOR SEQ ID NO:580:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:580:ACGUCGUAGCAAACC15(2) INFORMATION FOR SEQ ID NO:581:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:581:ACGCCCUCCUGGCCA15(2) INFORMATION FOR SEQ ID NO:582:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:582:GGGUUGUACCUUGUC15(2) INFORMATION FOR SEQ ID NO:583:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:583:GGGUUGUACCUUGUC15(2) INFORMATION FOR SEQ ID NO:584:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:584:UGUACCUUGUCUACU15(2) INFORMATION FOR SEQ ID NO:585:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:585:ACCUUGUCUACUCCC15(2) INFORMATION FOR SEQ ID NO:586:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:586:CUUGUCUACUCCCAG15(2) INFORMATION FOR SEQ ID NO:587:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:587:GUCUACUCCCAGGUU15(2) INFORMATION FOR SEQ ID NO:588:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:588:GUCUACUCCCAGGUU15(2) INFORMATION FOR SEQ ID NO:589:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:589:GUCUACUCCCAGGUU15(2) INFORMATION FOR SEQ ID NO:590:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:590:CCCAGGUUCUCUUCA15(2) INFORMATION FOR SEQ ID NO:591:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:591:CCAGGUUCUCUUCAA15(2) INFORMATION FOR SEQ ID NO:592:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:592:CCAGGUUCUCUUCAA15(2) INFORMATION FOR SEQ ID NO:593:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:593:AGGUUCUCUUCAAGG15(2) INFORMATION FOR SEQ ID NO:594:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:594:AGGUUCUCUUCAAGG15(2) INFORMATION FOR SEQ ID NO:595:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:595:GUUCUCUUCAAGGGA15(2) INFORMATION FOR SEQ ID NO:596:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:596:UUCUCUUCAAGGGAC15(2) INFORMATION FOR SEQ ID NO:597:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:597:CCCGACUACGUGCUC15(2) INFORMATION FOR SEQ ID NO:598:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:598:ACGUGCUCCUCACCC15(2) INFORMATION FOR SEQ ID NO:599:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:599:ACGUGCUCCUCACCC15(2) INFORMATION FOR SEQ ID NO:600:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:600:UGCUCCUCACCCACA15(2) INFORMATION FOR SEQ ID NO:601:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:601:ACACCGUCAGCCGAU15(2) INFORMATION FOR SEQ ID NO:602:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:602:ACACCGUCAGCCGAU15(2) INFORMATION FOR SEQ ID NO:603:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:603:AGCCGAUUUGCUAUC15(2) INFORMATION FOR SEQ ID NO:604:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:604:AUUUGCUAUCUCAUA15(2) INFORMATION FOR SEQ ID NO:605:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:605:UUGCUAUCUCAUACC15(2) INFORMATION FOR SEQ ID NO:606:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:606:GCUAUCUCAUACCAG15(2) INFORMATION FOR SEQ ID NO:607:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:607:AGAAAGUCAACCUCC15(2) INFORMATION FOR SEQ ID NO:608:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:608:UCAACCUCCUCUCUG15(2) INFORMATION FOR SEQ ID NO:609:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:609:UCAACCUCCUCUCUG15(2) INFORMATION FOR SEQ ID NO:610:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:610:ACCUCCUCUCUGCCG15(2) INFORMATION FOR SEQ ID NO:611:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:611:CUCCUCUCUGCCGUC15(2) INFORMATION FOR SEQ ID NO:612:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:612:CUGCCGUCAAGAGCC15(2) INFORMATION FOR SEQ ID NO:613:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:613:CUGCCGUCAAGAGCC15(2) INFORMATION FOR SEQ ID NO:614:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:614:CUGCCGUCAAGAGCC15(2) INFORMATION FOR SEQ ID NO:615:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:615:CCCUGGUAUGAGCCC15(2) INFORMATION FOR SEQ ID NO:616:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:616:CCCUGGUAUGAGCCC15(2) INFORMATION FOR SEQ ID NO:617:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:617:AGCCCAUAUACCUGG15(2) INFORMATION FOR SEQ ID NO:618:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:618:CCCAUAUACCUGGGA15(2) INFORMATION FOR SEQ ID NO:619:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:619:GAGGAGUCUUCCAGC15(2) INFORMATION FOR SEQ ID NO:620:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:620:GAGGAGUCUUCCAGC15(2) INFORMATION FOR SEQ ID NO:621:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:621:GGAGUCUUCCAGCUG15(2) INFORMATION FOR SEQ ID NO:622:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:622:GAGUCUUCCAGCUGG15(2) INFORMATION FOR SEQ ID NO:623:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:623:ACCAACUCAGCGCUG15(2) INFORMATION FOR SEQ ID NO:624:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:624:CUGAGGUCAAUCUGC15(2) INFORMATION FOR SEQ ID NO:625:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:625:GGUCAAUCUGCCCAA15(2) INFORMATION FOR SEQ ID NO:626:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:626:CCCAAGUACUUAGAC15(2) INFORMATION FOR SEQ ID NO:627:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:627:AGUACUUAGACUUUG15(2) INFORMATION FOR SEQ ID NO:628:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:628:UUAGACUUUGCGGAG15(2) INFORMATION FOR SEQ ID NO:629:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:629:UAGACUUUGCGGAGU15(2) INFORMATION FOR SEQ ID NO:630:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:630:GCGGAGUCCGGGCAG15(2) INFORMATION FOR SEQ ID NO:631:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:631:GGCAGGUCUACUUUG15(2) INFORMATION FOR SEQ ID NO:632:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:632:CAGGUCUACUUUGGA15(2) INFORMATION FOR SEQ ID NO:633:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:633:CAGGUCUACUUUGGA15(2) INFORMATION FOR SEQ ID NO:634:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:634:CAGGUCUACUUUGGA15(2) INFORMATION FOR SEQ ID NO:635:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:635:GUCUACUUUGGAGUC15(2) INFORMATION FOR SEQ ID NO:636:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:636:UCUACUUUGGAGUCA15(2) INFORMATION FOR SEQ ID NO:637:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:637:UUGGAGUCAUUGCUC15(2) INFORMATION FOR SEQ ID NO:638:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:638:GAGUCAUUGCUCUGU15(2) INFORMATION FOR SEQ ID NO:639:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:639:AUCCAUUCUCUACCC15(2) INFORMATION FOR SEQ ID NO:640:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:640:AUUCUCUACCCAGCC15(2) INFORMATION FOR SEQ ID NO:641:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:641:CCCCACUCUGACCCC15(2) INFORMATION FOR SEQ ID NO:642:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:642:CCCCACUCUGACCCC15(2) INFORMATION FOR SEQ ID NO:643:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:643:CCCCACUCUGACCCC15(2) INFORMATION FOR SEQ ID NO:644:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:644:GACCCCUUUACUCUG15(2) INFORMATION FOR SEQ ID NO:645:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:645:ACCCCUUUACUCUGA15(2) INFORMATION FOR SEQ ID NO:646:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:646:CUUUACUCUGACCCC15(2) INFORMATION FOR SEQ ID NO:647:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:647:GACCCCUUUAUUGUC15(2) INFORMATION FOR SEQ ID NO:648:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:648:GACCCCUUUAUUGUC15(2) INFORMATION FOR SEQ ID NO:649:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:649:CCUUUAUUGUCUACU15(2) INFORMATION FOR SEQ ID NO:650:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:650:GUCUACUCCUCAGAG15(2) INFORMATION FOR SEQ ID NO:651:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:651:UACUCCUCAGAGCCC15(2) INFORMATION FOR SEQ ID NO:652:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:652:UCUAACUUAGAAAGG15(2) INFORMATION FOR SEQ ID NO:653:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:653:UCUAACUUAGAAAGG15(2) INFORMATION FOR SEQ ID NO:654:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:654:CUAACUUAGAAAGGG15(2) INFORMATION FOR SEQ ID NO:655:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:655:AGGGGAUUAUGGCUC15(2) INFORMATION FOR SEQ ID NO:656:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:656:AGGGGAUUAUGGCUC15(2) INFORMATION FOR SEQ ID NO:657:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:657:GGGGAUUAUGGCUCA15(2) INFORMATION FOR SEQ ID NO:658:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:658:UCAGAGUCCAACUCU15(2) INFORMATION FOR SEQ ID NO:659:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:659:CUGUGCUCAGAGCUU15(2) INFORMATION FOR SEQ ID NO:660:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:660:CAGAGCUUUCAACAA15(2) INFORMATION FOR SEQ ID NO:661:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:661:AGAGCUUUCAACAAC15(2) INFORMATION FOR SEQ ID NO:662:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:662:GAGCUUUCAACAACU15(2) INFORMATION FOR SEQ ID NO:663:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:663:UGGGCCUCUCAUGCA15(2) INFORMATION FOR SEQ ID NO:664:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:664:AAGGACUCAAAUGGG15(2) INFORMATION FOR SEQ ID NO:665:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:665:AUGGGCUUUCCGAAU15(2) INFORMATION FOR SEQ ID NO:666:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:666:UGGGCUUUCCGAAUU15(2) INFORMATION FOR SEQ ID NO:667:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:667:GGGCUUUCCGAAUUC15(2) INFORMATION FOR SEQ ID NO:668:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:668:CCGAAUUCACUGGAG15(2) INFORMATION FOR SEQ ID NO:669:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:669:CGAAUGUCCAUUCCU15(2) INFORMATION FOR SEQ ID NO:670:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:670:GAGUGGUCAGGUUGC15(2) INFORMATION FOR SEQ ID NO:671:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:671:UCUGUCUCAGAAUGA15(2) INFORMATION FOR SEQ ID NO:672:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:672:AAGAUCUCAGGCCUU15(2) INFORMATION FOR SEQ ID NO:673:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:673:CAGGCCUUCCUACCU15(2) INFORMATION FOR SEQ ID NO:674:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:674:AGGCCUUCCUACCUU15(2) INFORMATION FOR SEQ ID NO:675:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:675:CCUUCCUACCUUCAG15(2) INFORMATION FOR SEQ ID NO:676:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:676:CCUACCUUCAGACCU15(2) INFORMATION FOR SEQ ID NO:677:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:677:CCUACCUUCAGACCU15(2) INFORMATION FOR SEQ ID NO:678:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:678:CCUACCUUCAGACCU15(2) INFORMATION FOR SEQ ID NO:679:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:679:CCUACCUUCAGACCU15(2) INFORMATION FOR SEQ ID NO:680:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:680:CUACCUUCAGACCUU15(2) INFORMATION FOR SEQ ID NO:681:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:681:CUACCUUCAGACCUU15(2) INFORMATION FOR SEQ ID NO:682:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:682:CAGACCUUUCCAGAC15(2) INFORMATION FOR SEQ ID NO:683:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:683:CAGACCUUUCCAGAC15(2) INFORMATION FOR SEQ ID NO:684:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:684:AGACCUUUCCAGACU15(2) INFORMATION FOR SEQ ID NO:685:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:685:AGACCUUUCCAGACU15(2) INFORMATION FOR SEQ ID NO:686:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:686:GACCUUUCCAGACUC15(2) INFORMATION FOR SEQ ID NO:687:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:687:GACUCUUCCCUGAGG15(2) INFORMATION FOR SEQ ID NO:688:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:688:CAGCCUUCCUCACAG15(2) INFORMATION FOR SEQ ID NO:689:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:689:CCCCCCUCUAUUUAU15(2) INFORMATION FOR SEQ ID NO:690:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:690:CCCCCCUCUAUUUAU15(2) INFORMATION FOR SEQ ID NO:691:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:691:CCCCUCUAUUUAUAU15(2) INFORMATION FOR SEQ ID NO:692:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:692:CCUCUAUUUAUAUUU15(2) INFORMATION FOR SEQ ID NO:693:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:693:CCUCUAUUUAUAUUU15(2) INFORMATION FOR SEQ ID NO:694:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:694:CUCUAUUUAUAUUUG15(2) INFORMATION FOR SEQ ID NO:695:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:695:UCUAUUUAUAUUUGC15(2) INFORMATION FOR SEQ ID NO:696:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:696:UUUAUAUUUGCACUU15(2) INFORMATION FOR SEQ ID NO:697:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:697:UUUAUAUUUGCACUU15(2) INFORMATION FOR SEQ ID NO:698:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:698:UUAUAUUUGCACUUA15(2) INFORMATION FOR SEQ ID NO:699:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:699:UUGCACUUAUUAUUU15(2) INFORMATION FOR SEQ ID NO:700:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:700:CACUUAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:701:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:701:ACUUAUUAUUUAUUA15(2) INFORMATION FOR SEQ ID NO:702:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:702:UUAUUAUUUAUUAUU15(2) INFORMATION FOR SEQ ID NO:703:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:703:UAUUAUUUAUUAUUU15(2) INFORMATION FOR SEQ ID NO:704:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:704:UAUUAUUUAUUAUUU15(2) INFORMATION FOR SEQ ID NO:705:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:705:AUUAUUUAUUAUUUA15(2) INFORMATION FOR SEQ ID NO:706:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:706:UAUUUAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:707:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:707:UAUUUAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:708:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:708:UAUUUAUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:709:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:709:AUUUAUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:710:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:710:AUUUAUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:711:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:711:AUUUAUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:712:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:712:UUAUUAUUUAUUUAU15(2) INFORMATION FOR SEQ ID NO:713:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:713:UUAUUAUUUAUUUAU15(2) INFORMATION FOR SEQ ID NO:714:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:714:UUAUUAUUUAUUUAU15(2) INFORMATION FOR SEQ ID NO:715:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:715:UAUUAUUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:716:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:716:UAUUAUUUAUUUAUU15(2) INFORMATION FOR SEQ ID NO:717:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:717:AUUAUUUAUUUAUUA15(2) INFORMATION FOR SEQ ID NO:718:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:718:UAUUUAUUUAUUAUU15(2) INFORMATION FOR SEQ ID NO:719:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:719:AUUUAUUUAUUAUUU15(2) INFORMATION FOR SEQ ID NO:720:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:720:UUUAUUUAUUAUUUA15(2) INFORMATION FOR SEQ ID NO:721:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:721:AUUAUUUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:722:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:722:UAUUUAUUUAUUUGC15(2) INFORMATION FOR SEQ ID NO:723:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:723:AUUUAUUUAUUUGCU15(2) INFORMATION FOR SEQ ID NO:724:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:724:UUUAUUUAUUUGCUU15(2) INFORMATION FOR SEQ ID NO:725:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:725:UAUUUAUUUGCUUAU15(2) INFORMATION FOR SEQ ID NO:726:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:726:AUUUAUUUGCUUAUG15(2) INFORMATION FOR SEQ ID NO:727:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:727:AUUUGCUUAUGAAUG15(2) INFORMATION FOR SEQ ID NO:728:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:728:UUUGCUUAUGAAUGU15(2) INFORMATION FOR SEQ ID NO:729:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:729:UGAAUGUAUUUAUUU15(2) INFORMATION FOR SEQ ID NO:730:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:730:AAUGUAUUUAUUUGG15(2) INFORMATION FOR SEQ ID NO:731:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:731:AUGUAUUUAUUUGGA15(2) INFORMATION FOR SEQ ID NO:732:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:732:UGUAUUUAUUUGGAA15(2) INFORMATION FOR SEQ ID NO:733:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:733:UAUUUAUUUGGAAGG15(2) INFORMATION FOR SEQ ID NO:734:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:734:UAUUUAUUUGGAAGG15(2) INFORMATION FOR SEQ ID NO:735:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:735:AUUUAUUUGGAAGGC15(2) INFORMATION FOR SEQ ID NO:736:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:736:GGGGUGUCCUGGAGG15(2) INFORMATION FOR SEQ ID NO:737:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:737:GCUGUCUUCAGACAG15(2) INFORMATION FOR SEQ ID NO:738:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:738:GCUGUCUUCAGACAG15(2) INFORMATION FOR SEQ ID NO:739:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:739:GACAUGUUUUCUGUG15(2) INFORMATION FOR SEQ ID NO:740:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:740:ACAUGUUUUCUGUGA15(2) INFORMATION FOR SEQ ID NO:741:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:741:CAUGUUUUCUGUGAA15(2) INFORMATION FOR SEQ ID NO:742:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:742:AUGUUUUCUGUGAAA15(2) INFORMATION FOR SEQ ID NO:743:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:743:AUGUUUUCUGUGAAA15(2) INFORMATION FOR SEQ ID NO:744:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:744:GAGCUGUCCCCACCU15(2) INFORMATION FOR SEQ ID NO:745:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:745:CUGGCCUCUCUACCU15(2) INFORMATION FOR SEQ ID NO:746:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:746:GGCCUCUCUACCUUG15(2) INFORMATION FOR SEQ ID NO:747:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:747:ACCUUGUUGCCUCCU15(2) INFORMATION FOR SEQ ID NO:748:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:748:GCCUCCUCUUUUGCU15(2) INFORMATION FOR SEQ ID NO:749:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:749:CUCCUCUUUUGCUUA15(2) INFORMATION FOR SEQ ID NO:750:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:750:UCCUCUUUUGCUUAU15(2) INFORMATION FOR SEQ ID NO:751:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:751:CCUCUUUUGCUUAUG15(2) INFORMATION FOR SEQ ID NO:752:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:752:UUUUGCUUAUGUUUA15(2) INFORMATION FOR SEQ ID NO:753:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:753:UUUGCUUAUGUUUAA15(2) INFORMATION FOR SEQ ID NO:754:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:754:UUUGCUUAUGUUUAA15(2) INFORMATION FOR SEQ ID NO:755:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:755:UUAUGUUUAAAACAA15(2) INFORMATION FOR SEQ ID NO:756:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:756:AAAUAUUUAUCUAAC15(2) INFORMATION FOR SEQ ID NO:757:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:757:ACCCAAUUGUCUUAA15(2) INFORMATION FOR SEQ ID NO:758:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:758:CAAUUGUCUUAAUAA15(2) INFORMATION FOR SEQ ID NO:759:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:759:AUUGUCUUAAUAACG15(2) INFORMATION FOR SEQ ID NO:760:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:760:CGCUGAUUUGGUGAC15(2) INFORMATION FOR SEQ ID NO:761:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:761:CGCUGAUUUGGUGAC15(2) INFORMATION FOR SEQ ID NO:762:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:762:GCUGAUUUGGUGACC15(2) INFORMATION FOR SEQ ID NO:763:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:763:GCUGAUUUGGUGACC15(2) INFORMATION FOR SEQ ID NO:764:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:764:UGAACCUCUGCUCCC15(2) INFORMATION FOR SEQ ID NO:765:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:765:UGAACCUCUGCUCCC15(2) INFORMATION FOR SEQ ID NO:766:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:766:CUCUGCUCCCCACGG15(2) INFORMATION FOR SEQ ID NO:767:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:767:UGACUGUAAUUGCCC15(2) INFORMATION FOR SEQ ID NO:768:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:768:CUGUAAUUGCCCUAC15(2) INFORMATION FOR SEQ ID NO:769:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:769:GAGAAAUAAAGAUCG15(2) INFORMATION FOR SEQ ID NO:770:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:770:UAAAGAUCGCUUAAA15(2) INFORMATION FOR SEQ ID NO:771:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:771:UUAAAAUAAAAAACC15(2) INFORMATION FOR SEQ ID NO:772:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:772:AGGGACUAGCCAGGA15(2) INFORMATION FOR SEQ ID NO:773:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:773:UCCUGGCCUGAUGAGGCCGAAAGGCCGAAAGUCCCU36(2) INFORMATION FOR SEQ ID NO:774:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:774:UGGGAGCCUGAUGAGGCCGAAAGGCCGAAAUUUCCA36(2) INFORMATION FOR SEQ ID NO:775:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:775:GGGACAGCUGAUGAGGCCGAAAGGCCGAAACCUGCC36(2) INFORMATION FOR SEQ ID NO:776:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:776:GGGACAGCUGAUGAGGCCGAAAGGCCGAAACCUGCC36(2) INFORMATION FOR SEQ ID NO:777:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:777:AGGGACACUGAUGAGGCCGAAAGGCCGAAAACCUGC36(2) INFORMATION FOR SEQ ID NO:778:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:778:AGGGACACUGAUGAGGCCGAAAGGCCGAAAACCUGC36(2) INFORMATION FOR SEQ ID NO:779:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:779:UGAAAGGCUGAUGAGGCCGAAAGGCCGAAACAGAAC36(2) INFORMATION FOR SEQ ID NO:780:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:780:UGAGUGACUGAUGAGGCCGAAAGGCCGAAAGGGACA36(2) INFORMATION FOR SEQ ID NO:781:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:781:GUGAGUGCUGAUGAGGCCGAAAGGCCGAAAAGGGAC36(2) INFORMATION FOR SEQ ID NO:782:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:782:GUGAGUGCUGAUGAGGCCGAAAGGCCGAAAAGGGAC36(2) INFORMATION FOR SEQ ID NO:783:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:783:AGUGAGUCUGAUGAGGCCGAAAGGCCGAAAAAGGGA36(2) INFORMATION FOR SEQ ID NO:784:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:784:GGCCAGUCUGAUGAGGCCGAAAGGCCGAAAGUGAAA36(2) INFORMATION FOR SEQ ID NO:785:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:785:GGAGGGACUGAUGAGGCCGAAAGGCCGAAAUGUGGC36(2) INFORMATION FOR SEQ ID NO:786:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:786:CUGGAGGCUGAUGAGGCCGAAAGGCCGAAAGAUGUG36(2) INFORMATION FOR SEQ ID NO:787:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:787:CGUCGCGCUGAUGAGGCCGAAAGGCCGAAAUCAUGC36(2) INFORMATION FOR SEQ ID NO:788:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:788:UUUGGGGCUGAUGAGGCCGAAAGGCCGAAAGUGCCU36(2) INFORMATION FOR SEQ ID NO:789:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:789:AGUUCUGCUGAUGAGGCCGAAAGGCCGAAAAGCCCC36(2) INFORMATION FOR SEQ ID NO:790:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:790:AGUUCUGCUGAUGAGGCCGAAAGGCCGAAAAGCCCC36(2) INFORMATION FOR SEQ ID NO:791:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:791:CCGCCUGCUGAUGAGGCCGAAAGGCCGAAAGUUCUG36(2) INFORMATION FOR SEQ ID NO:792:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:792:CCGCCUGCUGAUGAGGCCGAAAGGCCGAAAGUUCUG36(2) INFORMATION FOR SEQ ID NO:793:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:793:UGAGACACUGAUGAGGCCGAAAGGCCGAAAGGCACC36(2) INFORMATION FOR SEQ ID NO:794:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:794:UGAGACACUGAUGAGGCCGAAAGGCCGAAAGGCACC36(2) INFORMATION FOR SEQ ID NO:795:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:795:AUGAGAACUGAUGAGGCCGAAAGGCCGAAAGGCUGA36(2) INFORMATION FOR SEQ ID NO:796:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:796:AUGAGAACUGAUGAGGCCGAAAGGCCGAAAGGCUGA36(2) INFORMATION FOR SEQ ID NO:797:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:797:GAAUGAGCUGAUGAGGCCGAAAGGCCGAAAGAGGCU36(2) INFORMATION FOR SEQ ID NO:798:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:798:GAAUGAGCUGAUGAGGCCGAAAGGCCGAAAGAGGCU36(2) INFORMATION FOR SEQ ID NO:799:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:799:GGAAUGACUGAUGAGGCCGAAAGGCCGAAAAGAGGC36(2) INFORMATION FOR SEQ ID NO:800:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:800:GGAAUGACUGAUGAGGCCGAAAGGCCGAAAAGAGGC36(2) INFORMATION FOR SEQ ID NO:801:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:801:CAGGAAUCUGAUGAGGCCGAAAGGCCGAAAGAAGAG36(2) INFORMATION FOR SEQ ID NO:802:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:802:AAGCAGGCUGAUGAGGCCGAAAGGCCGAAAUGAGAA36(2) INFORMATION FOR SEQ ID NO:803:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:803:CAAGCAGCUGAUGAGGCCGAAAGGCCGAAAAUGAGA36(2) INFORMATION FOR SEQ ID NO:804:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:804:CUGCCACCUGAUGAGGCCGAAAGGCCGAAAGCAGGA36(2) INFORMATION FOR SEQ ID NO:805:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:805:GACAGAACUGAUGAGGCCGAAAGGCCGAAAGCGUGG36(2) INFORMATION FOR SEQ ID NO:806:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:806:UAGACAGCUGAUGAGGCCGAAAGGCCGAAAGAGCGU36(2) INFORMATION FOR SEQ ID NO:807:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:807:GUAGACACUGAUGAGGCCGAAAGGCCGAAAAGAGCG36(2) INFORMATION FOR SEQ ID NO:808:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:808:UUCAGUACUGAUGAGGCCGAAAGGCCGAAACAGAAG36(2) INFORMATION FOR SEQ ID NO:809:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:809:AGUUCAGCUGAUGAGGCCGAAAGGCCGAAAGACAGA36(2) INFORMATION FOR SEQ ID NO:810:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:810:CACCCCGCUGAUGAGGCCGAAAGGCCGAAAGUUCAG36(2) INFORMATION FOR SEQ ID NO:811:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:811:UCACCCCCUGAUGAGGCCGAAAGGCCGAAAAGUUCA36(2) INFORMATION FOR SEQ ID NO:812:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:812:UCACCCCCUGAUGAGGCCGAAAGGCCGAAAAGUUCA36(2) INFORMATION FOR SEQ ID NO:813:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:813:GGGGACCCUGAUGAGGCCGAAAGGCCGAAAUCACCC36(2) INFORMATION FOR SEQ ID NO:814:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:814:GGGGACCCUGAUGAGGCCGAAAGGCCGAAAUCACCC36(2) INFORMATION FOR SEQ ID NO:815:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:815:AUUUGGGCUGAUGAGGCCGAAAGGCCGAAACUUCUC36(2) INFORMATION FOR SEQ ID NO:816:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:816:CUGAUGACUGAUGAGGCCGAAAGGCCGAAAGGGAGG36(2) INFORMATION FOR SEQ ID NO:817:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:817:AACUGAUCUGAUGAGGCCGAAAGGCCGAAAGAGGGA36(2) INFORMATION FOR SEQ ID NO:818:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:818:AACUGAUCUGAUGAGGCCGAAAGGCCGAAAGAGGGA36(2) INFORMATION FOR SEQ ID NO:819:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:819:UAGAACUCUGAUGAGGCCGAAAGGCCGAAAUGAGAG36(2) INFORMATION FOR SEQ ID NO:820:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:820:UGGGCCACUGAUGAGGCCGAAAGGCCGAAAGAACUG36(2) INFORMATION FOR SEQ ID NO:821:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:821:UGAGUGUCUGAUGAGGCCGAAAGGCCGAAAGGGUCU36(2) INFORMATION FOR SEQ ID NO:822:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:822:AUGAUCUCUGAUGAGGCCGAAAGGCCGAAAGUGUGA36(2) INFORMATION FOR SEQ ID NO:823:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:823:AGAAGAUCUGAUGAGGCCGAAAGGCCGAAAUCUGAG36(2) INFORMATION FOR SEQ ID NO:824:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:824:UUGAGAACUGAUGAGGCCGAAAGGCCGAAAUGAUCU36(2) INFORMATION FOR SEQ ID NO:825:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:825:UUUUGAGCUGAUGAGGCCGAAAGGCCGAAAGAUGAU36(2) INFORMATION FOR SEQ ID NO:826:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:826:UUUUGAGCUGAUGAGGCCGAAAGGCCGAAAGAUGAU36(2) INFORMATION FOR SEQ ID NO:827:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:827:AUUUUGACUGAUGAGGCCGAAAGGCCGAAAAGAUGA36(2) INFORMATION FOR SEQ ID NO:828:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:828:GAAUUUUCUGAUGAGGCCGAAAGGCCGAAAGAAGAU36(2) INFORMATION FOR SEQ ID NO:829:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:829:GAAUUUUCUGAUGAGGCCGAAAGGCCGAAAGAAGAU36(2) INFORMATION FOR SEQ ID NO:830:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:830:GAAUUUUCUGAUGAGGCCGAAAGGCCGAAAGAAGAU36(2) INFORMATION FOR SEQ ID NO:831:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:831:CGUGGGCCUGAUGAGGCCGAAAGGCCGAAACAGGCU36(2) INFORMATION FOR SEQ ID NO:832:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:832:GGUUUGCCUGAUGAGGCCGAAAGGCCGAAACGACGU36(2) INFORMATION FOR SEQ ID NO:833:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:833:UGGCCAGCUGAUGAGGCCGAAAGGCCGAAAGGGCGU36(2) INFORMATION FOR SEQ ID NO:834:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:834:GACAAGGCUGAUGAGGCCGAAAGGCCGAAACAACCC36(2) INFORMATION FOR SEQ ID NO:835:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:835:GACAAGGCUGAUGAGGCCGAAAGGCCGAAACAACCC36(2) INFORMATION FOR SEQ ID NO:836:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:836:AGUAGACCUGAUGAGGCCGAAAGGCCGAAAGGUACA36(2) INFORMATION FOR SEQ ID NO:837:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:837:GGGAGUACUGAUGAGGCCGAAAGGCCGAAACAAGGU36(2) INFORMATION FOR SEQ ID NO:838:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:838:CUGGGAGCUGAUGAGGCCGAAAGGCCGAAAGACAAG36(2) INFORMATION FOR SEQ ID NO:839:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:839:AACCUGGCUGAUGAGGCCGAAAGGCCGAAAGUAGAC36(2) INFORMATION FOR SEQ ID NO:840:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:840:AACCUGGCUGAUGAGGCCGAAAGGCCGAAAGUAGAC36(2) INFORMATION FOR SEQ ID NO:841:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:841:AACCUGGCUGAUGAGGCCGAAAGGCCGAAAGUAGAC36(2) INFORMATION FOR SEQ ID NO:842:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:842:UGAAGAGCUGAUGAGGCCGAAAGGCCGAAACCUGGG36(2) INFORMATION FOR SEQ ID NO:843:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:843:UUGAAGACUGAUGAGGCCGAAAGGCCGAAAACCUGG36(2) INFORMATION FOR SEQ ID NO:844:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:844:UUGAAGACUGAUGAGGCCGAAAGGCCGAAAACCUGG36(2) INFORMATION FOR SEQ ID NO:845:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:845:CCUUGAACUGAUGAGGCCGAAAGGCCGAAAGAACCU36(2) INFORMATION FOR SEQ ID NO:846:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:846:CCUUGAACUGAUGAGGCCGAAAGGCCGAAAGAACCU36(2) INFORMATION FOR SEQ ID NO:847:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:847:UCCCUUGCUGAUGAGGCCGAAAGGCCGAAAGAGAAC36(2) INFORMATION FOR SEQ ID NO:848:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:848:GUCCCUUCUGAUGAGGCCGAAAGGCCGAAAAGAGAA36(2) INFORMATION FOR SEQ ID NO:849:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:849:GAGCACGCUGAUGAGGCCGAAAGGCCGAAAGUCGGG36(2) INFORMATION FOR SEQ ID NO:850:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:850:GGGUGAGCUGAUGAGGCCGAAAGGCCGAAAGCACGU36(2) INFORMATION FOR SEQ ID NO:851:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:851:GGGUGAGCUGAUGAGGCCGAAAGGCCGAAAGCACGU36(2) INFORMATION FOR SEQ ID NO:852:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:852:UGUGGGUCUGAUGAGGCCGAAAGGCCGAAAGGAGCA36(2) INFORMATION FOR SEQ ID NO:853:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:853:AUCGGCUCUGAUGAGGCCGAAAGGCCGAAACGGUGU36(2) INFORMATION FOR SEQ ID NO:854:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:854:AUCGGCUCUGAUGAGGCCGAAAGGCCGAAACGGUGU36(2) INFORMATION FOR SEQ ID NO:855:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:855:GAUAGCACUGAUGAGGCCGAAAGGCCGAAAUCGGCU36(2) INFORMATION FOR SEQ ID NO:856:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:856:UAUGAGACUGAUGAGGCCGAAAGGCCGAAAGCAAAU36(2) INFORMATION FOR SEQ ID NO:857:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:857:GGUAUGACUGAUGAGGCCGAAAGGCCGAAAUAGCAA36(2) INFORMATION FOR SEQ ID NO:858:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:858:CUGGUAUCUGAUGAGGCCGAAAGGCCGAAAGAUAGC36(2) INFORMATION FOR SEQ ID NO:859:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:859:GGAGGUUCUGAUGAGGCCGAAAGGCCGAAACUUUCU36(2) INFORMATION FOR SEQ ID NO:860:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:860:CAGAGAGCUGAUGAGGCCGAAAGGCCGAAAGGUUGA36(2) INFORMATION FOR SEQ ID NO:861:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:861:CAGAGAGCUGAUGAGGCCGAAAGGCCGAAAGGUUGA36(2) INFORMATION FOR SEQ ID NO:862:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:862:CGGCAGACUGAUGAGGCCGAAAGGCCGAAAGGAGGU36(2) INFORMATION FOR SEQ ID NO:863:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:863:GACGGCACUGAUGAGGCCGAAAGGCCGAAAGAGGAG36(2) INFORMATION FOR SEQ ID NO:864:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:864:GGCUCUUCUGAUGAGGCCGAAAGGCCGAAACGGCAG36(2) INFORMATION FOR SEQ ID NO:865:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:865:GGCUCUUCUGAUGAGGCCGAAAGGCCGAAACGGCAG36(2) INFORMATION FOR SEQ ID NO:866:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:866:GGCUCUUCUGAUGAGGCCGAAAGGCCGAAACGGCAG36(2) INFORMATION FOR SEQ ID NO:867:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:867:GGGCUCACUGAUGAGGCCGAAAGGCCGAAACCAGGG36(2) INFORMATION FOR SEQ ID NO:868:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:868:GGGCUCACUGAUGAGGCCGAAAGGCCGAAACCAGGG36(2) INFORMATION FOR SEQ ID NO:869:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:869:CCAGGUACUGAUGAGGCCGAAAGGCCGAAAUGGGCU36(2) INFORMATION FOR SEQ ID NO:870:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:870:UCCCAGGCUGAUGAGGCCGAAAGGCCGAAAUAUGGG36(2) INFORMATION FOR SEQ ID NO:871:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:871:GCUGGAACUGAUGAGGCCGAAAGGCCGAAACUCCUC36(2) INFORMATION FOR SEQ ID NO:872:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:872:GCUGGAACUGAUGAGGCCGAAAGGCCGAAACUCCUC36(2) INFORMATION FOR SEQ ID NO:873:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:873:CAGCUGGCUGAUGAGGCCGAAAGGCCGAAAGACUCC36(2) INFORMATION FOR SEQ ID NO:874:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:874:CCAGCUGCUGAUGAGGCCGAAAGGCCGAAAAGACUC36(2) INFORMATION FOR SEQ ID NO:875:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:875:CAGCGCUCUGAUGAGGCCGAAAGGCCGAAAGUUGGU36(2) INFORMATION FOR SEQ ID NO:876:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:876:GCAGAUUCUGAUGAGGCCGAAAGGCCGAAACCUCAG36(2) INFORMATION FOR SEQ ID NO:877:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:877:UUGGGCACUGAUGAGGCCGAAAGGCCGAAAUUGACC36(2) INFORMATION FOR SEQ ID NO:878:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:878:GUCUAAGCUGAUGAGGCCGAAAGGCCGAAACUUGGG36(2) INFORMATION FOR SEQ ID NO:879:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:879:CAAAGUCCUGAUGAGGCCGAAAGGCCGAAAAGUACU36(2) INFORMATION FOR SEQ ID NO:880:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:880:CUCCGCACUGAUGAGGCCGAAAGGCCGAAAGUCUAA36(2) INFORMATION FOR SEQ ID NO:881:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:881:ACUCCGCCUGAUGAGGCCGAAAGGCCGAAAAGUCUA36(2) INFORMATION FOR SEQ ID NO:882:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:882:CUGCCCGCUGAUGAGGCCGAAAGGCCGAAACUCCGC36(2) INFORMATION FOR SEQ ID NO:883:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:883:CAAAGUACUGAUGAGGCCGAAAGGCCGAAACCUGCC36(2) INFORMATION FOR SEQ ID NO:884:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:884:UCCAAAGCUGAUGAGGCCGAAAGGCCGAAAGACCUG36(2) INFORMATION FOR SEQ ID NO:885:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:885:UCCAAAGCUGAUGAGGCCGAAAGGCCGAAAGACCUG36(2) INFORMATION FOR SEQ ID NO:886:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:886:UCCAAAGCUGAUGAGGCCGAAAGGCCGAAAGACCUG36(2) INFORMATION FOR SEQ ID NO:887:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:887:GACUCCACUGAUGAGGCCGAAAGGCCGAAAGUAGAC36(2) INFORMATION FOR SEQ ID NO:888:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:888:UGACUCCCUGAUGAGGCCGAAAGGCCGAAAAGUAGA36(2) INFORMATION FOR SEQ ID NO:889:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:889:GAGCAAUCUGAUGAGGCCGAAAGGCCGAAACUCCAA36(2) INFORMATION FOR SEQ ID NO:890:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:890:ACAGAGCCUGAUGAGGCCGAAAGGCCGAAAUGACUC36(2) INFORMATION FOR SEQ ID NO:891:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:891:GGGUAGACUGAUGAGGCCGAAAGGCCGAAAAUGGAU36(2) INFORMATION FOR SEQ ID NO:892:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:892:GGCUGGGCUGAUGAGGCCGAAAGGCCGAAAGAGAAU36(2) INFORMATION FOR SEQ ID NO:893:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:893:GGGGUCACUGAUGAGGCCGAAAGGCCGAAAGUGGGG36(2) INFORMATION FOR SEQ ID NO:894:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:894:GGGGUCACUGAUGAGGCCGAAAGGCCGAAAGUGGGG36(2) INFORMATION FOR SEQ ID NO:895:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:895:GGGGUCACUGAUGAGGCCGAAAGGCCGAAAGUGGGG36(2) INFORMATION FOR SEQ ID NO:896:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:896:CAGAGUACUGAUGAGGCCGAAAGGCCGAAAGGGGUC36(2) INFORMATION FOR SEQ ID NO:897:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:897:UCAGAGUCUGAUGAGGCCGAAAGGCCGAAAAGGGGU36(2) INFORMATION FOR SEQ ID NO:898:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:898:GGGGUCACUGAUGAGGCCGAAAGGCCGAAAGUAAAG36(2) INFORMATION FOR SEQ ID NO:899:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:899:GACAAUACUGAUGAGGCCGAAAGGCCGAAAGGGGUC36(2) INFORMATION FOR SEQ ID NO:900:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:900:GACAAUACUGAUGAGGCCGAAAGGCCGAAAGGGGUC36(2) INFORMATION FOR SEQ ID NO:901:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:901:AGUAGACCUGAUGAGGCCGAAAGGCCGAAAUAAAGG36(2) INFORMATION FOR SEQ ID NO:902:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:902:CUCUGAGCUGAUGAGGCCGAAAGGCCGAAAGUAGAC36(2) INFORMATION FOR SEQ ID NO:903:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:903:GGGCUCUCUGAUGAGGCCGAAAGGCCGAAAGGAGUA36(2) INFORMATION FOR SEQ ID NO:904:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:904:CCUUUCUCUGAUGAGGCCGAAAGGCCGAAAGUUAGA36(2) INFORMATION FOR SEQ ID NO:905:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:905:CCUUUCUCUGAUGAGGCCGAAAGGCCGAAAGUUAGA36(2) INFORMATION FOR SEQ ID NO:906:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:906:CCCUUUCCUGAUGAGGCCGAAAGGCCGAAAAGUUAG36(2) INFORMATION FOR SEQ ID NO:907:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:907:GAGCCAUCUGAUGAGGCCGAAAGGCCGAAAUCCCCU36(2) INFORMATION FOR SEQ ID NO:908:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:908:GAGCCAUCUGAUGAGGCCGAAAGGCCGAAAUCCCCU36(2) INFORMATION FOR SEQ ID NO:909:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:909:UGAGCCACUGAUGAGGCCGAAAGGCCGAAAAUCCCC36(2) INFORMATION FOR SEQ ID NO:910:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:910:AGAGUUGCUGAUGAGGCCGAAAGGCCGAAACUCUGA36(2) INFORMATION FOR SEQ ID NO:911:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:911:AAGCUCUCUGAUGAGGCCGAAAGGCCGAAAGCACAG36(2) INFORMATION FOR SEQ ID NO:912:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:912:UUGUUGACUGAUGAGGCCGAAAGGCCGAAAGCUCUG36(2) INFORMATION FOR SEQ ID NO:913:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:913:GUUGUUGCUGAUGAGGCCGAAAGGCCGAAAAGCUCU36(2) INFORMATION FOR SEQ ID NO:914:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:914:AGUUGUUCUGAUGAGGCCGAAAGGCCGAAAAAGCUC36(2) INFORMATION FOR SEQ ID NO:915:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:915:UGCAUGACUGAUGAGGCCGAAAGGCCGAAAGGCCCA36(2) INFORMATION FOR SEQ ID NO:916:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:916:CCCAUUUCUGAUGAGGCCGAAAGGCCGAAAGUCCUU36(2) INFORMATION FOR SEQ ID NO:917:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:917:AUUCGGACUGAUGAGGCCGAAAGGCCGAAAGCCCAU36(2) INFORMATION FOR SEQ ID NO:918:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:918:AAUUCGGCUGAUGAGGCCGAAAGGCCGAAAAGCCCA36(2) INFORMATION FOR SEQ ID NO:919:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:919:GAAUUCGCUGAUGAGGCCGAAAGGCCGAAAAAGCCC36(2) INFORMATION FOR SEQ ID NO:920:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:920:CUCCAGUCUGAUGAGGCCGAAAGGCCGAAAAUUCGG36(2) INFORMATION FOR SEQ ID NO:921:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:921:AGGAAUGCUGAUGAGGCCGAAAGGCCGAAACAUUCG36(2) INFORMATION FOR SEQ ID NO:922:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:922:GCAACCUCUGAUGAGGCCGAAAGGCCGAAACCACUC36(2) INFORMATION FOR SEQ ID NO:923:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:923:UCAUUCUCUGAUGAGGCCGAAAGGCCGAAAGACAGA36(2) INFORMATION FOR SEQ ID NO:924:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:924:AAGGCCUCUGAUGAGGCCGAAAGGCCGAAAGAUCUU36(2) INFORMATION FOR SEQ ID NO:925:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:925:AGGUAGGCUGAUGAGGCCGAAAGGCCGAAAGGCCUG36(2) INFORMATION FOR SEQ ID NO:926:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:926:AAGGUAGCUGAUGAGGCCGAAAGGCCGAAAAGGCCU36(2) INFORMATION FOR SEQ ID NO:927:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:927:CUGAAGGCUGAUGAGGCCGAAAGGCCGAAAGGAAGG36(2) INFORMATION FOR SEQ ID NO:928:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:928:AGGUCUGCUGAUGAGGCCGAAAGGCCGAAAGGUAGG36(2) INFORMATION FOR SEQ ID NO:929:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:929:AGGUCUGCUGAUGAGGCCGAAAGGCCGAAAGGUAGG36(2) INFORMATION FOR SEQ ID NO:930:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:930:AGGUCUGCUGAUGAGGCCGAAAGGCCGAAAGGUAGG36(2) INFORMATION FOR SEQ ID NO:931:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:931:AGGUCUGCUGAUGAGGCCGAAAGGCCGAAAGGUAGG36(2) INFORMATION FOR SEQ ID NO:932:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:932:AAGGUCUCUGAUGAGGCCGAAAGGCCGAAAAGGUAG36(2) INFORMATION FOR SEQ ID NO:933:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:933:AAGGUCUCUGAUGAGGCCGAAAGGCCGAAAAGGUAG36(2) INFORMATION FOR SEQ ID NO:934:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:934:GUCUGGACUGAUGAGGCCGAAAGGCCGAAAGGUCUG36(2) INFORMATION FOR SEQ ID NO:935:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:935:GUCUGGACUGAUGAGGCCGAAAGGCCGAAAGGUCUG36(2) INFORMATION FOR SEQ ID NO:936:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:936:AGUCUGGCUGAUGAGGCCGAAAGGCCGAAAAGGUCU36(2) INFORMATION FOR SEQ ID NO:937:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:937:AGUCUGGCUGAUGAGGCCGAAAGGCCGAAAAGGUCU36(2) INFORMATION FOR SEQ ID NO:938:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:938:GAGUCUGCUGAUGAGGCCGAAAGGCCGAAAAAGGUC36(2) INFORMATION FOR SEQ ID NO:939:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:939:CCUCAGGCUGAUGAGGCCGAAAGGCCGAAAAGAGUC36(2) INFORMATION FOR SEQ ID NO:940:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:940:CUGUGAGCUGAUGAGGCCGAAAGGCCGAAAAGGCUG36(2) INFORMATION FOR SEQ ID NO:941:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:941:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAGGGGGG36(2) INFORMATION FOR SEQ ID NO:942:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:942:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAGGGGGG36(2) INFORMATION FOR SEQ ID NO:943:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:943:AUAUAAACUGAUGAGGCCGAAAGGCCGAAAGAGGGG36(2) INFORMATION FOR SEQ ID NO:944:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:944:AAAUAUACUGAUGAGGCCGAAAGGCCGAAAUAGAGG36(2) INFORMATION FOR SEQ ID NO:945:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:945:AAAUAUACUGAUGAGGCCGAAAGGCCGAAAUAGAGG36(2) INFORMATION FOR SEQ ID NO:946:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:946:CAAAUAUCUGAUGAGGCCGAAAGGCCGAAAAUAGAG36(2) INFORMATION FOR SEQ ID NO:947:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:947:GCAAAUACUGAUGAGGCCGAAAGGCCGAAAAAUAGA36(2) INFORMATION FOR SEQ ID NO:948:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:948:AAGUGCACUGAUGAGGCCGAAAGGCCGAAAUAUAAA36(2) INFORMATION FOR SEQ ID NO:949:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:949:AAGUGCACUGAUGAGGCCGAAAGGCCGAAAUAUAAA36(2) INFORMATION FOR SEQ ID NO:950:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:950:UAAGUGCCUGAUGAGGCCGAAAGGCCGAAAAUAUAA36(2) INFORMATION FOR SEQ ID NO:951:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:951:AAAUAAUCUGAUGAGGCCGAAAGGCCGAAAGUGCAA36(2) INFORMATION FOR SEQ ID NO:952:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:952:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUAAGUG36(2) INFORMATION FOR SEQ ID NO:953:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:953:UAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUAAGU36(2) INFORMATION FOR SEQ ID NO:954:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:954:AAUAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUAA36(2) INFORMATION FOR SEQ ID NO:955:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:955:AAAUAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUA36(2) INFORMATION FOR SEQ ID NO:956:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:956:AAAUAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUA36(2) INFORMATION FOR SEQ ID NO:957:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:957:UAAAUAACUGAUGAGGCCGAAAGGCCGAAAAAUAAU36(2) INFORMATION FOR SEQ ID NO:958:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:958:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:959:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:959:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:960:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:960:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:961:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:961:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:962:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:962:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:963:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:963:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:964:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:964:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUAA36(2) INFORMATION FOR SEQ ID NO:965:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:965:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUAA36(2) INFORMATION FOR SEQ ID NO:966:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:966:AUAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAUAA36(2) INFORMATION FOR SEQ ID NO:967:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:967:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUA36(2) INFORMATION FOR SEQ ID NO:968:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:968:AAUAAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAUA36(2) INFORMATION FOR SEQ ID NO:969:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:969:UAAUAAACUGAUGAGGCCGAAAGGCCGAAAAAUAAU36(2) INFORMATION FOR SEQ ID NO:970:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:970:AAUAAUACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:971:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:971:AAAUAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:972:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:972:UAAAUAACUGAUGAGGCCGAAAGGCCGAAAAAUAAA36(2) INFORMATION FOR SEQ ID NO:973:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:973:AAAUAAACUGAUGAGGCCGAAAGGCCGAAAAAUAAU36(2) INFORMATION FOR SEQ ID NO:974:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:974:GCAAAUACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:975:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:975:AGCAAAUCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:976:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:976:AAGCAAACUGAUGAGGCCGAAAGGCCGAAAAAUAAA36(2) INFORMATION FOR SEQ ID NO:977:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:977:AUAAGCACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:978:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:978:CAUAAGCCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:979:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:979:CAUUCAUCUGAUGAGGCCGAAAGGCCGAAAGCAAAU36(2) INFORMATION FOR SEQ ID NO:980:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:980:ACAUUCACUGAUGAGGCCGAAAGGCCGAAAAGCAAA36(2) INFORMATION FOR SEQ ID NO:981:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:981:AAAUAAACUGAUGAGGCCGAAAGGCCGAAACAUUCA36(2) INFORMATION FOR SEQ ID NO:982:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:982:CCAAAUACUGAUGAGGCCGAAAGGCCGAAAUACAUU36(2) INFORMATION FOR SEQ ID NO:983:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:983:UCCAAAUCUGAUGAGGCCGAAAGGCCGAAAAUACAU36(2) INFORMATION FOR SEQ ID NO:984:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:984:UUCCAAACUGAUGAGGCCGAAAGGCCGAAAAAUACA36(2) INFORMATION FOR SEQ ID NO:985:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:985:CCUUCCACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:986:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:986:CCUUCCACUGAUGAGGCCGAAAGGCCGAAAUAAAUA36(2) INFORMATION FOR SEQ ID NO:987:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:987:GCCUUCCCUGAUGAGGCCGAAAGGCCGAAAAUAAAU36(2) INFORMATION FOR SEQ ID NO:988:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:988:CCUCCAGCUGAUGAGGCCGAAAGGCCGAAACACCCC36(2) INFORMATION FOR SEQ ID NO:989:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:989:CUGUCUGCUGAUGAGGCCGAAAGGCCGAAAGACAGC36(2) INFORMATION FOR SEQ ID NO:990:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:990:CUGUCUGCUGAUGAGGCCGAAAGGCCGAAAGACAGC36(2) INFORMATION FOR SEQ ID NO:991:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:991:CACAGAACUGAUGAGGCCGAAAGGCCGAAACAUGUC36(2) INFORMATION FOR SEQ ID NO:992:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:992:UCACAGACUGAUGAGGCCGAAAGGCCGAAAACAUGU36(2) INFORMATION FOR SEQ ID NO:993:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:993:UUCACAGCUGAUGAGGCCGAAAGGCCGAAAAACAUG36(2) INFORMATION FOR SEQ ID NO:994:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:994:UUUCACACUGAUGAGGCCGAAAGGCCGAAAAAACAU36(2) INFORMATION FOR SEQ ID NO:995:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:995:UUUCACACUGAUGAGGCCGAAAGGCCGAAAAAACAU36(2) INFORMATION FOR SEQ ID NO:996:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:996:AGGUGGGCUGAUGAGGCCGAAAGGCCGAAACAGCUC36(2) INFORMATION FOR SEQ ID NO:997:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:997:AGGUAGACUGAUGAGGCCGAAAGGCCGAAAGGCCAG36(2) INFORMATION FOR SEQ ID NO:998:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:998:CAAGGUACUGAUGAGGCCGAAAGGCCGAAAGAGGCC36(2) INFORMATION FOR SEQ ID NO:999:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:999:AACAAGGCUGAUGAGGCCGAAAGGCCGAAAGAGAGG36(2) INFORMATION FOR SEQ ID NO:1000:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1000:AGGAGGCCUGAUGAGGCCGAAAGGCCGAAACAAGGU36(2) INFORMATION FOR SEQ ID NO:1001:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1001:AGCAAAACUGAUGAGGCCGAAAGGCCGAAAGGAGGC36(2) INFORMATION FOR SEQ ID NO:1002:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1002:UAAGCAACUGAUGAGGCCGAAAGGCCGAAAGAGGAG36(2) INFORMATION FOR SEQ ID NO:1003:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1003:AUAAGCACUGAUGAGGCCGAAAGGCCGAAAAGAGGA36(2) INFORMATION FOR SEQ ID NO:1004:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1004:CAUAAGCCUGAUGAGGCCGAAAGGCCGAAAAAGAGG36(2) INFORMATION FOR SEQ ID NO:1005:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1005:UAAACAUCUGAUGAGGCCGAAAGGCCGAAAGCAAAA36(2) INFORMATION FOR SEQ ID NO:1006:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1006:UUAAACACUGAUGAGGCCGAAAGGCCGAAAAGCAAA36(2) INFORMATION FOR SEQ ID NO:1007:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1007:UUAAACACUGAUGAGGCCGAAAGGCCGAAAAGCAAA36(2) INFORMATION FOR SEQ ID NO:1008:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1008:UUGUUUUCUGAUGAGGCCGAAAGGCCGAAAACAUAA36(2) INFORMATION FOR SEQ ID NO:1009:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1009:GUUAGAUCUGAUGAGGCCGAAAGGCCGAAAAUAUUU36(2) INFORMATION FOR SEQ ID NO:1010:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1010:UUAAGACCUGAUGAGGCCGAAAGGCCGAAAUUGGGU36(2) INFORMATION FOR SEQ ID NO:1011:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1011:UUAUUAACUGAUGAGGCCGAAAGGCCGAAACAAUUG36(2) INFORMATION FOR SEQ ID NO:1012:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1012:CGUUAUUCUGAUGAGGCCGAAAGGCCGAAAGACAAU36(2) INFORMATION FOR SEQ ID NO:1013:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1013:GUCACCACUGAUGAGGCCGAAAGGCCGAAAUCAGCG36(2) INFORMATION FOR SEQ ID NO:1014:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1014:GUCACCACUGAUGAGGCCGAAAGGCCGAAAUCAGCG36(2) INFORMATION FOR SEQ ID NO:1015:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1015:GGUCACCCUGAUGAGGCCGAAAGGCCGAAAAUCAGC36(2) INFORMATION FOR SEQ ID NO:1016:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1016:GGUCACCCUGAUGAGGCCGAAAGGCCGAAAAUCAGC36(2) INFORMATION FOR SEQ ID NO:1017:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1017:GGGAGCACUGAUGAGGCCGAAAGGCCGAAAGGUUCA36(2) INFORMATION FOR SEQ ID NO:1018:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1018:GGGAGCACUGAUGAGGCCGAAAGGCCGAAAGGUUCA36(2) INFORMATION FOR SEQ ID NO:1019:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1019:CCGUGGGCUGAUGAGGCCGAAAGGCCGAAAGCAGAG36(2) INFORMATION FOR SEQ ID NO:1020:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1020:GGGCAAUCUGAUGAGGCCGAAAGGCCGAAACAGUCA36(2) INFORMATION FOR SEQ ID NO:1021:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1021:GUAGGGCCUGAUGAGGCCGAAAGGCCGAAAUUACAG36(2) INFORMATION FOR SEQ ID NO:1022:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1022:CGAUCUUCUGAUGAGGCCGAAAGGCCGAAAUUUCUC36(2) INFORMATION FOR SEQ ID NO:1023:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1023:UUUAAGCCUGAUGAGGCCGAAAGGCCGAAAUCUUUA36(2) INFORMATION FOR SEQ ID NO:1024:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1024:GGUUUUUCUGAUGAGGCCGAAAGGCCGAAAUUUUAA36(2) INFORMATION FOR SEQ ID NO:1025:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1025:AGCCGUGGAGAAGUAUGUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1026:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1026:GAGGGUGGAGAAGUGGGUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1027:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1027:GGAGAAGAAGAAGAGGAAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1028:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1028:CUGCCACGAGAAGGAAGGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1029:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1029:GUGCAGCAAGAAGAAGAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1030:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1030:CAAAGUGCAGAAGGCAGAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1031:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1031:CCUCUGGGAGAAGAUCACACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1032:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1032:GGCCAGAGAGAAGAUUAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1033:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1033:AGAAGAUGAGAAGACUGCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1034:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1034:GCCACUGGAGAAGCCCCUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1035:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1035:AUUGGCCCAGAAGUUCAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1036:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1036:GCACCACCAGAAGGUUAUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1037:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1037:GGUGGAGGAGAAGCCUUGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1038:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1038:GGCGAUGCAGAAGAUGGUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1039:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1039:UGGUAGGAAGAAGCGAUGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1040:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1040:UGACCUUGAGAAGGUAGGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1041:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1041:CCUUCUCCAGAAGGAAGAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1042:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1042:AGCGCUGAAGAAGUCACCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1043:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1043:GAUAGUCGAGAAGAUUGAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1044:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1044:UCGAGAUAAGAAGGCCGAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1045:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1045:GGGAUUGGAGAAGGGGAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1046:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1046:GGGAUCAAAGAAGUAGGCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1047:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1047:CUGGAAACAGAAGGAGAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1048:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1048:UCAAGGAAAGAAGGAAACACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1049:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1049:AUGGGGAGAGAAGGGCUCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1050:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1050:AUAGAGGGAGAAGGCUCCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1051:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1051:AUACAUUCAGAAGUAAAUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1052:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1052:UGAGCCAAAGAAGCUCCUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1053:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1053:UACAUGGGAGAAGCCUAUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1054:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1054:ACAACUUAAGAAGAUAAUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1055:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1055:GUCACCAAAGAAGCAUUGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1056:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1056:CCCUGGGGAGAAGAGGCCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1057:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1057:GAAUAGUAAGAAGAUUACACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1058:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1058:ACAUACUGACCCACGGCU18(2) INFORMATION FOR SEQ ID NO:1059:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1059:ACCCACGGCUCCACCCUC18(2) INFORMATION FOR SEQ ID NO:1060:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1060:UUCCUCAGCCUCUUCUCC18(2) INFORMATION FOR SEQ ID NO:1061:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1061:CCUUCCUGAUCGUGGCAG18(2) INFORMATION FOR SEQ ID NO:1062:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1062:CUCUUCUGCCUGCUGCAC18(2) INFORMATION FOR SEQ ID NO:1063:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1063:UCUGCCUGCUGCACUUUG18(2) INFORMATION FOR SEQ ID NO:1064:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1064:GUGAUCGGCCCCCAGAGG18(2) INFORMATION FOR SEQ ID NO:1065:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1065:CUAAUCAGCCCUCUGGCC18(2) INFORMATION FOR SEQ ID NO:1066:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1066:GCAGUCAGAUCAUCUUCU18(2) INFORMATION FOR SEQ ID NO:1067:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1067:AGGGGCAGCUCCAGUGGC18(2) INFORMATION FOR SEQ ID NO:1068:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1068:CUGAACCGCCGGGCCAAU18(2) INFORMATION FOR SEQ ID NO:1069:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1069:AUAACCAGCUGGUGGUGC18(2) INFORMATION FOR SEQ ID NO:1070:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1070:CAAGGCUGCCCCUCCACC18(2) INFORMATION FOR SEQ ID NO:1071:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1071:ACCAUCAGCCGCAUCGCC18(2) INFORMATION FOR SEQ ID NO:1072:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1072:CAUCGCCGUCUCCUACCA18(2) INFORMATION FOR SEQ ID NO:1073:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1073:CCUACCAGACCAAGGUCA18(2) INFORMATION FOR SEQ ID NO:1074:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1074:UCUUCCAGCUGGAGAAGG18(2) INFORMATION FOR SEQ ID NO:1075:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1075:GGUGACCGACUCAGCGCU18(2) INFORMATION FOR SEQ ID NO:1076:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1076:UCAAUCGGCCCGACUAUC18(2) INFORMATION FOR SEQ ID NO:1077:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1077:UCGGCCCGACUAUCUCGA18(2) INFORMATION FOR SEQ ID NO:1078:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1078:CUCCCCUGCCCCAAUCCC18(2) INFORMATION FOR SEQ ID NO:1079:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1079:GCCUACAGCUUUGAUCCC18(2) INFORMATION FOR SEQ ID NO:1080:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1080:CUCUCCAGAUGUUUCCAG18(2) INFORMATION FOR SEQ ID NO:1081:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1081:GUUUCCAGACUUCCUUGA18(2) INFORMATION FOR SEQ ID NO:1082:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1082:GAGCCCAGCCCUCCCCAU18(2) INFORMATION FOR SEQ ID NO:1083:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1083:GGAGCCAGCUCCCUCUAU18(2) INFORMATION FOR SEQ ID NO:1084:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1084:AUUUACAGAUGAAUGUAU18(2) INFORMATION FOR SEQ ID NO:1085:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1085:AGGAGCUGCCUUGGCUCA18(2) INFORMATION FOR SEQ ID NO:1086:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1086:AUAGGCUGUUCCCAUGUA18(2) INFORMATION FOR SEQ ID NO:1087:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1087:AUUAUCUGAUUAAGUUGU18(2) INFORMATION FOR SEQ ID NO:1088:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1088:CAAUGCUGAUUUGGUGAC18(2) INFORMATION FOR SEQ ID NO:1089:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1089:GGCCUCUGCUCCCCAGGG18(2) INFORMATION FOR SEQ ID NO:1090:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1090:GUAAUCGGCCUACUAUUC18(2) INFORMATION FOR SEQ ID NO:1091:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1091:GUGAAAGGAGAAGAACCUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1092:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1092:UGAGAAGAAGAAGAGACAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1093:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1093:CUGCCACAAGAAGGAAUGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1094:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1094:GUUCAGUAAGAAGAAGAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1095:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1095:CCUUUGGGAGAAGAUCACACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1096:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1096:GGCCAUAGAGAAGAUGAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1097:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1097:GUGUGAGGAGAAGGGCCAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1098:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1098:AGAAGAUGAGAAGAGUGUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1099:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1099:GCCACUCCAGAAGCUCCUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1100:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1100:AACCCAUCAGAAGGCACCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1101:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1101:UACAACCCAGAAGCUGGCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1102:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1102:GUAGUCGGAGAAGCCUUGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1103:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1103:AGCACGUAAGAAGGGCAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1104:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1104:AGCAAAUCAGAAGACGGUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1105:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1105:GAUAGCAAAGAAGCUGACACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1106:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1106:CUCUUGACAGAAGAGAGGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1107:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1107:GUCCUUGGAGAAGGGGCUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1108:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1108:CCUUCUCCAGAAGGAAGAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1109:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1109:AGUACUUGAGAAGAUUGAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1110:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1110:AGAGUGGGAGAAGGGUAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1111:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1111:GUAAAGGGAGAAGAGUGGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1112:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1112:AUAAAGGGAGAAGAGUAAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1113:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1113:AGGACACAAGAAGGGGGCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1114:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1114:CAUUCUGAAGAAGAGGCAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1115:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1115:CUGGAAAGAGAAGAAGGUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1116:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1116:AGGGAAGAAGAAGGAAAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1117:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1117:GUGAGGAAAGAAGUGCAUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1118:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1118:UAGAGGGGAGAAGGCUCUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1119:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1119:UGUCUGAAAGAAGCUUCCACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1120:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1120:CAGGUGGGAGAAGCUCAGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1121:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1121:GUCACCAAAGAAGCGUUAACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1122:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1122:GAUGUAGCAGAAGCCUGGACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1123:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 54 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1123:CCGUGGGGAGAAGAGGUUACCAGAGAAACACACGUUGUGGUACAUUACCUGGUA54(2) INFORMATION FOR SEQ ID NO:1124:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1124:AGGUUCUGUCCCUUUCAC18(2) INFORMATION FOR SEQ ID NO:1125:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1125:UGUCUCAGCCUCUUCUCA18(2) INFORMATION FOR SEQ ID NO:1126:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1126:CAUUCCUGCUUGUGGCAG18(2) INFORMATION FOR SEQ ID NO:1127:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1127:CUCUUCUGUCUACUGAAC18(2) INFORMATION FOR SEQ ID NO:1128:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1128:GUGAUCGGUCCCCAAAGG18(2) INFORMATION FOR SEQ ID NO:1129:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1129:CUCAUCAGUUCUAUGGCC18(2) INFORMATION FOR SEQ ID NO:1130:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1130:UGGCCCAGACCCUCACAC18(2) INFORMATION FOR SEQ ID NO:1131:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1131:ACACUCAGAUCAUCUUCU18(2) INFORMATION FOR SEQ ID NO:1132:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1132:AGGAGCAGCUGGAGUGGC18(2) INFORMATION FOR SEQ ID NO:1133:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1133:GGUGCCAGCCGAUGGGUU18(2) INFORMATION FOR SEQ ID NO:1134:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1134:GCCAGCCGAUGGGUUGUA18(2) INFORMATION FOR SEQ ID NO:1135:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1135:CAAGGCUGCCCCGACUAC18(2) INFORMATION FOR SEQ ID NO:1136:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1136:CUGCCCCGACUACGUGCU18(2) INFORMATION FOR SEQ ID NO:1137:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1137:ACCGUCAGCCGAUUUGCU18(2) INFORMATION FOR SEQ ID NO:1138:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1138:GUCAGCCGAUUUGCUAUC18(2) INFORMATION FOR SEQ ID NO:1139:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1139:CCUCUCUGCCGUCAAGAG18(2) INFORMATION FOR SEQ ID NO:1140:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1140:AGCCCCUGCCCCAAGGAC18(2) INFORMATION FOR SEQ ID NO:1141:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1141:UCUUCCAGCUGGAGAAGG18(2) INFORMATION FOR SEQ ID NO:1142:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1142:UCAAUCUGCCCAAGUACU18(2) INFORMATION FOR SEQ ID NO:1143:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1143:CUACCCAGCCCCCACUCU18(2) INFORMATION FOR SEQ ID NO:1144:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1144:CCACUCUGACCCCUUUAC18(2) INFORMATION FOR SEQ ID NO:1145:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1145:UUACUCUGACCCCUUUAU18(2) INFORMATION FOR SEQ ID NO:1146:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1146:GCCCCCAGUCUGUGUCCU18(2) INFORMATION FOR SEQ ID NO:1147:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1147:UGCCUCUGUCUCAGAAUG18(2) INFORMATION FOR SEQ ID NO:1148:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1148:ACCUUCAGACCUUUCCAG18(2) INFORMATION FOR SEQ ID NO:1149:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1149:CUUUCCAGACUCUUCCCU18(2) INFORMATION FOR SEQ ID NO:1150:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1150:AUGCACAGCCUUCCUCAC18(2) INFORMATION FOR SEQ ID NO:1151:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1151:AGAGCCAGCCCCCCUCUA18(2) INFORMATION FOR SEQ ID NO:1152:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1152:GGAAGCUGUCUUCAGACA18(2) INFORMATION FOR SEQ ID NO:1153:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1153:CUGAGCUGUCCCCACCUG18(2) INFORMATION FOR SEQ ID NO:1154:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1154:UAACGCUGAUUUGGUGAC18(2) INFORMATION FOR SEQ ID NO:1155:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1155:CCAGGCUGUCGCUACAUC18(2) INFORMATION FOR SEQ ID NO:1156:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 18 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1156:AACCUCUGCUCCCCACGG18(2) INFORMATION FOR SEQ ID NO:1157:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 12 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1157:GGCCGAAAGGCC12__________________________________________________________________________

Claims

1. An enzymatic RNA molecule which cleaves TNF-.alpha. mRNA wherein said enzymatic RNA molecule comprises sequences complementary to any of sequences defined as Seq ID Nos. 15-267, 522-772, 1058-1090, or 1124-1156.

2. An enzymatic RNA molecule which cleaves TNF-.alpha. mRNA the binding arms of which contain sequences complementary to the sequences defined as Seq. ID Nos. 15-267 or 522-772, wherein said enzymatic RNA molecule is in a hammerhead motif.

3. An enzymatic RNA molecule which cleaves TNF-.alpha. mRNA, the binding arms of which contain sequences complementary to the sequences defined as Seq. ID Nos. 1058-1090 or 1124-1156, wherein said enzymatic RNA molecule is in a hairpin motif.

4. The enzymatic RNA molecule of claim 2 or 3, wherein said ribozyme comprises between 12 and 100 bases complementary to said mRNA.

5. The enzymatic RNA molecule of claim 4, wherein said ribozyme comprises between 14 and 24 bases complementary to said mRNA.

6. The enzymatic RNA molecule of claim 2, wherein said enzymatic RNA molecule comprises any sequence selected from the group consisting of Sequence ID Nos. 268-521, and 773-1024.

7. A mammalian cell in vitro including an enzymatic RNA molecule of claims 2 or 3.

8. The cell of claim 7, wherein said cell is a human cell.

9. An expression vector including nucleic acid encoding an enzymatic RNA molecule or multiple enzymatic molecules of claims 1, 2, or 3 in a manner which allows expression of that enzymatic RNA molecule(s) within a mammalian cell in vitro.

10. A mammalian cell including an expression vector of claim 9.

11. The cell of claim 10, wherein said cell is a human cell.

12. The enzymatic RNA molecule of claim 1, wherein said enzymatic RNA molecule comprises at least one sugar modification.

13. The enzymatic RNA molecule of claim 3, wherein said enzymatic RNA molecule comprises any sequence selected from the group consisting of Sequence ID Nos. 1025-1057, and 1091-1123.